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Abstract 
Background 
Chronic pain can be disabling. It is a major cause of morbidity and increased usage of 
healthcare services. The effects of a physiotherapy led-programme using Interactive 
Behavioural modification therapy (IBMT) with a 3-month follow-up for patients with 
musculoskeletal pain is unknown. 
Aims 
To examine pre to post and medium term (3 months) effects of a physiotherapy-led 
programme, the Functional Rehabilitation programme (FRP), for patients with chronic 
musculoskeletal pain, in terms of fear of movement, disability, self-efficacy, depression 
and physical function. 
Design 
The study included two phases. Phase one was a preliminary retrospective study using 
data from 278 patients. Phase two used a prospective pre-experimental medium-term 
follow-up study design with 53 participants. The FRP programme was delivered over a 5-
week period, each group had between 8 and 10 participants. Both phases were 
undertaken at Fairfield General Hospital outpatient physiotherapy department, Pennine 
Acute NHS Hospitals Trust. 
Outcome measures 
Primary outcome was Tampa scale of Kinesiophobia (TSK), secondary measures included; 
Roland Morris Disability Questionnaire (RMDQ), Pain disability questionnaire (PDQ), pain 
self-efficacy questionnaire (PSEQ) and the Hospital anxiety and depression scale (HADS). 
In addition physical function tests included speed and distance of walking and step up 
repetition. 
Results 
Improvements were observed in all outcome measures. Minimal clinical important 
difference (MCID) was reached in those measures with recognised levels (TSK and RMDQ) 
and were sustained at 3-month follow-up. In addition, depression scores reduced to 
iv 
 
within normal level (0-7). There was no statistically significant difference in outcomes 
between condition types. 
Conclusions 
A physiotherapy-led group intervention using a psychologically informed approach 
produced positive changes in reducing fear relating to movement, pain-related disability, 
depression and anxiety in a mixed chronic pain aetiology group. There was no statistically 
significant difference in outcomes between low back pain and multi-site pain. Future 
studies should look at a longer term follow-up with an RCT design of the impact of 
physiotherapist’s management. 
In relation to the growing problem of managing increasing numbers of people with 
chronic pain, this study adds to the growing body of evidence of how physiotherapist’s 
could take a lead role in chronic pain management. This would help to address the 
current shortage of skilled professionals to deliver pain management and expand the 
professions repertoire. Further, it adds weight on previous research carried out by 
physiotherapists which has focussed on chronic low back pain to this study’s mixed 
chronic pain cohort. 
Keywords 
Chronic musculoskeletal pain; fear; disability; self-efficacy; Psychology; Physiotherapy; 
group-treatment. 
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1 Introduction 
Sir Liam Donaldson, the Chief Medical Officer, in 2009, reported that the growing 
prevalence of chronic pain was a ‘ticking time bomb’ for the National Health Service 
(Donaldson, 2009). This has been further endorsed by the International Association 
for the Study of Pain (IASP) in 2015, reporting that the intractable nature of chronic 
pain is a community problem in terms of health and economic implications for the 
individuals and their families and society. Chronic pain is recognised as amongst the 
10 worst conditions for years lived with disability, according to the 2010 Global 
Burden of Diseases study (Murray et al. 2013). Chronic pain is a complex 
phenomenon. People are affected by both the symptoms of pain and the impact that 
pain has on their lives. In 2005, only 14% of people suffering with chronic pain 
reported seeing a pain specialist. Access to integrated pain services was found to be a 
problem recognised in the chief medical officer’s report (Donaldson, 2009). However, 
(Nicholas, 2015) suggests that the problem lies not solely with access to pain services 
but the treatments on offer. He discusses the key to effective chronic pain 
management is firstly acceptance and an understanding from the sufferer that they 
have a major role to play in their own self-management. Secondly, he suggests that 
health providers need to recognise that some people seeking help with chronic pain 
require good quality pain management from non-pain specialist services. This, he 
argues would address the concern about growing demand and access to pain 
services. Sowden (2006) suggests that physiotherapists are in an enviable position to 
help address this workforce shortage and take a lead role in the management of 
people with chronic pain. Currently, physiotherapists are the lead clinicians for 
management of chronic low back pain. Nicholas (2015) outlines, the effect of 
physiotherapy-led interventions in delivering pain management for people with 
chronic musculoskeletal pain needs to be explored before the profession can develop 
its role and lead policy change in this area. 
1.1 Pain definition 
Blyth et al. (2010, cited in Croft et al. 2010) state that pain is frequent and 
accompanies the human experience. It is a universally shared experience. Despite 
this, defining what pain is has been challenging. The most widely used definition of 
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pain is defined by the International Association for the Study of Pain (IASP) in 1994 
(online: no page number) as; 
“An unpleasant sensory and emotional experience associated with actual or 
potential tissue damage, or described in terms of such damage” 
 
Despite pain being a universally shared experience, the reality is that it is a private 
event and expressed to others as a series of behaviours e.g. taking pain relief 
medication, seeking help, grimacing and changing movement patterns (Linton and 
Shaw, 2011). The IASP broad definition relates to acute pain, cancer pain and chronic 
non-cancer pain. It recognises that pain is an experience and highlights the sensory 
and emotional aspects of pain in addition to acknowledging that pain can be present 
with either actual or potential tissue damage. Despite this definition, pain is usually 
described in terms of acute or chronic. Acute or nociceptive pain is generally 
accepted as being recent onset, limited duration (under 12 weeks), with a causal 
relationship with injury or disease and with limited, if any, psychological factors 
(Duarte, 1997). 
One of the fundamental aims of medicine and health care is to help relieve pain and 
the suffering which accompanies pain. Despite this aim, the challenge of managing 
pain that persists beyond acute pain and becomes chronic, is elusive. 
1.2 Chronic pain and its epidemiology 
The British Pain Society (BPS) 2013, defines chronic pain as: 
“Chronic pain is continuous, long-term pain of more than 12 weeks or 
after the time that healing would have been thought to have occurred 
in pain after trauma or surgery” (online: no page number) 
This limited definition focuses solely on the time aspect of pain and fails short to 
describe the magnitude of the problems associated with chronic pain. 
In Western industrialised countries, musculoskeletal (MSK) chronic pain is a major 
and growing public health concern with over 20% of the adult population reporting 
chronic pain as a problem (Nicholas, 2015). The majority of patients with chronic pain 
also have increased disability and mental health disturbances compared to patients 
without chronic pain. Croft et al. (2010) reported that the consequences of untreated 
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chronic pain are not only to the individual but also for healthcare providers and the 
wider economy e.g. loss of earning due to sick leave. 
It is difficult to establish an accurate figure of patients living with chronic pain in the 
United Kingdom (UK). In the UK, recent estimates indicate the prevalence of chronic 
pain affects between 7.8 and 10 million people, depending on the source. The 
National Pain Audit (2012) reported that 7.8 million people in the UK are suffering 
with chronic pain, whereas the British Pain Society report (2014) estimate 
approximately 10 million; (over 10% of the UK population). The incidence of low back 
pain alone is thought to affect over 17 million people in the UK, with a further 3.5 
million each year reporting their first episode of which 3.1 million still report 
persistent symptoms at 1 year, (The Arthritis Musculoskeletal Alliance (ARMA) 
guidelines (2004). Despite wide variation in the incidence of pain in several studies, 
chronic pain represents a major public health problem that requires a change to 
current pain management delivery (Nicholas, 2015). The declaration of Montreal in 
2010 was adopted at the end of the world congress for pain and stated that access to 
pain management was a fundamental human right as a response to the increasing 
prevalence of chronic pain. In 2012, The Department of Health in the UK 
acknowledged this growing problem and recognised chronic pain as a long-term 
condition. The English Pain Summit report (2012) set one of their primary objectives 
to make chronic pain a “high street” disease; recognisable and with timely access to 
treatment, care and education. More recently in a clinical update for the 
management of pain for IASP (Nicholas, 2015) has called for urgent action to broaden 
the scope of who can deliver pain management services to cope with the demand. 
This calls for a review of current guidelines and service provision. 
1.2.1 Economic cost 
Chronic pain has far reaching consequences for the individual but also to society in 
terms of the cost of health care and wider economy effects (The English Pain Summit, 
2012). 
Foster et al. (2010), report that 1.6 million adults in the UK report low back pain per 
year and out of those people who consult their GP with low back pain typically 60-
80% continue to experience pain and disability at 12 months post-consultation. 
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Critchley et al. (2007) reported the annual expenditure to the National Health Service 
(NHS) on low back pain alone was estimated at £1.1 billion. The ARMA guidelines for 
low back pain (2004) break the cost down into £141 million in GP consultations, a 
further £512 million in hospital care and private health care costs of £565 million, 
which brings the total to nearer £1.6 billion a year. The Royal College of General 
Practitioners in 2014 endorsed this figure, suggesting that patients with chronic pain 
consult their family doctors 5 times more frequently than those without chronic pain. 
In addition to the direct healthcare costs in the UK, musculoskeletal pain is the 
commonest cause for incapacity with around 25% of people who are not working 
citing pain as the main reason. Low Back Pain (LBP) is cited in nearly half of those 
absent from work with MSK pain (Johnstone et al. 2002). Between 1994 and 1995, 
116 million workdays were lost due to low back pain with an estimated cost of 
£10,668 million in production and informal care costs (Hansen et al. 2010). The total 
costs to the UK economy are estimated to be 1-2% of the Gross National Product 
(GNP) (ARMA guidelines 2004). 
1.3 Aetiology 
Chronic pain is recognised as multi-faceted in terms of the effects it has on both the 
sufferer, family and society. There have been advances in identifying risk factors and 
understanding the pathological processes involved in the development of chronic 
pain. Psychological, social and behavioural risk factors have been found to be 
stronger predictors of chronic pain than physical risk factors i.e. structural changes or 
pathology (Swinkels-Meewisse et al. 2003). However, despite awareness of these risk 
markers, the causal relationship of these factors to the incidence of pain has not 
been well established. In this thesis, an overview of the risk factors for chronic pain 
are discussed. 
1.3.1 Socio-demographic factors associated with pain 
1.3.1.1 Gender 
Being female is a well-established risk factor for developing chronic pain (Blyth et al. 
2010, cited in Croft et al. 2010). Lombana and Vidal (2012) suggest that hormonal 
changes that occur during the monthly cycle in females may account for some of the 
variability in pain tolerance. They suggest higher oestrogen levels in the first part of 
the cycle have a protective pain mechanism and during this part of the cycle there is 
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little difference between reporting of pain from noxious stimuli between men and 
women. When oestrogen levels fall (getting lower) there is a marked difference with 
women reporting more pain at lower thresholds, in addition to a higher level of pain 
intensity from noxious stimuli (Riley et al. 1998). However (Gran, 2003), in a 
systematic review of the epidemiology of pain, summarising the results of several 
studies showed that there was no link between hormonal changes and pain 
perception. 
Furthermore, (Fillingim et al. 2009) report the findings of a study looking at the 
prevalence of chronic musculoskeletal pain and found that across 17 countries there 
was a higher prevalence amongst females; 45% compared to 31% for males. This is 
further supported in (Blyth et al. 2010, cited in Croft et al. 2010) who report that 
females are more likely to report multiple areas of pain, lower pain threshold and a 
greater severity of pain intensity. In addition, Fibromyalgia, a widespread chronic 
pain state characterised by multiple trigger areas of pain, is more likely to be 
diagnosed in females than in males. Lombana and Vidal (2012) suggest that the social 
role expectation between the sexes accounts for some of the difference; females are 
more often linked to “the more sensitive side of mankind” and additionally they are 
also more likely to seek medical advice for pain symptoms. Gran (2003) suggested 
that the difference in pain perception between the sexes was a combination of 
biological, psychological and social factors. However, the exact mechanism(s) and the 
pathway that affects individuals is not fully known. Benign Joint hypermobility (BJH) 
is a musculoskeletal disorder known to have a higher incidence in females (Larsen et 
al. 1987). It is reported to affect more than 30% of the adult population and in 
addition to a female dominance is also more prevalent in Asian and African 
populations (Graham, 2001). People with BJHS may present with early osteoarthritis, 
subluxation or dislocation of peripheral joints, tendinopathy or bursitis (Smith et al. 
2014). The association of chronic pain and psychological distress with BJH has also 
been well documented (Graham, 2001; Smith et al. 2014). 
1.3.1.2 Socioeconomic 
McBeth and Jones (2007) suggest that socioeconomic factors including low 
educational attainment, low income and unemployment are all associated with an 
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increased prevalence of chronic pain. The mechanism of the association between 
these factors is not clear. However (Croft et al. 2010) suggest that there may be a link 
between pain and socioeconomic factors based on the influence of lifestyle choices 
including smoking, participating in physical activity and dietary choices. Lionel (2014) 
suggests that individuals with a higher educational level find more time to engage in 
physical activity and perceive they have more control over their health choices and in 
general this reflects in a healthier lifestyle. Coleman et al. (2012) report the outcomes 
of an osteoarthritis self-management programme as being potentially influenced by 
the participant’s socioeconomic status. They describe a large number of participants 
were from higher socioeconomic areas and in part they suggested this was due to the 
self-enrolment recruitment process utilised in the study. They reported that using 
this recruitment process potentially attracted participants who were more 
predisposed to use self-management strategies anyway. The authors report previous 
problems trying to recruit patients from lower socioeconomic groups and 
acknowledge this needs to be addressed in future studies. 
1.3.2 Clinical and psychological factors associated with pain – age and co-morbidities 
Several studies have reported that the prevalence of chronic pain is consistently 
associated with older age (McBeth and Jones 2007; Croft et al. 2010; Van Hecke et al. 
2013). For 16-34 the incidence of those reporting chronic pain is reported as 15% in 
men and 18% in women. This increases to 53% in men and 59% in women of those 
aged 75 and above (Craig and Mindell, 2011). The prevalence of osteoarthritis, is also 
known to increase with age. Physiological processes that occur in osteoarthritis 
involve both structural changes and potential nociception stimulation of the bone, 
capsule, ligaments and surrounding muscle system. Bennell et al. (2012) state that 
despite these known physiological changes the correlation between structural 
changes and pain severity is not well correlated. Harding et al. (1994) suggest that 
because of the weak correlation between structural changes and pain severity, a uni-
dimensional medical model of diagnosis and treatment does not fit. In addition, 
Arthritis Research UK (2013) in their public health document, suggest that four out of 
five people with osteoarthritis have at least one other long-term condition which 
impacts on their general health and well-being. Pain is also a symptom that can be 
associated with other long-term medical conditions such as diabetes, coronary heart 
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disease and osteoporosis. The number of people living with one or more long-term 
conditions is increasing. Currently, 58% of those aged 60 and over live with one long-
term condition, in addition the likelihood of living with multiple long-term conditions 
increases with age (Coleman et al. 2012). Van Hecke et al. (2013) reported people 
were more than twice as likely to die from ischaemic heart disease or respiratory 
disease if they reported suffering with chronic pain. They suggested this link might be 
related to lower physical activity levels in people with chronic pain. 
1.4 Psychological risk factors for chronic pain 
Psychological problems are potential risk factors for the progression of pain from 
mild to disabling chronic pain. The factors thought to play a significant role in 
development of chronic pain are poor coping strategies, beliefs, distress and 
depressive mood. These factors, if present and not adequately treated are also 
thought to have deleterious impact on outcome following intervention (Foster et al. 
2010). 
1.4.1 Depression and catastrophizing 
Linton et al. (2011) report that a large number of patients who suffer with 
musculoskeletal pain are also depressed. Arthritis Research UK (2013) suggest that 
two thirds of patients with osteoarthritis report having symptoms of depression and 
those living with persistent pain are four times more likely to exhibit elevated level of 
depression. Van Hecke et al. (2013) suggest that whilst the association of depression 
and pain is well established, the definitive cause is unclear and is likely to be bi-
directional, i.e. both central and behavioural. Additionally, the presence of 
depression is widely reported as a significant risk factor for poor outcome following 
intervention (Woby et al. 2008; Linton and Shaw, 2011). This is surprising considering 
that the theory of increasing physical activity and self-efficacy, the cornerstone of 
pain management would be associated with reduced depression (Linton et al. 2011). 
Sowden et al. (2006) suggests that psychological distress such as depression can 
interfere with an individual’s ability to engage with intervention and therefore this 
may be a reason for poorer outcome. They suggest that pain management 
programmes which include CBT, a well-established treatment for depression, may 
have better outcomes compared to physiotherapy-led approaches as found in (Hay et 
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al. 2005; Woby et al. 2008; Hill et al. 2011). Catastrophic thinking styles, which can be 
associated with depression in patients with chronic pain can also impact on 
treatment adherence if not addressed (Linton and Shaw, 2011). Pain catastrophizing 
is described as a magnification of the threat of a noxious stimulus, seeing the worst 
possible scenario from activities and an inability to regulate pain-related negative 
thoughts (Quartana et al. 2009). 
1.4.2 Fear avoidance and Pain Beliefs 
This has been one of the most influential models in the explanation of psychological 
factors in the development and maintenance of chronic pain (Roelofs et al. 2004). 
The model suggests that if patients interpret chronic pain as a threatening stimulus 
(pain catastrophizing) then this may lead to fear which can result in two responses; 
confrontation or avoidance. Confrontation is closely linked to self-efficacy and is 
considered to be an active adaptive strategy that long-term results in reduced fear 
and increased daily functioning (de Moraes Vieira et al. 2013). The alternative 
response is the adoption of avoidance behaviour. Avoidance behaviours may be to 
limit movement or activities in anticipation of increasing pain combined with the 
meaning for the increased pain; fear of making their symptoms worse, or fear of 
causing further damage. Ultimately, the use of avoidance behaviour as the primary 
pain coping strategy results in deconditioning, lower pain tolerance, reduced 
functioning, increased fear and depression (Linton and Shaw, 2011). Fear avoidance 
behaviours are also closely related to certain beliefs about activity restriction, i.e. 
“pain is a sign to stop what you are doing” or “hurt equals harm” which are 
associated with the development of long-term pain and disability (Linton and Shaw, 
2011). 
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Figure 1 - The fear avoidance cycle of chronic pain taken from (Vlaeyen and Linton. 2012) 
 
1.4.3 Self-efficacy 
The concept of self-efficacy is important in the management of any individual who 
has a long-term condition including persistent pain (Sowden et al. 2006). It has been 
reported across several studies that patients who exhibit fear avoidance beliefs also 
report higher pain intensity and greater levels of disability (Woby et al. 2005; 
Nicholas et al. 2007; Hill et al. 2011). The concept was originally described by Bandura 
in 1977, as confidence in one’s own ability to carry out an activity and how much 
effort and how long they will persist in the face of obstacles and aversive experiences 
(Nicholas et al. 2007). Jackson et al. (2014) in relation to pain, suggests that self-
efficacy affects the adoption of active behaviours to control and manage pain 
symptoms. Foster et al. (2010) found self-efficacy to be one of the strongest 
predictors of outcome in a cohort of patients with low back pain from primary care. 
They reported that low self-efficacy was associated with passive coping strategies, 
e.g. inactivity. An improvement in an individual’s self-efficacy is a realistic benchmark 
to be aiming for with any chronic long term condition (Perry et al. 2013). The idea of 
living well despite having obstacles might be how people with chronic long term 
conditions who don’t seek health care intervention function and live well. The 
development of the pain self-efficacy questionnaire by (Nicholas et al. 2007) suggests 
that the measure can be used as both a screening tool and an outcome measure. The 
study also suggests that post treatment scores on the pain self-efficacy scale may be 
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predictive of a person’s ability to make long lasting behavioural changes and self-
manage, or whether they are at risk of relapsing. If this suggestion is replicated in 
further research studies then this would potentially be a useful prognostic indicator 
in clinical practice. Furthermore, it could also be important for service design, to 
identify those patients who may benefit from follow-up or further support following 
an intervention to reduce the impact of re-lapse and prevent re-referral back into the 
health-care system. 
1.5 UK Chronic Pain management guidance 
The British Pain Society published their revised guidelines on Pain Management 
Programmes (PMP) for adults with non-cancer chronic pain in 2013. For a pain 
management programme to be recognised by the BPS it has to be delivered by an 
inter-disciplinary team, be based on Cognitive Behavioural Principles (CBT) and be 
time-intense with a minimum of 36 hours or 12 half-days extending to intensive 
residential programmes for complex cases in tertiary centres. This type of 
programme requires a team of different health care professionals (clinician intense), 
and is also time and cost intense. The majority are found in secondary and tertiary 
care settings. Although this management option is considered to be a ‘gold standard’, 
the cost implication and the accessibility of such an approach requires consideration. 
The BPS has recently worked with the Royal College of General Practitioners to devise 
pain-centred care pathways from primary through to tertiary care with an emphasis 
on biopsychosocial interventions at each stage. The role of the physiotherapist within 
the BPS PMP is clearly defined as being limited to the exercise and movement aspect 
of the programme and it is clear that consideration of a PMP being delivered by one 
profession is considered neither desirable nor efficacious. 
1.5.1 CBT 
The role of psychological risks factors and their effect on chronicity of pain is well 
established in the research (Foster et al. 2010; Morley et al. 2013). The use of 
psychological interventions as a treatment strategy for chronic pain is recognised as 
being central in a holistic approach and integral to the revised 2013 British Pain 
Society guidelines for the management of chronic pain. 
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CBT is one of the most recognised psychological treatment interventions for chronic 
pain. The development of CBT was a synthesis of work of Wilbert Fordyce, a 
psychologist, and Aaron Temkin Beck, a psychiatrist (Ehde et al. 2014). Fordyce’s 
work in the 1970s looked at the role of learning theory and behavioural principles 
and how these related to pain behaviours in those suffering with chronic pain. He 
identified that pain behaviours could be modified by social and environmental factors 
(Ehde et al. 2014). In 1979, Beck developed cognitive behavioural therapy for 
depression after identifying patients in his care had characteristic thought processes 
which affected their function and behaviour (Brunner, 2013). The role of cognitions 
and how this affected mood, anxiety and behaviour stimulated interest in combing 
the two therapies for the treatment of chronic pain. CBT has over the last three 
decades evolved to become a mainstream treatment option for chronic pain. It is 
recognised as central to the BPS 2013 pain management programmes. 
CBT is not a standard treatment technique rather it is a skill-based approach that the 
individual works through with the therapist in order to develop strategies to manage 
their own problems. Common CBT strategies include the use of relaxation, 
mindfulness and relaxed breathing along with techniques which include challenging 
automatic negative thoughts and developing adaptive responses to threatening 
situations (Nash et al. 2013). CBT also uses exercise as an integral behavioural skill. 
The main goals of CBT in chronic pain management are to improve function, self-
efficacy and pain relief whilst alleviating psychological distress (Ehde et al. 2014). 
Despite the endorsement by the BPS and recognition in the UK Map of Medicine 
pathways for chronic pain (Morley, 2010) argues that the nature of CBT makes 
conducting ‘gold standard’ randomised control trials to establish its effect is 
challenging. Furthermore, he suggests that even defining what CBT is can be 
problematic. Despite these unresolved issues (Ehde et al. 2014) argue that CBT lacks 
the associated risks of other interventions used for treatment of chronic pain, 
including medication, surgery, and injection therapies In support of this (Harding et 
al. 1994) suggests that traditional medicine offers people living with chronic pain very 
little in the way of useful or permanent solutions for their condition. In contrast, CBT 
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guides the individual to enable them to develop positive coping strategies and use 
self-management principles. 
1.5.2 UK low back pain guidelines 
There are national guidelines that influence practice relating to management of 
people with low back pain; these are Clinical Standards Advisory Group (CSAG) on 
low back pain: CSAG (1994); Arthritis Musculoskeletal Alliance (ARMA) 2004; The 
National Institute for Clinical Excellence (NICE) 2009; The Keele STaRT back tool (Hill 
et al.2011) and the (Map of Medicine low back pain pathways, 2012). 
CSAG (1994) relates to the diagnostic triage into three distinct groups for people 
presenting with low back pain; simple low back pain 80-85%; nerve root pain 5-10%; 
and potential serious spinal pathology 1-2%. In 2004, ARMA published their 
standards of care for people with low back pain, which suggested referral for multi-
disciplinary group CBT if pain persisted beyond 12 weeks. This recommendation was 
reinforced by NICE who published recommendations for the management of non-
specific low back pain in May 2009. This guideline relates to the treatment that 
people who have persistent non-specific low back pain can expect from the NHS in 
England and Wales to help them manage their pain. It is currently under review and 
the revised guidelines are expected to be published in 2016. This has been further 
reinforced by the recently published Map of Medicine pathways for low back pain 
(2014). In addition to the recommendation for early referral on to pain management 
services, the pathways use the Keele STaRT Back Screening Tool (SBST). The SBST is a 
9-item prognostic screening tool designed to be used in general practice with 
patients presenting with low back pain. The SBST was designed to aid clinicians 
identify risks factors both biomedical and psychosocial. The SBST score stratifies 
patients into three groups; low, medium and high risk of developing chronicity. The 
score is used to direct clinicians to a matched treatment package; specific 
physiotherapy management for each SBST group. The SBST represents the most 
significant change to management of low back pain in the last 10 years and also 
outlines the role of psychologically informed physiotherapy management for people 
at high risk due to psycho-social factors. 
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1.6 Psychologically-informed practice and Physiotherapy management of chronic 
pain 
Linton and Shaw (2011) report that whilst 63% of physiotherapists were aware of the 
impact of psychological factors in chronic pain, only 43% had knowledge about how 
to utilise these in their management. They argue that whilst physiotherapists are well 
placed to manage chronic pain, to be the therapist of choice will require a 
philosophical shift in clinical practice. The majority of Physiotherapists use a 
biomedical perspective where treatment focuses on the musculoskeletal origin of the 
‘pain,’ and a look at the other contextual factors that impact on the pain. The 
identification of psychological factors with the use of “yellow flag” questions during 
clinical assessments is crucial to enable an effective management plan. The concept 
of the flag system is widely used in practice and was based on the work of (Linton et 
al. 1999). There are two categories of flags, clinical and psycho-social. Clinical flags 
are red and more recently orange has been added. Red flags are potential signs of 
serious pathology that require urgent attention and pathways exist within health care 
establishments to deal with these presentations. More recently orange flags have 
been introduced to distinguish psychiatric or serious mental health conditions from 
milder problems commonly associated with musculoskeletal chronic pain, as 
discussed earlier. Psycho-social flags are referred to as yellow; while blue and black 
relate to occupational factors. Yellow flags, along with red, are the most commonly 
utilised by physiotherapists and aid identification of psycho-social risk factors. They 
include questions on beliefs, behaviours, family support, work, fear and coping 
strategies. The identification of yellow flags should form the basis of management, 
i.e. if beliefs about pain are an obstacle then reconceptualising pain to reassure and 
explain and techniques such as graded exposure to get patients re-engaged with 
activity should be utilised (See Appendix 5 - Flag indicators on page 132). 
There is a growing evidence base for physiotherapists delivering this type of CBT 
approach or working in a more psychologically-informed way in the management of 
chronic pain. The focus has been on the management of low back pain, with clinically 
significant effects (Critchley et al. 2007; Hill et al. 2011; Lamb et al. 2012). This is 
explored in chapter 3. Although chronic low back pain remains the largest single 
musculoskeletal condition for seeking healthcare intervention, pain-related disability 
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and sick absence from work, it does not cover all conditions where chronic pain is a 
symptom. There is now a need for health professions like physiotherapy to expand 
the research base into other areas of chronic pain management, e.g. fibromyalgia 
and chronic widespread pain. Despite recognition that costly secondary and tertiary 
centre pain management care is appropriate for those people who have complex 
presentations, serious consideration should be given to the effectiveness in terms of 
cost, clinical outcome and patient satisfaction of interventions based on a CBT 
approach delivered by non-psychology professions in a variety of settings (Nicholas, 
2015). 
1.7 Summary 
Chronic pain is recognised as a growing worldwide problem that has multiple known 
risks factors and associations with other chronic diseases. Nicholas (2015) calls for a 
fundamental change in the model of health care provision for chronic pain. In 2013, 
in the UK, NHS England in the report “Everyone Counts Planning for Patients 
2014/15-2018/19”, emphasise that the demand on healthcare is changing and this 
will pose significant challenges to how services are funded and delivered. The report 
also outlines how meeting these challenges will mean that services will have to be 
innovative to meet these growing demands. 
There is a gap in the literature and in current UK guidelines of clinical and cost 
effectiveness of quality services that do not use intensive multidisciplinary 
approaches. There is promising evidence that physiotherapists using CBT or working 
in a psychologically informed way can effectively manage patients who have chronic 
low back pain with psychosocial factors. However the evidence of physiotherapy-led 
management of other chronic pain conditions is lacking. Arguably the techniques 
used in CBT are also commonly utilised by physiotherapists in their clinical practice, 
for example exercise therapy, pacing, goal setting, problem solving and therefore 
there is scope that with additional under or postgraduate training physiotherapist 
can be innovative and transform their services to meet the growing need of 
healthcare provision. Harding et al. (1994) supports this view but with the caution 
that despite the techniques appearing to be the same the method of delivery is quite 
different and would require a significant shift in training to achieve effectiveness. In 
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chapter 2 the current available evidence of physiotherapists using CBT or 
psychologically informed practice is explored. 
This study was undertaken to investigate the short- and medium-term effects of a 
physiotherapy-led group intervention for the management of patients who 
presented to an outpatient physiotherapy department with chronic musculoskeletal 
pain interfering with different aspects of their life. This study was conducted in two 
phases; the preliminary phase was a retrospective study investigating current 
physiotherapy-led service provision of patients with chronic pain and will be 
discussed on page 51. The main prospective phase of the study will be discussed on 
page 51. 
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2 Literature Review 
A comprehensive review was undertaken to evaluate the current literature on 
physiotherapy-led group management of adults with chronic musculoskeletal pain, 
delivered using principles that are recognised as part of a cognitive behavioural 
approach, i.e., pacing, goal setting, graded activity, etc. 
2.1 Search Strategy 
AMED, MEDLINE, CINAHL, ScienceDirect, and SCOPUS were included in the search 
strategy and all were searched from 1985 to present. Hand searching was performed 
on the reference articles found to be relevant. The Cochrane controlled Registers 
were also searched for relevant trials and reviews. 
2.2 Search terms 
The following keywords were used to search each of the databases. Each term 
(keyword) was searched separately, then individual searches were combined. See 
Appendix 1 – Results for the database search carried out on 23/03/2015 on page 118. 
Physiotherap* OR Physical therap* “CBT” OR “CBT approach” OR “cog behav ther” 
OR behav* thera*; “chronic pain” OR “persistent pain” OR “low back pain”;“group 
therapy” OR group OR programme* OR class OR “group treatment” 
2.3 Inclusion and exclusion criteria 
All search lists from each database were screened and Table 2.1 shows the inclusion 
criteria for the studies that were included in the final literature review. Studies were 
excluded if pain was acute or was not musculoskeletal in origin. Studies that 
examined using specific passive treatment modalities i.e. acupuncture, TENS or those 
delivering interventions as an in-patient were also excluded. Finally those studies that 
involved under 18s and those with a recognised history of sexual or physical abuse 
were also excluded. Many of the studies identified in the initial database search 
strategy were those where the group intervention was not solely delivered by a 
physiotherapist but involved a multi- or inter-disciplinary team. After applying the 
criteria, a total of eleven studies were included in this literature review. 
2.3.1 Quality assessment 
The PEDro scale (see Appendix 2 - PEDro scale 
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 on page 119) was used to review and score the methodological quality of RCT studies 
with a cut-off score of 6 and above showing acceptable quality (Maher et al. 2003). 
Those studies that were reported on as non-randomised, cohort or observational 
studies were reviewed using the Critical Appraisal Skills Programme (CASP) 2014 (see 
Appendix 3 - CASP tool for cohort studies on page 121). A summary of the papers 
included in the literature review can be found in Appendix 4 - Summary of papers in 
literature review with PEDro scale on page 127. 
Table 2.1 - Inclusion criteria for study selection 
Criteria Description 
Design Full reports in a peer-reviewed Journal 
Randomised, non-randomised and observational studies 
English language 
Participants Adults over 18 with: 
Chronic musculoskeletal pain from any origin, i.e. osteoarthritis, 
low back pain, fibromyalgia 
Intervention Treatment intervention that included evidence of an 
educational, exercise and a self-management element within 
cognitive behavioural principles. 
• Delivered by a physiotherapist in a group format OR 
• Delivered on an individual basis by a physiotherapist  
Outcome measures No studies were excluded based on outcome measure 
Comparisons No studies were excluded based on no comparison group 
 
2.4 Summary of the papers included for this literature review 
This review has identified a changing perspective within the research relating to 
physiotherapy and pain management. There is a clear development in the literature 
from research involving a biomedical perspective to a newer psychologically 
informed physiotherapy practice. 
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2.5 Research with physiotherapy from a biomedical model 
Physiotherapy research for musculoskeletal chronic conditions has focussed on the 
area of low back pain management. Physiotherapy is traditionally seen as a core 
treatment for low back pain. This is supported by the Clinical Standards advisory 
guidelines (CSAG) 1994; European guidelines (2004) for acute and chronic low back 
pain; National Institute of Clinical Excellence (NICE) guidelines for the management of 
low back pain (2009); and more recently in the (Map of Medicine pathways guidance 
for low back pain, 2014). 
2.5.1 Randomised Control/Pragmatic trials for low back pain comparing manual therapy 
and psychosocial interventions 
The UK BEAM (Back Exercise And Manipulation) Trial 2004, was a large–scale, 
randomised control study that compared physical treatments for low back pain, best 
care advice in general practice and an exercise class; “back to fitness” based on 
cognitive behavioural principles. The trial scored 8 on the Pedro scale. The trial’s 
main aim was to determine the effectiveness of manipulation for low back pain and 
to determine whether the location (NHS or private premises) affected the outcome. 
At the time of this trial, the predominant guidelines for the management of low back 
pain in the UK were the Royal College of General Practitioners (RCGP,) 1999, (Wadell 
et al. 1999) who advocated manipulation as a first line treatment option for acute 
and sub-acute low back pain, alongside advice to stay active and avoid bed rest. 
The cohort of 1170 patients were constrained in the respect of both age (18-65) 
years and existing medical co-morbidities. In addition, the duration of time the 
participants had had back pain was unclear and therefore it is difficult to state if they 
had acute, sub-acute or chronic pain. The symptom requirement for the inclusion in 
the study was the presence of continuous pain for 20 out of the last 28 days. 
However, this could have been the participants’ first ever episode of pain or equally 
they could have had long-standing pain. The relevance of this criterion may relate to 
resolution of symptoms and degree of psychosocial factors present. The exclusion 
criteria of specific co-morbidities were, e.g. osteoporosis, anticoagulant therapy and 
steroid therapy. These were necessary because of the contraindications associated 
with manipulation, the study’s treatment modality. Similarly (Cecchi et al. 2010) 
explored the efficacy of a back school intervention compared to other physical 
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treatments defined as; spinal manipulation delivered by a physician and individual 
physiotherapy, including exercise, passive mobilisations and soft tissue work. This 
study used an Italian cohort of 210 participants with chronic, non-specific low back 
pain. The study scored 9 on the Pedro scale. Although not explicitly stated, the 
description of where the participants were recruited from was likely to be a 
secondary care setting. Interestingly, despite investigating the effects of 
manipulation on low back pain too, they had a broader inclusion criteria and didn’t 
exclude any medical comorbidities or age. The mean (SD) age of the participants was 
58.1 (SD+/- 12.2). All of the participants had standard spinal radiographs and a 
further ninety had CT or MRI scans. This may have been in respect of excluding spinal 
bony pathology, however, this is not explicitly stated by the authors. The UK based 
studies (UK BEAM trial 2004; Critchley et al. 2007), would not have been able to 
provide this level of investigation as RCGP guidelines 1999 do not advocate 
radiograph or similar investigations for non-specific low back pain (Waddell et al. 
1999). 
In contrast, Critchley et al. (2007) used a broader inclusion criteria for their UK cohort 
of 212 patients recruited from primary care with chronic low back pain. They used a 
randomised pragmatic study design to investigate the clinical- and cost-effectiveness 
of three types of physiotherapy over an 18-month time period. The study scored only 
6 on the Pedro scale which is the cut-off for acceptable methodological quality. 
Participants were referred to a UK hospital physiotherapy department from either 
primary or secondary care sources. 
Treatment arm one was individual physiotherapy (IP) this was delivered to a 
maximum dosage of six hours, in 30-minute appointments over 12 sessions. The 
actual treatment in the physiotherapy arm was left to the physiotherapists’ discretion 
so could have contained a combination of manual, electrotherapy and exercise 
therapy. 
Treatment arm two was spinal stabilisation exercises (SSE). Each patient was assessed 
and given an individual programme. This was carried out in a group setting with a 
maximum of eight patients supervised by a physiotherapist and assistant to a 
maximum of 12 hours, over 8-sessions of 90-minute duration. The third treatment 
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arm was a pain management programme (PMP), delivered in a group format by a 
physiotherapist and an assistant. A cognitive behavioural approach was used, to the 
same sessions and times as treatment arm two. 
The premise of the study was similar to the (UK BEAM trial, 2004); the effect of 
physical treatment compared to spinal stabilisation exercises and a pain management 
class, all delivered by physiotherapists. The nature of the physiotherapy treatment 
was left to the discretion of the clinician, therefore modification of techniques could 
have been employed in respect of existing co-morbidities. Critchley et al. (2007) and 
(Cecchi et al. 2010) studies came after the release of the European guidelines for the 
management of acute and chronic low back pain (2004). This suggests that, whilst 
there was reasonable evidence for manual therapy, there was insufficient evidence 
about specific spinal exercises and cognitive behavioural approaches (CBA). 
2.5.2 Interventions 
The manipulation intervention was eight 20-minute sessions performed by a 
physiotherapist, osteopath or chiropractor over a 12-week period in the (UK BEAM 
trial, 2004). The exact type and number of manipulations delivered in each session 
was unknown. This has been challenged as a criticism to their intervention, (Vogel et 
al. 2005). The “back to fitness” class was equally poor in description of content. The 
study reported that the participants were invited to attend up to eight sessions of 60-
minutes over 4-8 weeks, suggesting that it was left up to the participant whether or 
how many to attend. The team suggest that this could have affected the findings, 
reporting that, whilst 92% of those receiving manipulation treatment had what they 
defined as “basic minimum treatment,” only 63% of those randomised to the “back 
to fitness” group. This potentially jeopardises the generalisability of the results and is 
a threat to external validity. In contrast (Cecchi et al. 2010) reported a high retention 
of 210 participants for their back school intervention with only 2 lost at 12-month 
follow-up. Whilst their study has similarities with the (UK BEAM trial, 2004) the 
difference with their back school intervention was that the class had structure to 
each session and participants were expected to attend. It was delivered by two 
physiotherapists in fifteen, 1-hour sessions over 3 weeks. However, the description of 
the intervention suggests that it was ‘traditional’ in content rather than a CBA with 
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the emphasis on pathology, anatomy and ergonomics in the first 5 sessions, and then 
exercise and relaxation in the last 10 sessions. Critchley et al. (2007) also reported a 
reproducible structure for their pain management class intervention delivered by 
physiotherapists, and yet, like the (UK BEAM trial, 2004), they still reported a higher 
than average attrition rate of 33% for the pain management intervention compared 
to 25% for the other two study interventions. 
2.5.3 Findings 
UK BEAM trial (2004), Hay et al. (2005), Critchley et al. (2007) and Cecchi et al. (2010), 
all used the Roland Morris Disability Questionnaire (RMDQ, 0-24; 0=no pain-related 
disability, and 24= total pain-related disability) as their primary outcome measure. 
This outcome measure is widely used in research trials and has been validated for 
both sub-acute and chronic low back pain populations. A wide range of secondary 
outcome measures were included for each of the trials, attempting to capture the 
multi-factorial nature of pain. 
Baseline data for the (UK BEAM Trial, 2004) and (Cecchi et al. 2010) was similar for all 
treatment arms. In contrast (Critchley et al. 2007) reported that their baseline data 
was similar for all three arms, however, a visual check of the data suggests that the 
PMP arm were less likely to be in full-time work and more likely to be receiving 
benefits, resulting in an apparently lower number of days off work at baseline. The 
SSE arm also reported higher baseline pain related disability with RMDQ; 12.8 
compared to 11.1 in the individual arm and 11.5 in the pain management group. This 
group also reported higher pain intensity as measured on the visual analogue scale 
(VAS 0-100; 0=no pain and 100= worse pain) 67 compared to individual 60 and pain 
management 59. The UK BEAM trial (2004) study started with an RMDQ score of 9 for 
all treatment arms whilst (Cecchi et al. 2010) reported no statistically significant 
differences of 8.4 in their spinal manipulation group, 9.5 in their back school and 9.7 
in the individual physiotherapy group, although this was not reported as statistically 
different. 
There was a 25% attrition rate across all three treatment arms, with the lowest 
retention in the PMP arm at 67%. The authors report that because of the wait to 
attend the pain management programme, some participants sought other treatment. 
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The authors do not make it clear as to whether these participants were excluded 
from the study or that this was given as a reason for them dropping out. This would 
clearly affect the results if the participants were allowed to continue with the study 
whilst receiving additional treatments. 
The studies were all powered to detect clinically relevant changes in their primary 
outcome measure RMDQ (UK BEAM trial 2004; Critchley et al. 2007) by 2.5 (Cecchi et 
al. 2010) by 2 points, respectively. These scores are consistent with other studies as 
representing a clinically meaningful reduction (Woby et al. 2008; Lamb et al. 2012). 
The UK BEAM trial (2004) reported a mean within-group drop in RMDQ of 3.3 at 3 
months and 3.5 at 12 months across all treatment arms, accordingly. The 
manipulation plus exercise sustained the largest changes at both 3-months (1.9) and 
12 months (1.3), whilst the exercise group alone had the smallest changes and these 
were only seen at 3-months (1.4). Critchley et al. (2007) showed no statistically 
significant difference between-groups in terms of patient reported outcome 
measures; pain related disability, pain intensity, quality of life or work limitation. 
Despite the lack of statistical difference between-groups, within-group changes had a 
mean RMDQ reduction of over 5 points and this was sustained to long-term follow-
up of 18 months, which is clinically and statistically relevant. In contrast (Cecchi et al. 
2010) reported a statistically significant (p < 0.001) between-group change score 
between their treatment interventions. They also reported large within-group 
changes for RMDQ and pain medication use; spinal manipulation RMDQ reducing by 
6.7; individual physiotherapy; 4.4 and back school; 3.7. Additionally they reported a 
reduction in the use of pain medication and the frequency of further episodes of low 
back pain. Conversely a statistically significant difference (p < 0.001) was observed at 
12 months for those participants in the spinal manipulation arm seeking further 
treatment. This suggests that manipulation increased the need for further treatment. 
This is not a desirable outcome for any chronic condition. The aim of treatment for 
those with chronic conditions is to equip the patient with skills to enable them to 
self-manage their condition not create reliance on healthcare providers. Despite 
reporting smaller changes with drop in RMDQ the (UK BEAM trial, 2004) reported 
that their combined manipulation and exercise arm also produced a not statistically 
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significant reduction in back pain beliefs and fear avoidance, which is potentially 
more relevant to long term pain and self-management. 
When considering these studies the large variation of results need to be considered 
with caution. Both (Critchley et al. 2007) and (Cecchi et al. 2010) had relatively 
smaller sample sizes, 212 and 210 respectively, therefore, they were possibly 
underpowered compared to the (UK BEAM trial, 2004). In addition, both had higher 
starting means of RMDQ which arguably requires a larger reduction compared to a 
lower starting mean. The Cecchi et al. (2010) cohort suggests recruitment from a 
secondary care source and is therefore not easily compared to either (UK BEAM trial 
2004; Critchley et al. 2007), both of whom recruited from primary care sources in the 
UK, although with different inclusion criteria. 
2.5.4 Cost effectiveness of the trials 
In view of the major social and economic loss associated with low back pain 
economic analyses are common to determine cost-effectiveness of interventions. The 
quality-adjusted life years (QALY) is used to assess the value for money of an 
intervention in terms of disease burden, including both the quality and the quantity 
of life lived (Van de Roer et al. 2008). Both the (UK BEAM trial 2004; Critchley et al. 
2007) report economic analysis of their studies. From a quality-adjusted life years 
(QALY) perspective (Critchley et al. 2007) reported that if health commissioners were 
willing to pay £30,000 per extra QALY then there would be approximately a 65% 
chance of PMP being cost effective and a 35% chance for individual physiotherapy. 
The pain management (PMP) arm had lower overall direct medical costs at £174. This 
was measured in visits to a general practitioner, consultant, investigations and 
medication (£174), individual physiotherapy (IP) cost £473 and spinal stabilisation 
(SSE) arm (£382). This reduced figure may have been affected by the high attrition 
rate in the PMP arm (33%): according to the Pedro scale less than 85% compliance 
can affect results. The UK BEAM trial (2004) reported lower overall costs: £195 for 
manipulation, £140 for exercise, and £125 for combined treatment. The UK BEAM 
trial (2004) report £10,000 for each extra QALY which, even taking into consideration 
the time difference between the two studies, is a significant difference. The authors 
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acknowledge that their cost estimation was lower than the 2004 UK 
recommendations. 
2.6 Research reflecting the changing role of Physiotherapists delivering 
psychosocial interventions in a primary lead role 
The preceding research has shown some evidence of physiotherapists using a CBA 
moving away from a biomedical perspective by starting to examine the efficacy of 
pain management rather than pain relief. It could be argued that the dominance of 
the British Pain Society and the publication of their guidelines for pain management 
programmes in 2007, and revised in 2013 have limited the exploration of pain 
management delivery outside of their gold standard interdisciplinary team delivery. 
However, in the next section of this literature review, the emerging role of 
psychologically informed physiotherapy practice and the emergence of 
physiotherapists as leads rather than working as part of an interdisciplinary team is 
explored. The context of this change in research strategy is on the recognition of a 
growing number of people suffering with chronic long-term conditions and the need 
for clinically and financially effective strategies that can be accessed by the majority 
of the population. Nicolas (2015) supports this change as a potentially sustainable 
answer to the growing problem faced by health systems worldwide. The following 
studies may reflect the change in significance of the psychosocial interventions 
delivered by physiotherapists, initially with low back pain participants but with 
development involving different chronic conditions. 
2.6.1 Pain management approach in non-group interventions – Overview 
Hay et al. (2005) used an RCT design comparing physiotherapists delivering a brief 
pain management intervention to individual physiotherapy for a UK cohort of 400 
participants with sub-acute low back pain recruited from general practice. Similarly 
(Van de Roer et al. 2008) used an RCT design for a cohort of Dutch participants with 
non-specific low back pain to compare individual physiotherapy and a group training 
protocol based on exercise and behavioural therapy. Whilst Hill et al. (2011) looked 
at individual physiotherapy delivery for participants with low back pain, their 
treatment was targeted to psychosocial risk factors. Their study showed a significant 
system change in current UK practice. From their published work on the Keele STaRT 
back screening tool (SBST). The SBST is a 9-item prognostic screening tool designed to 
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be used in general practice with patients presenting with low back pain. The SBST 
was designed to aid clinicians identify risks factors including both biomedical and 
psychosocial. The SBST score stratifies patients into three groups; low, medium and 
high risk of developing chronicity. The score is used to direct clinicians to a matched 
treatment package; specific physiotherapy management for each SBST group. The 
‘high’ risk group receives the pain management approach or ‘psychologically 
informed physiotherapy practice’. The study used an RCT design to compare the 
stratified physiotherapy care based on the SBST to current best practice care. 
Although (Hay et al. 2005) and (Van de Roer et al. 2008) both compared a pain 
management intervention with individual physiotherapy, the difference in inclusion 
criteria and dosage is significantly large. Hay et al. (2005) used up to six sessions with 
a maximum of 2 hours and 45 minutes for both interventions reflective of a typical 
UK NHS setting. Van de Roer et al. (2008) used 30 sessions for their intensive group 
training and left the individual physiotherapy to the clinicians’ discretion, for a mean 
number of 13 sessions. This high number of sessions is possibly typical of service 
delivery in the Netherlands and is reflective of health insurance systems. This is a 
significant threat to the generalizability and external validity of the results to other 
clinical settings. 
In contrast (Hill et al. 2011) compared the outcome of physiotherapy intervention 
based on a prognostic screening tool using a broad inclusion criteria; low back pain 
for any duration, minimum age 18, no upper age limit and only excluded those with 
serious co-morbidities. In this literature review, only (Woby et al. 2008) and (Lamb et 
al. 2012) included psychosocial markers in their inclusion criteria. However (Hill et al. 
2011) went beyond identifying these issues by targeting the physiotherapy 
management based on the psychosocial factors. Participants were randomised to 
either targeted or non-targeted treatment (best current practice). In the targeted 
treatment group the SBST was used. Those scoring ‘low’ risk were given a one-off, 30-
minute assessment, watched a 15-minute educational video and were provided with 
the back book (Roland et al. 2002) and a list of community based exercise groups, but 
no further treatment. The ‘medium’ risk group was defined as having predominantly 
physical prognostic indicators without high levels of psychosocial distress. This group 
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received standardised physiotherapy targeting symptoms and function of up to six 
30-minute sessions (mean number was 3.7 sessions). This intervention appears to be 
the closest to the interventions described in (Hay et al. 2005; Critchley et al. 2007; 
Van de Roer et al. 2008). The ‘high’ risk group had high levels of psychosocial 
indicators, e.g. anxiety and fear. They received six, one-hour sessions of a 
psychologically-informed physiotherapy intervention. This was alongside function 
and symptom relief. The control arm of (Hill et al. 2011) non-targeted treatment 
(best current practice), was referral for physiotherapy treatment based on the clinical 
findings of the initial assessment by a physiotherapist blinded to the SBST. 
Their findings on referral patterns for further treatment in the best current practice 
arm broadly suggest that physiotherapists were more likely to refer low risk 
participants; 50%, whilst 40% in the medium group and 33% in the high risk groups 
were not referred on for further physiotherapy treatment. This finding in itself has 
implications for physiotherapy practice and could suggest that physiotherapists are 
either not identifying psychosocial factors or are potentially not confident about their 
own skills to manage this cohort. Conversely, those with low risk are being potentially 
over-treated or over-medicalised (Hill et al. 2011). 
2.6.2 Psychosocial outcomes 
Hay et al. (2005) used RMDQ as the primary outcome measures and powered the 
study to detect a 2-point difference between groups. Secondary outcome measures 
included validated measures for depression (Zung), fear (Tampa scale of 
kinesiophobia; TSK) and subscales of the Coping strategies questionnaire (CS). 
Despite the cohort having sub-acute low back pain the mean starting RMDQ was 13.8 
which suggests a more disabled cohort than (UK BEAM trial 2004; Critchley et al. 
2007; Lamb et al. 2008), which were studies specifically looking at a chronic low back 
pain. They also reported a high baseline mean TSK of 40. There was only a 0.8 change 
between-groups in RMDQ at both 3 and 12-months. However, there were large 
within-group changes for both the IP and the BPM on the RMDQ at 3 and 12-months 
of 7.8 and 8.8. The interesting change which was unaccounted for in the (Hay et al. 
2005) study was an increase in TSK score in both groups from 40.7 to 46.7 and 45.5, 
respectively. This suggests the participants had a reduction in disability but an 
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increase in fear of movement, which might impact on participants’ ability to adopt 
active strategies, including exercise adherence. A 4-point score change is suggested 
to be clinically significant on the TSK score (Woby et al. 2007). Van de Roer et al. 
(2008), reported a similar choice of primary and secondary outcome measure 
selection. They powered their study to detect a 3-point difference in RMDQ at 12-
months. Baseline data was different in (van de Roer et al. 2008): the individual 
physiotherapy group were more likely to be non-European immigrants, not in paid 
work and with a higher percentage of constant symptoms, 37% compared to 43%. 
Despite the level of intensiveness of (van de Roer et al. 2008), the results show only a 
clinical significant change in reported pain intensity on the numerical rating scale 
(NRS) at 26 weeks. There were within-group RMDQ changes of 4.9 and 5, but no 
between-group changes in primary or secondary outcomes. Hill et al. (2011) also 
used RMDQ as their primary outcome measure with two hypotheses; to detect a 2.5 
difference between-groups for medium- and high-risk at 12 months at 5% 
significance level, and to detect an overall between-groups change of 1 at each time 
point (0, 4 and 12-months). They accounted for a 25% dropout rate and recruited 850 
participants. Secondary outcome measures included TSK, EuroQol, Pain self-efficacy 
(PSEQ), HAD and SF-12. Baseline data was similar for the control and treatment arm 
for each risk group, but was different between-groups, i.e. low and high, as expected. 
The reduction in RMDQ was larger in the intervention group compared to the control 
and statistically significant for both at 4 and 12-months; mean difference 1.81 
intervention and 1.06 control. The within-group changes were also significant ‘low’ 
risk 1.06; ‘medium’ risk 5.3 and ‘high’ 6.8 when compared to other large scale RCT; 
(UK BEAM trial 2004; Lamb et al. 2012). Although (Hay et al. 2005) reported a large 
within-group change for both interventions, their cohort increased on the secondary 
outcome measures and showed no between-group differences. As discussed earlier 
the difference in referral for further physiotherapy treatment in the control group 
may have accounted for differences in ‘medium’ and ‘high’ risk SBST group effect; 
mean ‘medium’ group-control reduction 3.4 compared to 5.3 in the intervention 
group. The ‘high’ risk group showed a similar reduction of 4.4 compared to 6.8 in the 
intervention group. Total cost of the intensive group intervention was £732 
compared to individual physiotherapy at £385. These costs were significantly more 
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than the previous studies reviewed. No costing was available for (Hay et al. 2005) 
however in light of the known maximum dosage the costs would be substantially less. 
2.6.3 Group-based pain management approaches with low back pain participants 
Johnson et al. (2007), used an RCT design to investigate the effectiveness of a 16-
hour cognitive behavioural intervention delivered by physiotherapists compared to 
best practice advice delivered via a postal educational pack for the control group. The 
study selected a cohort of UK patients with persistent disabling low back pain. An 
interesting selection procedure was used; all patients who consulted their GP with 
low back pain and who met the inclusion criteria were given a study information 
sheet and those who gave consent were contacted 3-months after their GP 
appointment to determine whether they were still reporting persistent disabling low 
back pain. The term persistent and disabling were defined as RMDQ >5 and Visual 
Analogue Scale (VAS; 0-100mm; 0=no pain) >20mm. Similarly (Lamb et al. 2012) in an 
RCT to investigate the effectiveness of a 9-hour cognitive behavioural intervention 
compared to best practice advice used a psychosocial factor in the inclusion criteria. 
They selected a cohort of UK patients with ‘moderately troublesome’ sub-acute to 
chronic low back pain recruited directly from general practice databases. There is 
little detail in the report how ‘troublesome’ was assessed, unlike (Johnson et al. 
2007), and indeed how ‘moderately’ troublesome is distinguished from ‘minimally’ or 
‘extremely’ troublesome. This suggests they were attempting to identify a specific 
cohort of patients with low back pain. This is in contrast to, (UK BEAM trial 2004; 
Critchley et al. 2007; Cecchi et al. 2010), who did not have any psycho-social inclusion 
criteria on their cohort. Johnson et al. (2007) used a similar age range, 18-65, as (UK 
BEAM trial, 2004; Critchley et al. 2007; Cecchi et al. 2010), however (Lamb et al. 
2012) only specified a lower age limit of 18, similar to (Hill et al. 2011). The choice to 
limit the age range is interesting as there were no contraindications for manual 
therapy to consider and there is a potential that the results may not be generalizable 
to clinical practice which manages a larger age spectrum. A potential justification for 
limiting age range would have been if the study had looked specifically at the impact 
of persistent disabling low back pain on work outcomes, however this is not the case 
in (Johnson et al. 2007). 
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Johnson et al. (2007) used a CBA for their 16-hour group intervention which was 
delivered by two physiotherapists. Each group had between 4 and 10 participants 
and consisted of eight 2-hour sessions over a six week period. Lamb et al. (2012) used 
a smaller CBA for their 9-hour group intervention, delivered by one health care 
professional including physiotherapists, nurses or occupational therapists. Each group 
started with 8 participants and consisted of an initial assessment followed by six 1.5-
hour sessions over a six week period. Additionally, both studies also defined 
treatment compliance of initial assessment and 3 subsequent sessions in (Lamb et al. 
2012) and half (4) of the group sessions (Johnson et al. 2007). 
Both studies reported on the additional training and measurement of competence to 
deliver the intervention and ensure treatment fidelity. Lamb et al. (2012) outlined 
their training package as comprising two classroom days and an assessment with an 
adapted competence tool. In addition the researchers randomly selected sessions to 
either audiotape or observe. In contrast (Johnson et al. 2007) described a training 
package of 4 classroom days followed by purposive sampling of audio-recorded 
sessions that were reviewed and rated by two external, independent examiners for 
compliance to cognitive behavioural principles. Despite ensuring that all 
physiotherapists were assessed, they reported that some therapists found difficulty 
in adopting the communication style required for a CBA. This may have accounted for 
only 63% being deemed as compliant with the intervention delivery. The random 
selection method used in (Lamb et al. 2012) resulted in only 57% being evaluated for 
their delivery of the CBI. In addition (Lamb et al. 2012) commented on observed 
sessions. There was variation ranging from 63-83% for compliance with CBT core 
elements which further jeopardises treatment fidelity. Both studies have identified 
possible issues with delivery of CBI by non-psychology professionals. This could be a 
potential barrier to expansion of such type of interventions away from specialist 
delivery as reported by (Nicholas, 2015). 
Both studies used randomisation technique from an independent unit, and allocated 
participants to either the intervention plus best practice advice (BPA+CBI) or the 
control arm; best practice advice alone (BPA). Johnson et al. (2007) mailed an 
educational package which contained nine leaflets and an audio-cassette covering 
Page 41 of 152 
 
different self-management strategies suitable for low back pain. The intervention 
arm received the same educational package in addition to attending a 16-hour 
physiotherapy-led CBI group. In Lamb et al. (2012) the BPA arm consisted of a single 
10-15 minute session with a trained health professional delivering advice about 
staying active. This was supported by The Back Book (Burton et al. 1999). The 
intervention arm (BPA + CBI) consisted of the same 10-15 minute BPA session and the 
9-hour CBI group. 
2.6.4 Outcome measures and findings 
Johnson et al. (2007) powered their study to detect a 3-point between-group change 
on RMDQ and a 12mm change on visual analogue scale (VAS), both of which were 
used as their primary outcome measures. A total of 234 participants were recruited; 
significantly more than the 84 per arm that was stated in their power calculation. The 
secondary outcome measure was health quality of life measured with the EuroQoL. 
Lamb et al. (2012) used a sample size of 701 calculated on a 2:1 (test: control) 
treatment allocation allowed for a 25% attrition. They aimed to detect a between-
group difference at 12-months of 1.8 on the primary outcome measure; RMDQ with 
90% power and 5% significance. The 12-month follow up data was adequately 
powered with a loss of only 10% for both arms. The study looked at a range of 
secondary outcome measures including the disability and pain subscales of the 
Modified Von Korfff, the EuroQol and self-rated benefit (only included on extended 
follow-up). 
Johnson et al. (2007) had a non-significant change of 0.6 points on RMDQ between-
groups at 15 months. They reported a within-group mean change of 3.8 at 12 months 
for the CBI arm, compared to 2.9 for the control. Additionally, they asked participants 
about treatment preference prior to randomisation and found clinically significant 
differences on outcomes based on these preferences at 9 and 15 months only; 49% 
CBI; 8% control; 49% no preference. This raises an interesting aspect of patient-
centred care around choice as well as the role of expectations and beliefs about what 
will help. Linton and Shaw (2011) discussed how the beliefs we have about pain and 
its management can have a considerable impact on our experience of pain and can 
Page 42 of 152 
 
drive coping behaviours. They also suggest that such beliefs and expectations are a 
good predictor of treatment outcome and this is supported in (Johnson et al. 2007). 
Lamb et al. (2012) reported a within-groups statistically significant difference in 
reduced disability on the RMDQ for both arms of the study at each time point 
measured; 3, 6, 12 months and extended follow-up, but there was no significance 
between-groups. The BPA had a mean reduction on RMDQ of 1.1-1.6 points and the 
BPA plus CBI reduced by 2.2 – 2.9 across the time periods measured. 
They have reported an extended follow-up period, mean 34 months (range 20-50 
months) and reported a larger attrition than expected, 51% in the BPA and 40% in the 
BPA + CBI group. The larger than expected loss at follow-up potentially effects the 
generalisability of the results from the extended follow-up. This loss of power 
compromises the generalisability of the findings as there are few studies which have 
examined follow-up beyond 12-18 months. This is important information for 
researchers and health care providers when seeking evidence about interventions for 
chronic long-term conditions. 
However, despite the potentially positive results for extended follow-up the attrition 
rate is significant. The authors commented on the scores for responders and non-
responders at baseline being no different but we do not know that this is the same 
case at extended follow-up as no comparable analysis was undertaken. Furthermore, 
there may be characteristics about those who chose to respond and those who 
didn’t. Any economic analysis based on further health care use in terms of days off 
work, hospital and GP visits should be viewed with caution as only 55% of the total 
participants had responded and this might affect the external validity of the findings. 
Despite this the 12-month results show positive evidence that a relatively low-cost 
group intervention for a varied cohort of low back pain patients can be provided by 
health care professionals including physiotherapists, not working in an 
interdisciplinary team and still produce the same results as studies driven by a 
biomedical perspective (UK BEAM trial, 2004; Critchley et al. 2007; Cecchi et al. 
2010). 
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It would have been useful for (Lamb et al. 2012) to have reported on the differences 
in outcomes between the different health professionals delivering the group. 
Particularly in view of (Johnson et al. 2007) who suggested that some of the 
physiotherapists struggled with the communication style that delivery required. This 
would be a relevant area for further research. 
2.7 Non-RCT study design of psychologically based interventions by 
physiotherapists 
Woby et al. (2008) was different from the previously discussed studies as it used a 
non-experimental pre-to post-study design. The study investigated the efficacy of a 
17.5 hour physiotherapist-led programme for patients presenting with chronic low 
back pain. The intervention was called ‘Work back to Life’, a group based approach 
using cognitive behavioural principles, but which the authors named Interactive 
Behavioural Modification Therapy (IBMT). Patients were referred to ‘work back to 
life’ following assessment by the hospital-based physiotherapy team. The group was 
delivered by two physiotherapists trained in the delivery of IBMT in a group with 
between 8-12 patients. The primary outcome measure was the RMDQ and a range of 
secondary self-reported outcome measures were used including those measuring 
cognitive processes, i.e. fear of movement with the Tampa Scale of Kinesiophobia 
(TSK 17-64, 17=no fear of movement or re-injury and 64= complete fear of 
movement or re-injury), depression with the Hospital Anxiety and Depression scale 
(0-21, 0-7=normal, 8-10 mild depression, 11-15 moderate depression and 16-21 
severe) in addition to pain intensity (Visual Analogue Scale; VAS, 0= no pain, 
10=worst pain). 
The inclusion criteria explicitly required that participants were showing psycho-social 
factors e.g. yellow flags, in addition to having chronic pain. This criterion is in direct 
contrast to the (UK BEAM 2004; Critchley et al. 2007; Cecchi et al. 2010) studies 
where the criteria were broader. The criteria used were similar but more explicit than 
in (van de Roer et al. 2008; Lamb et al. 2012). However, the criteria were based on 
the referring physiotherapists’ judgement of psychosocial factors which (Hill et al. 
2011) highlighted can be flawed. It should be noted that the STaRT back screening 
tool was not in use at the time of (Woby et al. 2008). 
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In view of the acknowledgement that the cohort in (Woby et al. 2008) study is 
chronic and had more psychosocial factors, it would be expected that the baseline 
data would be significantly different to the earlier studies discussed. However the 
baseline RMDQ of 11.6 for (Woby et al. 2008) was not significantly different to 
(Critchley et al. 2007) at 11.1, but was significantly different to (Lamb et al. 2012), 
9.1. Conversely, it is feasible that in this case the physiotherapy team might have 
identified more of the patients they assessed as suitable due to the effect of being 
part of a research study; the opposite finding to (Hill et al. 2011). 
Results pre- to post-group showed a mean reduction of 3.2 points, with a moderate 
effect size of 0.56 on the RMDQ. A change on the RMDQ of 2.5 is considered to be a 
Minimum Clinically Important Difference (MCID) (Critchley et al. 2007; Hansen et al. 
2010). Although the (Woby et al. 2008) study produced above the MCID on the 
RMDQ (Hansen et al. 2010; Murphy et al. 2013) suggest this is typical of a study 
looking at short term clinical benefits and that it is at this stage large differences are 
expected to be detected. In addition to the pain disability changes, the study also 
reported a mean reduced change of 5 on the TSK scale with a large effect size of 0.71. 
There are significant potential areas where bias could have been introduced in this 
study. Firstly selection bias; there were no specific details about how participants 
were recruited and there is a suggestion that the study used retrospective data 
rather than recruitment in a prospective manner. Selection bias is also a potential 
threat to the validity of the results as it was unclear as to when, where and by whom 
the baseline and post intervention data was collected. There was no blinding of 
patients to the treatment as there was no comparison group. In addition, the authors 
suggest that the study is potentially underpowered with no power calculation to set 
sample size. Therefore, whilst the results from this study appear promising and 
favourable for the physiotherapy-led IBMT intervention they should be treated with 
caution. The SBST was not in existence during the (Woby et al. 2008) study, it would 
have been interesting to combine the SBST with a group intervention approach as 
this consistently produced better and more cost-effective service delivery with 
similar clinical outcomes when compared to individual therapy or best advice 
practice, (Critchley et al. 2007; Lamb et al. 2012). Murphy et al. (2013) has proposed 
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a protocol looking at using the SBST and matching the score to group-based rather 
than individual treatment. No further information was available on the outcome of 
the study but it will possibly have implications for current UK practice, as well as 
adding to the body of evidence. 
2.7.1 Summary 
Despite the criticism about the study design used in (Woby et al. 2008), the study 
could be considered to represent a realistic representation of service delivery i.e. a 
broad range of medical conditions and age ranges. Arguably conditions found in an 
RCT, pragmatic or otherwise, are not necessarily desirable or the results necessarily 
transferable to a clinical setting (Jessep et al. 2009). 
This review has identified that there is an expanding body of evidence using high-
quality RCT designs of physiotherapists using cognitive behavioural principles to 
deliver pain management interventions, working in a new, psychologically-informed 
way. However, the studies discussed have all exclusively investigated participants 
with low back pain only. Whilst it is acknowledged that low back pain is the most 
common musculoskeletal pain and accounts for nearly 50% of those off work with 
pain (Johnstone et al. 2002), there are other non-spinal conditions which routinely 
present in physiotherapy departments with chronic pain. There is a scarcity of 
research that examined physiotherapy management of non-spinal conditions using 
the psychosocial approaches. The final section of the review will focus on the 
available research in non-spinal conditions to gain insight into the efficacy of 
interventions. 
2.8 Randomised Control/Pragmatic trials for osteoarthritis with physiotherapists 
using psychosocial interventions 
Two RCT designs have examined group interventions by physiotherapists for 
participants with chronic knee pain. Jessep et al. (2009) used a pragmatic randomised 
control study design to compare outpatient physiotherapy with an integrated 
rehabilitation intervention (ESCAPE) for a small UK cohort of 64 patients from general 
practice with chronic knee joint pain. The study cohort included people with chronic 
knee joint pain over the age of 50, (mean age 67), defined as having clinical 
osteoarthritis based on their presentation and history. In addition the study included 
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those with stable co-morbidities including those with pain in other areas including 
back, neck and upper limb pain. The study was therefore inadvertently looking at the 
effect of the control and the intervention on a mixed condition/presentation of 
chronic pain. Coleman et al. (2012) used a similar, broad inclusion criteria, but in 
contrast with (Jessep et al. 2009), had a large age range; 18 – no upper age limit. 
They used an RCT design evaluating a self-management programme for osteoarthritis 
of the knee (OAK) compared to a waiting list control for an Australian cohort of 146 
participants. The choice of such an age range is interesting as the incidence of 
osteoarthritis is associated with ageing. Hedari (2011), states that 10% of females and 
13% of men over the age of 60 will have symptomatic osteoarthritis (Zhang et al. 
2010) suggest in their cohort a figure closer to 19% in >45. The incidence of 
osteoarthritis in the 18-45 is uncommon. Inadvertently by lowering the age range 
inclusion the study could have potentially recruited participants complaining of 
chronic knee pain without the clinical features of osteoarthritis. Despite this, the 
mean age for the study was 65 years. Participants were recruited both from their 
family doctors (general practitioners) and self-referral in response to adverts in the 
local media. This threatens the external validity of the findings and was reflected in a 
difference between-groups of 62% in the high socioeconomic index by postcode. It 
could be argued that this finding reflects the participants who were recruited from 
adverts were already more likely to respond to a self-management approach because 
of self-enrolment (Coleman et al. 2012). The baseline data was different for each 
group, which may have effect on the outcomes of the study. 
2.8.1 Interventions 
In Jessep et al. (2009) the outpatient physiotherapy was delivered to the clinician’s 
choice of usual care up to a maximum of 10 sessions. The treatment intervention was 
delivered for 1-hour over 10 sessions held twice a week in a community centre with a 
4-month review. The treatment intervention is described as a collaborative approach 
challenging people’s beliefs, enabling self-management, developing active coping 
strategies with problem solving skills and planning, in addition to exercise. 
Interestingly, the intervention could be described as using strategies and skills 
commonly found in a cognitive behavioural approach, though this is not specified. 
There is recognition that the skills used in ESCAPE are commonly utilised by 
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physiotherapists in their daily practice; goal setting, problem solving, and graded 
approaches, but have recently become synonymous with cognitive behavioural 
therapy practice. OAK in (Coleman et al. 2012) was delivered by two health 
professionals over six 2.5-hour sessions using a CBA with exercise. This study utilised 
other health professionals, in addition to physiotherapists, to deliver the programme 
as in (Lamb et al. 2012), therefore there is potential that two physiotherapists could 
have delivered the group together, justifying the inclusion in this review. The control 
arm of the study was a delayed start of six months before participants could go on 
the OAK programme, which was effectively a waiting list control. 
2.8.2 Outcomes and findings 
The primary outcome measure in (Jessep et al. 2009) was the function subscale of the 
Western Ontario and McMaster Universities Index (WOMAC). The WOMAC has been 
widely used and is a validated measure for osteoarthritis. It comprises 24 items in 3 
subscales for symptoms associated with the osteoarthritis; WOMAC-pain (0-20, 0=no 
pain 20= worse pain), WOMAC-function (0-68, 0=no loss of function, 68=complete 
loss of function) and WOMAC-stiffness (0-8, 0=no stiffness, 8=complete stiffness). 
The study used WOMAC-pain, The Hospital Anxiety and Depression Scale and two 
non-validated measures; the aggregated functional performance time of four daily 
activities and exercise-related health beliefs and self-efficacy. Coleman et al. (2012) 
used WOMAC and the short form 36 (SF36), a quality of life measure over eight 
domains covering emotional and physical bases, as their primary outcome measures. 
They also included a range of secondary functional measures, including muscle 
strength and range of movement. 
Jessep et al. (2009) results revealed that both the control and treatment intervention 
produced more than the minimal clinical improvement difference (MCID) on the 
primary outcome measure of over 38% for both groups and that this was sustained at 
12 month follow-up. White et al. (2010) reports the MCID for the WOMAC between 
17- 26% from baseline. Interestingly, levels of anxiety increased, but not with 
statistical significance, for both the control and treatment groups by 1 point. This was 
not discussed and did not seem to correlate with changes in self-efficacy or increased 
healthcare utilisation. 
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However the results should be viewed with caution; first, the cohort was relatively 
well at baseline; quality of life (EQ-5d – 0.73, 100=best health and 0=worst health), 
low level of depression and anxiety (mean 3 and 4, 0-7=normal), high functioning 
(WOMAC-function 15.9, 0=no loss of function). The study excluded those who were 
unwilling or unable to exercise or unable to walk more than 100 metres. 
Interestingly, the reason for unable and unwilling to exercise is not elaborated on. 
There can be many reasons people are unable to exercise, one of which may be fear 
which is associated in those with chronic pain, as described in chapter 1. Second, the 
sample size was small; only 64 patients were recruited with a drop-out rate of 25%. 
The authors acknowledge this limitation and state it was designed as a feasibility 
study to provide preliminary data. A further additional bias was the acknowledgment 
that that there was no attempt to stop other treatment being given during the study 
period. This continued at the GP’s discretion. Although this is acknowledged as a 
potential bias, this is a realistic position of what happens in everyday clinical practice. 
Coleman et al. (2012) reported problems with their final results because of the last 
value carried forward (LVCF) analysis used. In the waiting list control group they had 
a higher than expected drop out at 8 weeks of 88% (64 started the trial and only 8 
responded at 8 weeks and 14 at 6 months). Unexpectedly, the responders increased 
in the control group at 6-month follow-up but because LVCF was used, it appeared 
that the control group results were stable across time points for both pain and 
function. The authors argue that this is unlikely to be the case because of the nature 
of osteoarthritis where deterioration in symptoms and function is more likely to be 
noted with passing time. However, we do not know the reasons; the authors suggest 
that a Hawthorne effect might be an answer, as well as the interaction between 
responders at the assessment time point with a health care professionals. The results 
did show an improvement in the OAK group in function at 8 weeks and at 6 months 
with both primary outcome measures. WOMAC-function improved by 38% within-
group for OAK group, similar to (Jessep et al. 2009). However, this reduced to only 
14% improvement at 6-month follow-up. The authors commented on this effect 
being expected after an intervention and the natural deterioration associated with 
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the chronicity of the condition. However (Jessep et al. 2009) sustained changes in 
both improved in physical function and reduced pain at 12-month in a similar cohort. 
2.8.3 Outcome and discussion 
Overall, the findings for (Jessep et al. 2009) were in support of (Critchley et al. 2007). 
Neither intervention was superior to the other but the group intervention was more 
cost effective, both in term of delivery (£63.67 compared to control £130.77) and in 
overall costs including further health care usage (GP, consultant visits and medication 
costs; £319.77 compared to £582.57). Critchley et al. (2007) suggests that their study 
adds support for physiotherapy delivery of a pain management approach for chronic 
low back pain in a group setting. Furthermore, the authors suggest that even a 50% 
shift in the management of patients referred with chronic low back pain to 
physiotherapy could result in savings for the NHS of £126 million per year (2003-2004 
prices). The additional recognition of the intervention being described as a 
behaviour-changing intervention being delivered by physiotherapists adds further 
evidence for the role of physiotherapists in chronic pain management. There are a 
number of issues relating to both internal and external validity to draw any 
generalizable conclusions from (Coleman et al. 2012). 
2.9 Summary of the literature review 
The studies that have been included in this literature review offer evidence that 
physiotherapists are making significant contributions to the development of practice 
within the management of chronic pain. It provides evidence that physiotherapists 
can manage a cohort of patients with chronic pain using techniques that are not 
considered traditional, i.e. graded exposure, psychological coping skills, in contrast to 
treatment techniques traditionally associated with physiotherapists; manual and 
electrotherapy. The studies included have looked at both management in a group 
and individually (UK BEAM trial 2004; Critchley et al. 2007; Cecchi et al. 2010) and 
have reported positive clinical changes that in some studies were sustained to long 
term follow-up (Jessep et al. 2009; Lamb et al. 2012). Interestingly, the studies that 
have included an economic analysis, regardless of their approach, put strong cases 
forward for both group (Critchley et al. 2007) and individual delivery (Hill et al. 2011) 
being both clinically and cost effective. 
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The focus of the research to date has been on the management of low back pain. 
Nicholas (2015) reports that low back pain is the leading cause of disability but 
despite this the vast majority of treatments achieve no more than 20% reduction in 
pain levels. The impact of our ageing society and the associated increased incidence 
and prevalence of chronic joint problems will potentially result in an increase number 
of people living with chronic pain. However, pain is a complex multi-factorial problem 
that cannot always simply be related to pathology as discussed in Chapter 1. 
The challenge for health care providers including physiotherapists is how to manage 
this growing number of multi-site pain presentations. This literature review has 
established that there is no existing evidence about physiotherapist-led management 
of chronic musculoskeletal pain in a group setting using a cognitive behavioural 
approach. Group management of people with mixed condition types/pathologies 
with psycho-social factors are found exclusively in specialist interdisciplinary pain 
clinic settings where physiotherapists are part of the team but do not deliver the 
entire pain management programme. The focus of this research is about the 
management of chronic pain by physiotherapists in a group setting. A pre-
experimental longitudinal study design was proposed to evaluate the efficacy of an 
existing service in a clinical setting and produce preliminary evidence. Nicholas (2015) 
supports increasing the research evidence of non-psychologists delivering pain 
management skills to enable more people to be able to access services. 
2.10 Study aims 
1. To explore the efficacy of a physiotherapist-led, group-based intervention for 
patients with chronic musculoskeletal (CMSK) disorders to reduce fear avoidance, 
disability, depression and increase in self-efficacy at pre to post 5 weeks intervention. 
2. To explore the medium-term benefits of the group-based intervention on the 
same outcomes at 3-month follow-up and to investigate differences between 
outcomes in terms of condition type and referral sources. 
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3 Phase 1 Preliminary Study 
3.1 Introduction 
In chapter 1, the growing problem of chronic pain was discussed in terms of 
consequences for the sufferer’s health and well-being, and the impact to society in 
terms of direct healthcare costs and lost work days. Nicholas (2015) calls for a review 
of the delivery of pain management services to keep up with this growing crisis. 
Physiotherapists work with people who have a wide variety of conditions and across 
age groups. They are potentially in a unique position to be involved in developing and 
delivering accessible pain services across healthcare boundaries (Sullivan, 2008). The 
cost implications for inter-disciplinary services also requires consideration. The British 
pain society, in the revised 2013 PMP guidelines, state that they are cost effective in 
terms of further healthcare usage, i.e. fewer GP appointments, less pain medication 
and reducing accident and emergency attendance, but there is a growing body of 
evidence to suggest some uni-disciplinary approaches can also have this effect (Hill et 
al. 2011; Woby et al. 2008). The recent economic downturn in the UK has resulted in 
a re-evaluation of priorities for public spending. Research is needed to define 
clinically based criteria for patients who may benefit from inter-disciplinary 
interventions and those who could be managed in effective but lower cost 
interventions. 
In response to this growing problem for patients with chronic pain a physiotherapy-
led group intervention was developed at Fairfield Hospital in Bury, Lancashire, based 
on the work of (Woby et al. 2008). The original work examined physiotherapists 
delivering a 17.5-hour group programme, 5 sessions of 3.5 hours, for people with 
chronic low back pain based on strategies identified from a cognitive behavioural 
approach. The term ‘Interactive Behavioural Modification Therapy’ (IBMT) was 
devised to identify the intervention as being in the spirit of, but different to, cognitive 
behavioural therapy. The cohort recruited for (Woby et al. 2008) were all chronic low 
back patients with psycho-social indicators. The study reported significant reductions 
and moderate treatment effect sizes in disability, fear of movement, catastrophizing 
and depression. The group at Fairfield Hospital in Bury has developed the service to 
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include patients with chronic musculoskeletal (MSK) pain from conditions other than 
low back pain. 
The primary aim of this present retrospective study was to evaluate the outcome of a 
physiotherapy-led functional restoration programme for patients with persistent 
musculoskeletal pain in an outpatient setting in terms of change scores on patient 
reported outcome measures (PROMS). The secondary objectives are to provide 
evidence of physiotherapy-led management of a mixed aetiology pain cohort and to 
determine the sample size for the phase two prospective study. 
3.2 Design 
This preliminary study was a retrospective service review of clinical data collected 
after a 15-hour physiotherapy-led programme for patients with chronic 
musculoskeletal pain who attended between January 2011 and December 2013. 
Patients were included if they had completed 3 or more sessions of the programme. 
In some cases, data was found to be missing; possibly from error or the patient may 
have not attended the final session for data collection. All patients attended a 
physiotherapy-led group intervention called the Functional Rehabilitation 
Programme (FRP). The purpose of this programme is for participants to develop self-
management strategies including pacing, managing exacerbations of pain, setback 
planning, stress management and knowledge about pain neurophysiology. The 
principles are then practically applied through the movement/exercise component of 
the programme. 
Approval for the study was granted by the Research and Development department of 
The Pennine Acute NHS Hospitals Trust. R&D Reference: 13RECNA20 (see Appendix 
14 - NHS permission letter for preliminary study on page 143). 
3.3 Patients 
Patients were referred to FRP following assessment by outpatient physiotherapists 
from Pennine NHS Acute Hospitals Trust. The original source of the physiotherapy 
referral were predominantly from General Practitioners, and secondary care services 
including orthopaedic, rheumatology and pain. Patients typically had chronic MSK 
pain which had been present for longer than a 3-month period and were displaying 
psychosocial signs/behaviour. This was identified by the physiotherapists using 
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yellow flag questions during their assessments. These typically included; fear of 
movement, avoidance of everyday activities, unhelpful beliefs about pain, 
catastrophizing about their conditions and using passive coping strategies. Patients 
were included in this study if they were enrolled on the Functional Rehabilitation 
Programme between the review dates, January 2011 to December 2013, and if they 
had completed at least three sessions. Patients were referred onto the programme 
by their physiotherapists. 
3.4 Physiotherapy-led pain management group intervention (FRP) 
The programme consists of 15-hours of group contact delivered by two Agenda for 
change band 7 physiotherapists in five, 3-hour sessions which was (delivered) over a 
5-week period. Sessions are delivered in an interactive and collaborative way to 
engage the patients as they develop new coping strategies. Specifically, the 
programme comprises interactive educational components, with exercise and goal-
setting principles covering topics recommended by the British Pain Society (BPS) as 
useful coping strategies for managing chronic MSK pain. The exercise session runs on 
each week and involves a circuit of 12 stations including resistance, cardiovascular 
and proprioceptive components. Patients are asked to stay on each station for 1 
minute and then move on to the next station. The emphasis during the exercise 
session is pacing whilst addressing patients fear and concerns relating to physical 
activity and movement. Each week has a different topic including the de-conditioning 
effects of persistent pain, pacing, flare up management/setback planning and long 
term maintenance. Throughout the programme there are three educational sessions 
entitled ‘Making Sense of Pain’ which covers pain mechanisms, neurophysiology and 
factors that influence the pain experience. This section is designed to explore the 
patient’s current pain knowledge and challenge unhelpful pain beliefs. There are also 
strong links with our third sector partners in local community services including a talk 
by the expert patient programme co-ordinator on the final session, in addition to 
direct referral pathways to health trainer services and exercise on prescription 
schemes. 
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3.5 Assessment Procedure 
Patient demographics were recorded on the patient’s physiotherapy case notes. 
Patients completed three patient-reported outcome measure before starting the 
programme and at the end of the programme. 
3.5.1 Fear of movement 
The Tampa Scale of Kinesiophobia (TSK, score range 17-64; 17=no fear related 
behaviour and 64= total fear of movement), is a 17-item questionnaire for assessing 
pain-related fear of movement and re-injury. Fear of movement has been shown to 
be a strong predictor of chronic disability in patients with chronic pain, and also can 
be a barrier to exercise and activity. The TSK is both a validated and reliable measure 
in a persistent pain population (Burwinkle et al. 2005). A minimum of a 4-point 
change score is suggested to be clinically meaningful post intervention (Woby et al. 
2005). 
The secondary outcome measures included; 
3.5.2 Pain-related disability for low back pain (RMDQ) 
The Roland Morris Disability Questionnaire (RMDQ, 0-24; 0=no pain-related disability, 
and 24= total pain-related disability), is a 24-item self-report questionnaire relating to 
low back pain. This measure is widely used in research for different low back pain 
populations and displays good levels of reliability and internal validity (Hansen et al. 
2010; Woby et al. 2008; Critchley et al. 2007). The above studies report reductions of 
between 1.8 and 4 points as being indicative of a clinically-meaningful change. 
3.5.3 Pain-related disability for multi-site pain (PDQ) 
If subjects presented with multi-site or widespread pain they completed the Pain 
Disability Questionnaire (PDQ, 0-150; 0=optimal function, 150=total disability), which 
is a generic disability questionnaire validated for use with a chronic musculoskeletal 
population. Categories for severity have been defined for the PDQ; 0-70 
mild/moderate disability, 71-100, severe disability and 101-150 extreme disability 
(Gatchel et al. 2006). There are no Minimally Clinical Difference (MCID) scores 
currently established for the PDQ. 
Finally, the patients completed the catastrophizing subscale of the Coping Strategies 
Questionnaire 24 (CSQ24). The CSQ24 is a shortened version of the Coping Strategies 
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Questionnaire and includes 24-items and four factors; Catastrophizing, Diversion, 
Reinterpreting, and Cognitive Coping (Harland et al. 2003). This tool was found to be 
a stable assessment tool in patients with chronic low back pain (Harland et al. 2013). 
However it has not currently not been validated for other chronic pain conditions. 
There are no MCID scores currently established for the CSQ24, however, a reduction 
in the catastrophizing score pre- to post-intervention suggests an improvement in 
coping styles. 
3.6 Patient comments 
A locally devised feedback form was given to the patients at the end of the 
programme and they were asked to complete it anonymously. Areas discussed were 
around session and exercise content, which sessions were most and least helpful. In 
addition patients were invited to make general comments on their experience of 
attending the programme and ideas for improvements. 
3.7 Data analysis 
Data was analysed in stages using SPSS. Firstly, baseline data including demographic 
and patient-reported outcome measures were evaluated using descriptive analysis 
such as frequency, mean and median. Secondly, the pre- to post-intervention scores 
on the patient reported outcome measures (continuous variables) were computed to 
determine if there were changes. Parametric paired t-test was used for variables 
which were normally distributed or non-parametric equivalent Mann-Whitney U test 
for non-normally distributed data. Effect sizes were also calculated to provide an 
indication of the size of change on each of the variables. Effect sizes were defined by 
Cohen as 0.20 small; 0.50 moderate and >0.8 as large (Lakens, 2013). Finally the data 
was split into condition types; low back pain and chronic widespread pain including 
fibromyalgia and the change score difference for TSK and CSQ-Cat were computed 
pre- to post-intervention. A Mann-Whitney U test was run to determine if there were 
differences in change scores between the two different condition types (low back 
pain and widespread pain). Significance was set at p < 0.05. 
3.8 Results 
Between January 2011 and December 2013 a total of 278 people were referred onto 
the FRP programme. Of these 278, 132 (47%) either did not start the programme or 
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failed to complete a minimum of 3 sessions and therefore complete data sets were 
not recorded. There was no additional information on the patient records to account 
for the reasons for not starting or completing the programme. Table 3.1 shows the 
demographic characteristics and source of referral for participants who attended 
(n=154) and those who did not attend (n=129). 
Table 3.1 - Baseline demographic data for patients who completed the programme and those who did not complete 
Characteristic Number 
 Attendees n=154 Non-attendees n=129 
Age Mean (SD) 51.06 (14.04) 47.02 (23.94) 
Range 21 – 90 19 – 71 
Gender, n n% n% 
Female 106 (68.8) 94 (72.9) 
Male 48 (31.2) 35 (27.1) 
Condition type, n (%)   
Low back pain 85 (55.2) 82 (63.5) 
Fibromyalgia/widespread pain 69 (44.8) 47 (36.5) 
Employment status   
Working 34 (22.1) 30 (23.3) 
Not working 76 (49.4) 70 (54.3) 
Retired 32 (20.8) 12 (9.3) 
Missing data 12 (7.8) 17 (13.2) 
Source of referral, n (%)   
Primary care 75 (48.7) 65 (50.4) 
Secondary care 68 (44.2) 55 (42.6) 
Missing data 11 (7.1) 9 (7.0) 
 
Those who attended had a mean age of 51, were predominantly female, not working 
and condition type was fairly equal between low back pain (55.2%) and chronic 
widespread pain (44.8%). There were more patients with low back pain who did not 
attend the programme (63.5%). A chi-square test for association was conducted 
between attendance of the programme (completed and not completed) and 
condition type, gender and referral source. All expected cell frequencies were greater 
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than five. There was no statistically significant association between attendance status 
and condition type, χ2(1) = 0.58, p = 0.446; gender χ2(1) = 0.55, p = 0.458; or referral 
source χ2(1) = 0.78, p = 0.077. Demographic characteristics for those who did not 
complete the programme were similar to those who attended, with the exception 
that they were younger with a mean age of 47. A Mann-Whitney U test was run to 
determine if there were differences in age between those who completed the 
programme and those who did not complete. Distributions of age for both groups 
were similar, as assessed by visual inspection. Median age was statistically 
significantly higher in those who completed (51) years than in those who did not 
complete (44) years, U = 6523, z = -3.488, p = 0.001. 
3.8.1 Fear of movement – (TSK) 
A paired-samples t-test was used to determine whether there was a statistically 
significant mean difference between the pre to post intervention scores in Table 3.2. 
Data are mean ± standard deviation, unless otherwise stated. There were no outliers 
detected, for TSK as assessed by inspection of a boxplot. The assumption of normality 
was not violated, as assessed by Shapiro-Wilk's test (p = 0.44). 
Table 3.2 shows the participants’ fear of movement reduced following the 
physiotherapy group from (39.94 ± 0.83) to (34.17 ± 8.32), a statistically and clinically 
significant reduction of -5.77 (95% CI, 4.56 to 6.98), t (152) = 9.44, p < 0.001, and 
moderate effect size calculated by Cohen’s d = 0.69. 
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Table 3.2 - Pre to post-intervention scores with paired t-test analysis and effect size 
Outcome 
Measure 
Pre-group 
mean 
(SD) 
Post-
group 
mean 
(SD) 
Mean 
difference 
t-test CI 95% p-
value 
Cohen’s 
d 
Tampa Scale of 
Kinesiophobia 
(TSK) n=152 
39.94 
(8.38) 
34.17 
(8.32) 
5.77 9.43 4.56 - 
6.97 
<0.001 0.69 
Roland Morris 
Disability 
Questionnaire 
(RMDQ) n=81 
12.80 
(5.11) 
8.38 
(5.00) 
4.51 7.51 3.31 - 
5.70 
<0.001 0.88 
Pain Disability 
Questionnaire 
(PDQ) 
91.73 
(23.70) 
81.13 
(27.72) 
9.25 3.60 4.10 - 
14.40 
<0.001 0.39 
Coping Strategies 
Questionnaire 
Catastrophizing 
(CSQ-Cat) 
15.13 12.27 2.85 4.74 1.66 - 
4.04 
<0.001 0.39 
 
3.8.2 Pain-related disability low back pain (RMDQ) 
There were two outliers detected. These were not extreme and were therefore left in 
the analysis. The assumption of normality was not violated, Shapiro-Wilk’s test (p = 
0.126). A reduction in pain was observed in patients with low back pain in pain-
related disability from (12.81± 5.09) to (8.31±4.94), a statistically and clinically 
significant reduction of 4.51 (95% CI, 3.31 to 5.70), t(81) = 7.51 p<0.001, d=0.83. 
3.8.3 Pain-related disability (PDQ) 
There were no outliers detected and the assumption of normality was not violated, 
Shapiro-Wilk’s test (p = 0.500). A reduction was observed in patients with non-spinal 
pain/widespread pain in pain-related disability from (91.16±23.44) to (81.91±27.28), 
a statistically significant reduction of 9.25 (95% CI, 4.105 to 14.40), t(55) = 3.60 
p<0.001, d=0.35. 
3.8.4 Catastrophizing (CSQ-Cat) 
There were multiple outliers and normality was violated, Shapiro-Wilk’s test (p=0.02), 
therefore a non-parametric Wilcoxon signed-rank test was run. There was a 
statistically significant median decrease (3.00) from baseline (16.00) to post group 
(12.00), z = -4.51, p < 0.001, d=0.39. Although catastrophizing as measured by the 
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CSQ24 reduced post intervention, because of the lack of MCID for the CSQ24 it is 
difficult to evaluate the scale of this change. 
3.9 Analysis of outcome measures between condition types 
The data for TSK and CSQ-Cat difference scores had multiple outliers and were not 
normally distributed therefore a Mann-Whitney U test was run to determine if there 
were differences in scores between patients with low back and chronic widespread 
pain. Only the TSK and CSQ-Cat were analysed as both condition groups completed 
different disability measures, (RMDQ and PDQ). Distributions of the TSK and CSQ-Cat 
difference scores were similar, as assessed by visual inspection. Median TSK and CSQ-
cat scores for low back pain (-6.00; -3.00) and chronic widespread pain (-4.00; -3.00) 
were not statistically significantly different, TSK; U = 3,106, z = 0.928, p = 0.35; CSQ-
Cat; U = 2,776, z = 0.37, p = 0.70. 
3.10 Qualitative feedback from patients post-programme 
Patients were asked to complete an informal locally devised feedback form following 
the completion of the programme and this was completed anonymously. Descriptive 
thematic analysis was performed (Cresswell and Clark, 2011). The majority of 
comments fell into the following broad themes; support from other patients, staff 
delivery of the programme, content of the programme and lifestyle changes. The 
following are comments from each theme described above; 
Analysis of the comments revealed that patients were positive about their experience 
of the group. The majority of comments fell into the following broad themes; support 
from other patients, staff delivery of the programme, content of the programme and 
lifestyle changes. The following are comments from each theme described above; 
Support from other patients: 
“I didn’t feel like I was on my own” 
“I couldn’t get over how many other people were living with pain. I thought it was 
only me” 
“I have made some real friends and we are going to meet up again to support each 
other” 
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Support from staff; 
“The delivery was done in a fun friendly way and I felt I could ask anything” 
“I felt believed for the first time and the staff made it feel like it was real and wasn’t 
all in my head” 
“We were able to laugh even though we were talking about serious problems it made 
it easier somehow” 
“The staff were friendly, approachable and enthusiastic” 
“I’ve been to physio lots of time before but didn’t get anywhere. I felt this time I was 
really listened to and believed and that means a lot – thank you” 
Content of the programme; 
“I enjoyed the exercises, I never thought I’d say that but I did!!” 
“I felt I have learnt new ways to help me manage the pain. I particularly liked the 
explain pain talks it made sense“ 
“I liked the way we weren’t talked at. We could all chip in and say what we thought 
and agree and disagree. I’ve stopped saying I can’t thanks to the pacing session” 
“For me the relaxation sessions were the best. I didn’t realise how my breathing had 
changed and how I was holding myself so stiffly” 
“To know that I wasn’t causing more harm that was the most important information 
and I have found that since then I’ve tried more things, things I wouldn’t have done 
before and my pain isn’t worse” 
Lifestyle changes; 
“I’ve stopped saying I can’t to everything” 
“I’ve started to park further away from the shops and use the stairs for more exercise” 
“I’ve stopped saying yes to everything. I’m talking to family and explaining to them 
how I need to pace” 
“I’ve joined a gym and I’m planning on going to Zumba” 
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“I’ve dug my Wii fit out of the attic and started using it: little and often; that’s the 
way” 
“I feel more confident now. I had a big black cloud over me and nothing was helping, 
pills weren’t touching it. I’m doing more now and the pain is no worse so that must 
mean I’m getting fitter or something” 
3.11 Summary of Key findings from Phase 1 
The physiotherapy-led intervention produced clinically and statistically significant 
short term (pre to post) changes in low back pain related disability (RMDQ) and fear 
of movement in a cohort of patients with chronic MSK pain. 
Improvements were also observed in pain-related disability for widespread pain 
(PDQ) and for catastrophizing. Due to the lack of MCID established for these outcome 
measures it is unclear as to whether the change scores observed were clinically 
significant however both were statistically significant p < 0.001. 
No difference in scores (TSK and Cat-A only) were observed between condition types 
(low back pain and widespread pain) suggesting that a physiotherapy-led 
intervention with a mixed aetiology group can produce positive changes. This 
observation may have potential clinical significance, but would be worth testing in a 
larger cohort of patients. Chapter 2 highlighted that most physiotherapy research in 
chronic pain group management has focused on either classes/groups for low back 
pain or osteoarthritis but not a mixed aetiology chronic pain group. 
Finally, although informal, qualitative responses from participants from the group 
appear to support changes observed on the patient reported outcome measures in 
relation to behaviour and lifestyle changes. 
3.12 Discussion 
The results from this service evaluation provide preliminary support for 
physiotherapy-led group management for patients with persistent pain from 
different conditions. The group achieved this by firstly integrating an interactive self-
management approach in an environment that supports behavioural exploration of 
movements/activities. Secondly by raising knowledge and awareness about other 
coping strategies that can be used to manage long-term conditions. 
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The overall findings of this service evaluation suggest that the physiotherapist-led 
group produced changes in reducing fear-related movement and pain-disability in a 
cohort of patients with persistent MSK pain including widespread, multi-site pain and 
fibromyalgia (44.8%) and low back pain (55.2%). Whilst the results are similar to 
those obtained by (Woby et al. 2008), these results are potentially important as they 
have shown no significant differences in fear-related movement (0.354) or 
catastrophizing outcomes (0.708) between the two condition types. The results 
suggest that different condition types do as well as in a mixed group setting as in a 
chronic low back pain-only group (Woby et al. 2008). This finding has capacity 
implications for service design in that diverse pain condition types could be managed 
in one group and this could potentially be both a clinical and cost-effective approach. 
It is recognised that the patient comments reported here were not collected or 
analysed using recognised qualitative research methodologies. Nonetheless there 
appeared to be a positive validation of the physiotherapy-led service and comments 
relating to changes in behaviour and lifestyle seemed to correlate with improvements 
in outcome measures. This finding is supported by (Lamb et al. 2012) who included 
semi-structured interviews as part of their mixed methodology study exploring 
participant’s views on non-psychology led pain management groups. 
3.13 Limitations 
This retrospective review only captured a limited view of the multi-faceted nature of 
persistent pain. The current evaluation is limited to disability and two constructs of 
fear; fear of movement and catastrophizing. It has been suggested that a reliance on 
patient self-reported measures may be a limitation in a persistent pain population as 
patients may exaggerate or minimise their reports of pain and suffering on self-
report measures (Wells Federman et al. 2002). However, the authors suggest that if 
this is indeed the case then it is reasonable to assume that they may be consistent 
with this over- or under-reporting. Gatchel et al. (2006) supports their use and 
discusses how self-report measures have become essential elements of assessing the 
effectiveness of musculoskeletal treatment. Harding et al. (1994), developed a 
battery of physical function tests to assess and evaluate physical aspects of a pain 
management intervention and this could arguably be used to enhance the patient 
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self-report measures. A further limitation with this current service provision is the 
lack of follow-up provision. The service evaluated in this preliminary study was set up 
to discharge patients on completion of the programme and therefore only the 
immediate pre- to post-effects are known for this intervention. It is recognised, both 
by the British Pain Society (2013) and in the Map of Medicine pathways for chronic 
pain (2012), that provision of a follow-up or review is essential for services managing 
long-term conditions to offer supported self-management. In addition, the high 
percentage (47%) of people who did not start or complete the group has clinical 
implications for the service and requires a review of the process of how and why 
physiotherapists refer patients into the group. 
3.14 Conclusion 
Despite the limitations of this service review, it offers encouraging support to the 
current service providers and has potential implications for the physiotherapy-led 
management of patients with persistent pain in a mixed aetiology group. 
Following the findings from this service evaluation, a prospective research study was 
proposed to evaluate the pre- to post-intervention changes with a 3-month follow-
up. The study will also evaluate a broader range of dimensions in the self-report 
measures to capture the multi-faceted nature of chronic pain and include physical 
function tests to measure physical performance. The findings from this preliminary 
study were used for the power calculation of the phase two prospective study. 
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4 Methodology 
4.1 Study design 
The study used a pre-experimental medium term follow-up study design. The reasons 
for selecting the study design were varied including whether the efficacy of 
treatment gained can be sustained (Lamb et al. 2012). From the literature review 
there appeared to be a growing body of evidence for physiotherapy-led group-
management of specific conditions, i.e. low back pain and osteoarthritis. However 
there was no research to support physiotherapy-led group management of patients 
reporting chronic pain as a limiting factor in daily activities in different conditions. 
However (Nicholas, 2015) suggests that to meet the needs of the growing number of 
people with chronic pain a range of health professionals in non-specialist services will 
need to be able to deliver pain management skills effectively. This study design was 
considered to be an appropriate choice to investigate the effects of an intervention in 
clinical, everyday practice (Murphy et al. 2013). This study set out to establish 
whether current service provision at Pennine Acute NHS Hospitals produces changes 
in terms of patient-reported outcome measures for a group of people with mixed 
chronic pain presentations, i.e. low back pain, and multi-joint or chronic widespread 
pain. The current service is based on the work of (Woby et al. 2008), however their 
work exclusively explored patients with chronic low back pain. The current study 
examined the effect of a similar intervention on a mixed chronic pain group. Sim and 
Wright (2000), state that the disadvantages of a pre-experimental study design 
include both internal and external validity. Internal validity relates to the extent to 
which the results can be attributed to the intervention being studied whilst external 
validity relates to the generalizability of the results (Creswell and Clark, 2011). 
Another factor that influenced study design was that there was no funding granted to 
provide administrative support, nor staff for the organisation to conduct a 
randomised controlled trial. The time frame for completion of the prospective phase 
of the study was an addition extraneous factor. In addition as part of the 
development of the prospective study design an initial preliminary retrospective 
service evaluation was performed and this is reported in Phase 1 Preliminary Study 
on page 51. 
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4.2 Setting 
A physiotherapy musculoskeletal outpatient department within a hospital in Bury, 
Lancashire. 
4.2.1 Participants 
Patients who presented to the outpatient physiotherapy departments of Pennine 
Acute NHS trust with chronic musculoskeletal pain (present for 3 months or longer) 
and with signs of psychosocial factors were identified by a physiotherapist during 
their assessment using yellow flag questions (Kendall et al. 1997; Nicholas et al. 
2011). 
4.2.2 Eligibility criteria 
The intervention is designed for an adult population aged 18 years and over with no 
upper age limit. This minimum age limit is in keeping with other research studies that 
examined patients with chronic pain (Critchley et al. 2007; Woby et al. 2008; Hansen 
et al. 2010). However, a few studies have included an upper age limit of 65 (UK BEAM 
trial 2004; Critchley et al. 2007). However, as this study explored a routine service 
provision and in acknowledgment of prevalence of chronic pain increases, an upper 
age limit was not set as an exclusion criteria (Hill et al. 2011; Lamb et al. 2012). 
All participants reported a current history of chronic pain from a musculoskeletal 
disorder, with a duration of more than three months and that they were seeking 
treatment for. During the initial physiotherapy assessment, each participant was 
screened for ‘red flags’; signs of potential serious pathology. Any evidence of red 
flags were appropriately referred on for further investigation through the 
appropriate hospital pathways, (see Appendix 5 - Flag indicators on page 132). 
Participants were asked to commit to all five sessions with an explanation that each 
session covered a different aspect of pain management and that each session, rather 
than being a stand-alone topic, built from the previous weeks. Hansen et al. (2010), 
who investigated the effect of a CBT approach for chronic low back pain by a single 
profession, suggested that attendance of 5.5 hours out of a possible 10 hours was a 
pragmatic decision of compliance with their study intervention. This study defined 
compliance as attendance of at least 3 sessions, 9 hours out of a possible 15 hours. 
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Participants required having adequate command of spoken English to allow full 
participation in the group discussions. This was is in line with similar studies of this 
type of intervention (Critchley et al. 2007; Murphy et al. 2013). There are examples of 
studies investigating a similar cohort that excluded participants if they could not read 
or write in English (Nicholas et al. 2013; Broderick et al. 2014). As this study looked at 
an existing service, provision was made to accommodate this. 
4.2.3 Exclusion criteria 
Participants were excluded from the study if they had already completed a pain 
management programme. This was an attempt to prevent previous exposure to a 
cognitive behavioural or pain management approach being an extraneous variable 
that may affect the findings of the study (Lamb et al. 2012). In addition it was felt that 
if a participant had already been through this type of intervention previously, the 
reasons for further referral needed to be explored and other management options 
discussed (Hansen et al. 2010). 
It is recognised that having one long-term condition increases the risk of developing 
multiple long-term conditions, although it is unclear as to the causative link (Long 
Term Condition Compendium Third Edition 2012). Participants were excluded if they 
had unstable co-existing pathologies which prevented full participation in the group 
activities whether this was the exercise or group discussions. Examples of exclusion 
included unstable angina, recent myocardial infection, severe chronic obstructive 
pulmonary disease and severe mental illness. The hospital provides specific group 
and individual interventions for these conditions. These exclusions were also 
supported in similar cohorts (Critchley et al. 2007; Woby et al. 2008), and also in 
cohorts with more complex presentations in specialist centres (Nicholas et al. 2013; 
Amris et al. 2014). 
4.3 Study procedures 
4.3.1 Recruitment phase 
Patients were identified as potential participants by the physiotherapists working in 
the MSK outpatient team. The physiotherapists were a representative team of mixed 
grades from junior, agenda for change (AfC) band 5, to clinical specialist level AfC 
band 8. The team were aware of the study protocol. The intervention in the study 
Page 67 of 152 
 
was an existing service that the physiotherapy team were already aware of and used 
for patients with chronic MSK pain. If they identified during their initial assessment 
that the patient had a history of chronic MSK pain present for longer than three 
months, displaying psycho-social factors and meeting the inclusion criteria they were 
considered for the study. Psycho-social factors were identified using yellow flag 
questions. This recruitment process is reflective of routine clinical practice and is in 
keeping with the study design by (Woby et al. 2008) that employed a similar 
recruitment process. 
4.3.2 Consent phase 
Following the initial assessment, if a patient was identified as suitable for the group 
intervention study then the physiotherapist discussed the study with the patient and 
provided a study invitation letter, a participant information sheet and a consent 
form, (see Appendix 15 - Participant study consent form, Appendix 16 - Participant 
study invitation letter & Appendix 17 - Participant study information sheet on pages 
144 - 146). The physiotherapist responded to the patient’s questions directly and 
they also invited the patients to contact the principal researcher if they had any 
further queries about participating in the study. The patients were asked to return 
the consent form in the envelope provided or return the form to the first session of 
the group. This ensured that all patients had a minimum of 48 hours to make an 
informed decision about participating in the study. Potential participants were aware 
that if they did not want to participate in the study that they could still attend the 
group intervention as this was an established service offered for this client group and 
that their non-participation in the study would not affect their treatment. 
4.3.3 Baseline Assessment 
During the first session of the intervention all participants who had consented 
completed four patient-reported outcome measures and a physical function test (see 
Appendix 8 - Study physical function tests on page 136). The questionnaires were 
administered and scored independently by an outpatient physiotherapist who was 
not involved in the study. The physical function test was recorded during the first 
session by the second group physiotherapist and not the principal researcher. The 
physical function test was performed in a set order for all participants both at 
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baseline and post intervention. The test started with the timed 20 metre walk test, 
then the 5 minute walk, followed by the 1 minute timed step up test (see Appendix 8 - 
Study physical function tests on page 136). Data was transferred from patient 
physiotherapy records to an anonymised data collection sheet. Participant 
identification was by unique study code and this was not kept alongside the patient 
consent form or patient treatment records. Data collection sheets were kept in a 
secure filing cabinet in the physiotherapy department. Demographic data was 
collected including age, gender, work status, ethnicity, referral source and condition 
type. All data was recorded following the baseline assessments, on an SPSS 
worksheet. Following completion of baseline assessments each participant met with 
one of the physiotherapists facilitating the group for an individual review. The review 
lasted for 10 minutes and covered what the patients’ expectations/concerns were for 
the group, if anything had changed since they were last seen in physiotherapy and if 
there were any reasons why they could not attend all the group sessions. This review 
was recorded on a separate sheet and attached to the patients’ physiotherapy record 
and was not included on the study data extraction form. 
4.4 Intervention 
All participants completed a physiotherapist-led group intervention called the 
Functional Rehabilitation Programme (FRP). The programme is similar in structure to 
the group intervention in (Woby et al. 2008), which looked at the intervention for a 
cohort of participants with chronic low back pain. This intervention has been 
described as using an ‘Interactive behavioural modification therapy’ (IBMT) which is 
based on the main principles of cognitive behavioural therapy but not delivered by a 
trained CBT therapist. This type of intervention has also been described in (Critchley 
et al. 2007) and (Jessep et al. 2009). FRP has been adapted from this initial work to 
treat patients with a range of chronic musculoskeletal condition including low back 
pain and widespread chronic pain. The intervention was delivered by two AfC band 7 
physiotherapists both trained in the delivery of IBMT. 
Specifically, participants attended five sessions; once a week for 3 hours. Sessions 
were delivered in an interactive and collaborative way to engage the participants as 
they developed new coping strategies. The content of the programme comprised an 
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aerobic exercise component, group discussion, problem solving and making sense of 
pain education. Patients worked towards identifying a value-based goal that was set 
by the end of the group and reviewed at 3-month follow up. 
The core content of the programme covered topics recommended by the British Pain 
Society (in their revised guidelines for adult pain management programmes 2013), as 
useful coping strategies for managing chronic pain. These included exercise, pacing, 
graded activity, flare-up and setback planning, maintaining change, explaining pain 
processes and on-discharge access to community based resources/support (see 
Appendix 6 - Programme timetable on page 134). 
The exercise component included a combination of stretching and a mixed circuit 
(see Appendix 7 - Exercise component for study intervention on page 135). The 
stretching exercises were demonstrated by the physiotherapist in the first session 
and the group worked through them together. Patients were expected to continue 
with these exercises at home, and for the next 4 sessions they completed the 
stretching exercises unsupervised in the group. The rationale for this was to increase 
patients’ ownership of the exercises and to move away from ‘correction of 
movement’ that could potentially increase fear of movement and the fear of harm by 
doing the exercise incorrectly. It also helped to reduce reliance on the 
physiotherapist and provide a better and more realistic transition to future 
community or home based exercise. This rationale was supported in the Long-term 
condition compendium 2013 about patients taking ownership of their long-term 
condition. The circuit was completed on session’s two to five. There were 12 stations 
in total and the exercises used were a combination of balance, co-ordination and 
resistance exercises as well as incorporating movements or positions that patients 
may have been actively avoiding due to fear, e.g. getting on or off the floor. Amris et 
al. (2014) used similar functional movements as their primary outcome measure and 
they demonstrated that following a group intervention ease of movement improved 
despite no change on patient-reported outcome measures. Mosley et al. (2004) 
demonstrated that forward flexion in patients with chronic low back pain improved 
following a 3-hour session and homework of explaining pain neurophysiology, 
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despite not showing any significant changes on the RMDQ which was similar to 
(Amris et al. 2014). 
4.5 Final assessment 
All participants completed the same patient-reported questionnaires from session 
one and repeated the physical function tests. Each participant met with one of the 
group physiotherapists individually to discuss their experience of the group and their 
plans on leaving the group in relation to use of community-based services and what 
strategies they were going to use in their flare-up plan. The Map of Medicine 
guidelines (2013) advocate patient reviews as part of their pathways for chronic 
widespread pain and low back pain. 
4.6 Follow-up and end of trial 
Following completion of the group, participants who gave consent to be included in 
the study were given a date to return for a group follow-up session which lasted for 2 
hours. At the follow-up all participants completed the patient-reported outcome 
measures from session 1 and 5, repeated physical function test and were asked 
about the use of community services, and use of coping strategies in their flare up 
plan. The group discussed barriers to change they had encountered after they had 
finished the intervention, what progress they have made with their goals and any 
experience of changed behaviour. This was an informal and qualitative discussion 
without a structured questionnaire. Hansen et al. (2010), stated in their study of a 
CBT approach that unless participants had been asked to keep a detailed diary of all 
expenses and visits a full cost and health care utilisation projection was impossible. 
The scope of further health care utilisation was beyond the scope of this current 
study. All participants were discharged after the follow-up session. 
4.7 Outcome assessments 
Measuring clinical outcomes is important for any treatment intervention (Dworkin et 
al. 2005) and an increasingly important aspect of any musculoskeletal research 
(Gatchel, 2006). The multi-factorial nature of chronic pain and the range of 
interventions used for treatment makes the decision on what and how to measure 
challenging. Change in chronic pain status cannot be assessed in the same way as 
disease processes that can be evaluated using biomedical procedures e.g. 
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erythrocyte sedimentation rate to measure inflammation in rheumatoid arthritis or a 
blood pressure reading in hypertension. The interaction between the different multi-
factorial components in chronic pain is complex and calls for a range of observed and 
patient-reported outcome measures to be utilised (Anagnostis et al. 2003). The 
following outcome measures were selected to attempt to capture the range and 
depth of the effect of chronic musculoskeletal pain and to quantify the effect a 
physiotherapy-led intervention has on the different dimensions measured. 
4.7.1 Primary outcome measure and power calculation 
The primary outcome measure was the Tampa Scale of Kinesiophobia (TSK). One of 
the primary aims of this study was to investigate the effectiveness of physiotherapists 
delivering a psycho-social intervention for a mixed chronic pain cohort. There is a 
large body of research exploring the relationship between fear of movement and the 
maintenance of pain and disability (Vlaeyen et al. 1995; Roelofs et al. 2004; Burwinkle 
et al. 2005). This is further supported by the fear avoidance model of pain discussed 
in chapter 1. The role of physiotherapists in interdisciplinary pain management 
programmes is primarily with the exercise and movement component delivery 
(Sullivan et al. 2010). Therefore the choice of TSK was considered appropriate to look 
at a cognitive factor associated with movement, rather than solely physical 
parameters of increasing exercise. 
The TSK is a 17-item questionnaire for assessing pain-related fear of movement 
(kinesiophobia). Each item is scored on a 4-point scale ranging from “totally agree” to 
“totally disagree”, the scores are added and the total score ranges from 17-68 with a 
higher score indicative of greater fear of movement and re-injury. There are currently 
no specific score ranges that would indicate the range of the respondent’s fear level 
i.e., mild, moderate or severe, etc. Nicholas et al. (2008) looked at 5,941 pain patients 
who had been referred to a pain specialist centre in Australia to establish normative 
data for chronic pain measures and TSK was included. In the (Nicholas et al. 2008) 
population studied they found that mean TSK was 41.44 for patients with chronic low 
back pain and 42.3 for those with pain in two or more sites. Studies using a chronic 
low back pain population with physiotherapy-led or single profession-led 
interventions report similar baseline TSK scores (Hay et al. 2005), 40.7; (Woby et al. 
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2008), 39.5 and (De Moraes Vieira et al. 2013), 42.0. In addition to no clear indicators 
for score and severity, there is also little in the research about what constitutes a 
clinically significant change score. Woby et al. (2005) suggested a reduction of at least 
four points, in their evaluation of the psychometric properties of both the original 17-
item TSK and the shortened 11-item version. A reduction of 4-points appeared to 
correlate with a meaningful reduction in fear avoidance in a chronic low back pain 
sample. Therefore, using the (Woby et al. 2005) suggestion and the findings of the 
phase one retrospective service evaluation discussed in chapter 2 (which found a 
5.77 point change in TSK) a power calculation was made to estimate sample size. 
Taking the minimal, clinically-significant difference on the Tampa scale of 
kinesiophobia (TSK) as an improvement of 4-points and assuming 20% dropout, then 
by using an 80% power with 2-sided hypothesis and significant level at 5% requires a 
minimum of 40 patients (see Appendix 9 - Tampa Scale of Kinesiophobia on page 
137). 
4.7.2 Secondary patient-reported outcome measures 
1. The Roland Morris Disability questionnaire (RMDQ) or 
2. The Pain Disability Questionnaire (PDQ) 
3. The Pain Self Efficacy Questionnaire (PSEQ) 
4. The Hospital Anxiety and Depression scale (HAD) 
4.7.3 Functional/physical tests 
Based on Harding et al. (2004) battery of functional tests for people with chronic pain 
5. 20 metre timed walk test 
6. 5 minute timed walk test 
7. 1 minute timed step-ups 
4.7.4 The Roland Morris Disability questionnaire (RMDQ) 
The RMDQ is a 24-item self-report questionnaire relating to low back pain. A higher 
score indicates a greater degree of disability. The RMDQ was originally derived from 
the 136 item Sickness Impact Profile, a generic health status questionnaire, and was 
originally intended only for research purposes (Anagnostis et al. 2003). Despite its 
initial use, the RMDQ is now used routinely in clinical practice as an outcome 
measure pre- and post-treatment intervention. This measure is widely used in 
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research for different low back pain populations and displays good levels of reliability 
and internal validity (Critchley et al. 2007; Woby et al. 2008; Hansen et al. 2010). The 
above studies report reductions of between 1.8 and 4 points as being indicative of a 
clinically-meaningful change. Hansen et al. (2010) suggest that studies that include 
small sample sizes, and only pre- to post-design report a higher change and that this 
is to be expected post any intervention. Grotle et al. (2004), investigated the 
responsiveness of the RMDQ compared to other outcome measures and found it to 
be superior to others in a chronic low back pain population. However, Anagnostis et 
al. (2003) found that the responsiveness of the RMDQ was most reliable in its mid-
range scores and is less sensitive to higher scores equating to a greater perceived 
degree of disability. Based on the retrospective service evaluation it was envisaged 
that the sample would score around the mid-scale point (12), this is a similar pre-
intervention score to other studies using referrals from a primary care or non-pain 
specialist centre population, and therefore the RMDQ was considered to have 
sufficient sensitivity (see Appendix 12 - The Roland-Morris Disability Questionnaire 
on page 140). 
4.7.5 The Pain Disability Questionnaire (PDQ) 
The PDQ is a generic disability questionnaire that was devised from a range of other 
pain-related, dysfunction questionnaires including the RMDQ, short form health 
questionnaire (SF-36), and the McGill pain questionnaire. It was primarily designed to 
be used with chronic musculoskeletal conditions, including spinal pain (Gatchel, 
2006). The 15-item questionnaire is scored on a 10-point scale (from 0 = no relevance 
to 10 = excellent relevance). The score ranges from 0 (optimal function) to 150 (total 
disability) and (Gatchel et al. 2006) reported three distinct categories from the total 
score; Mild/Moderate (scores of 0-70); Severe (71-100); and extreme (101-150). Their 
study reported the pre- to post-PDQ score changes 1 year after a multi-disciplinary, 
functional restoration pain programme for people with chronic pain. They found an 
association between severe and extreme PDQ scores and depression, absence from 
work and increased healthcare utilisation, compared to those scoring mild/moderate. 
Anagnostis et al. (2003) described a thorough validation and reliability process using 
four different populations including a normative sample, acute pain sample and two 
chronic pain samples; one working group and one unemployed. The PDQ was 
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compared to other widely used functional outcome measures including RMDQ and 
SF-36 and was found to be at least comparable, and in some instances superior, to 
existing measures. Despite this promising validation and reliability process, the PDQ 
remains underused in large-scale research trials. It was therefore used in this study as 
the functional measure for those participants with pain in more than one site. It 
could have been used as the only functional measure but the decision to include the 
RMDQ for participants with chronic low back pain was based on its use in previous 
studies (Hill et al. 2011; Critchley et al. 2007) and (Lamb et al. 2012) using a similar 
intervention to that reported in this study. It was therefore considered that it would 
aid comparison and, despite some reservations in its responsiveness, it remains 
widely used as a low back pain disability measure in research (see Appendix 10 - Pain 
Disability Questionnaire on page 138). 
4.7.6 The Pain Self Efficacy Questionnaire (PSEQ) 
The PSEQ is a 10-item scale measuring the respondent’s confidence to carry out 
physical and social activities despite having pain. The score range is between 0-60 
with a higher score indicating a greater self-confidence in performing these activities. 
The development of the Pain Self-Efficacy Questionnaire by (Nicholas, 2007) suggests 
that the measure can be used as both a screening tool and an outcome measure. 
Nicholas et al. (2008) report normative data for the PSEQ with a mean score for 
chronic low back pain as 24.9 and pain in more than two sites at 23.7. The normative 
data was collated from referrals to a specialist pain centre in Australia from their 
family doctor. Other studies report a range of different self-efficacy scores from 
(Nicholas et al. 2013) in a chronic pain sample of 34.1; (Lamb et al. 2012), report a 
mean PSEQ score of 39.1 in their primary care-recruited chronic low back pain 
population. Miles et al. (2011) investigated six different forms of self-efficacy 
measurement tool including the PSEQ and found it had reliable internal consistency 
but they reported there were problems determining responsiveness. They also 
highlighted problems with the interpretability of the scores in all six of the self-
efficacy measures evaluated and suggested that this could potentially limit use in 
clinical practice. However (Nicholas, 2007) suggested that post-treatment scores on 
the pain self-efficacy scale may be predictive of a person’s ability to make long lasting 
behavioural changes and self-manage, or whether they are at risk of relapsing. A 
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patient who makes behavioural changes but does not score >40 is still at potential 
risk of relapsing and probably requires follow-up or monitoring, (see Appendix 11 - 
Pain Self Efficacy Questionnaire on page 140). 
4.7.7 The Hospital Anxiety and Depression Scale (HADS) 
Depression has been found to be present in many patients who report chronic 
musculoskeletal pain, although it is not well understood as to whether one is 
attributable to the other (Yohannes et al. 2010). Linton et al. (2011) reported that 
depression 52% of patients with chronic pain fulfilled criteria for depression and that 
the presence of depression is often associated with poor treatment outcomes. The 
Hospital Anxiety and Depression Scale (HADS) is a fourteen-item scale that measures 
the level of anxiety and depression in patients with physical health problems 
(Crawford et al. 2001). Seven items on the scale relate to anxiety and seven to 
depression. Participants are asked to respond on a scale from 0 to 3 as to how much 
they agree with each statement. A score of 10 or above has been widely accepted as 
a score indicating levels of anxiety or depressive symptoms which are clinically 
relevant and would benefit from referral to appropriate services (Crawford et al. 
2001). The HADS was included in this study for several reasons; to assess the level of 
depression present and also to evaluate the level of depression pre- to post-
intervention compared to change scores on the other outcome measures. Although 
the association between depression and chronic pain is acknowledged, many 
physiotherapists may feel that managing depression is not within their scope of 
practice to manage. Woby et al. (2008) demonstrated that with a physiotherapist-led 
intervention, changes in disability and self-efficacy were associated with a reduction 
in depression and argues that some levels of depression are therefore affected by 
physiotherapy treatment. However the study also suggested that there is a level at 
which severe depression will not be amenable to this type of intervention. The 
inclusion of the HADS will therefore support the development of future 
inclusion/exclusion criteria for the study intervention and when referring on to 
appropriately trained specialists is required. The HADS has shown good internal and 
external validity in similar chronic pain populations (Hill et al. 2011; Lamb et al. 2012) 
(see Appendix 13 - The Hospital Anxiety and Depression Scale on page 142). 
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4.7.8 Physical function tests 
The physical tests (5-7) are taken from the work of (Harding et al. 1994) who 
described a range of different physical tests to try and assess function under 
controlled conditions. The study found that some of the tests, 20 metre and 5 minute 
walking test, were reliable while others were unacceptable; the balance and grip 
strength tests. The validity of the tests was found to be good as most replicated 
everyday activities e.g. walking, getting out of a chair, etc. The authors highlighted 
that the reliability of the tests was compromised by the variability in instructions 
given to each participant by the testers. As a result, in this study the same group 
physiotherapist, not the principal researcher, recorded the results of the functional 
tests. The physiotherapist read a set of written instructions so that each patient 
heard the same information. The physiotherapist was also instructed not to talk to 
the participant during any of the tests unless the participant reported an adverse 
reaction or the participant requested to stop the tests (see appendix for full 
functional test procedure). Amris et al. (2014) used functional tests as their primary 
outcome measure and self-reported measures as secondary outcomes. Their findings 
suggested that the functional tests improved but the self-reported measures did not: 
in their results they found the main difference was between what the patient 
perceived they could do, (what they reported on the outcome measure), and what 
the tester actually observed the patient doing during the functional test. Morley et al. 
(2008) used a 5-minute walk test in addition to self-report measures to add depth to 
their overall results. They recorded not only the distance covered but also the quality 
of the walking i.e. use of aids, grimacing, holding onto walls, etc. pre- to post-
intervention. Harding et al. (1994) reported that the measures could be used on their 
own or a selection to add support to patient self-reported outcome measures, but 
that consideration should be given to the population being studied (see Appendix 8 - 
Study physical function tests on page 136). 
4.8 Ethical issues 
4.8.1 Risks, benefits and potential side effects 
Potential risk one; was considered as increased pain during or after the exercise 
session. All participants in this study reported a reduced mobility level pre-
intervention and an over activity/underactivity cycle of daily activity. Increased pain 
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was discussed as an inevitable but normal consequence of increasing activity during 
session one. Using terms including acceptable and non-acceptable pain to describe 
this temporary increase in a participant’s pain as discussed in (Booth, 2014), 
reassurance was given as to the physiological reasons behind the increase in pain. 
This was discussed in terms of an increase in pain being ‘normal’ and should return to 
the participant’s baseline level within a short period time, although this time was not 
specifically defined. To minimise this risk, participants were advised before exercising 
to pace each exercise. This was demonstrated by the physiotherapists leading the 
group who remained present throughout the exercise component of the session. 
Potential risk two; Participants may also have experienced increased discomfort from 
sitting on different chairs during the discussion component of the group. At the start 
of each session participants were reminded that they were free to get up and stretch 
or move around to the back of their chair whenever they needed too but to stay 
within the chair circle so that they could still participate in the discussions. Regular 
comfort breaks were timetabled into the group based on recommendations from the 
Department of Health document; Sedentary Behaviour and Obesity: Review of the 
Scientific Evidence (2010), which suggests an active break from sitting every 30 
minutes. 
Potential risk three; increased fatigue or tiredness due to the length of each session. 
This was minimised by ensuring that the timetable allowed for comfort breaks and 
that there was access to water during the sessions to help keep the participants 
hydrated. 
Potential burden one; attending the physiotherapy department for 5 weeks and each 
session lasting 3 hours. This may have required the participant to organise work, 
caring responsibilities and organisation of themselves to get to the hospital for the 
start of the session. The group had been running in its current format for over five 
years and previous attendees of the group had not cited this as a major burden or 
obstacle to attend. It was also felt that the number of hours is small in comparison to 
multidisciplinary pain management programmes where the patients are expected to 
attend full days for up to 2 weeks (Nicholas et al. 2008). 
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Potential burden two; the time taken to complete the patient-reported outcome 
measures may be seen as a potentially time consuming part of the group. The 
number of outcome measures and functional tests where included to capture the 
multifaceted nature of chronic pain. Previous participants have expressed interest in 
their pre- to post-group scores and how this related to their symptoms and behaviour 
changes. Harding et al. (1994) discussed patients undertaking functional and clinical 
outcome measures and stated that consideration should be given for the population 
being assisted. This study used a similar range of outcome measures as utilised by 
studies investigating both a similar intervention and cohort of patients and therefore 
the time was considered justified (Woby et al. 2008; Hansen et al. 2010; Murphy et 
al. 2013). 
4.8.2 Confidentiality and anonymity 
Participant’s information for the study was transferred form physiotherapy records 
onto a data extraction form and was given a unique study code. The form did not 
have any identifiable participant’s details on it. The forms were stored in a locked 
filing cabinet in the outpatient department of Fairfield General Hospital. This was to 
ensure anonymity, privacy and confidentiality according to Trust Caldicott regulations 
that any NHS patient’s notes and documentation are required to follow. The data 
from the form was transferred to an NHS computer. This computer required 2 
passwords to access files, and the data was not stored on the hard-drive of the 
computer. Only the researcher had access to the study data and the filing cabinet. 
Information gained from the study was not used for any other purpose after the 
study had finished. The computer data will be deleted 12 months following the study 
completion and the extraction forms destroyed in the hospitals confidential waste 
according to trust information governance policy. 
4.8.3 Ethical approval 
Ethical approval for this study was granted on 31 January 2014 by the National 
Research Ethics Committee (NRES) North West. REC reference: 14/NW/0042. IRAS 
project ID: 143694 (see Appendix 18 - NHS REC ethical approval letter on page 148). 
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Ethical approval was also granted by Manchester Metropolitan University (MMU) 
Ethics committee on 12 February 2014. MMU ethics application 1217. (See Appendix 
22 – MMU ethical approval confirmation on page 152.) 
4.9 Data Analysis 
Data were analysed using SPSS. Data were analysed in stages. Firstly baseline data 
including demographic and patient-reported outcome measure was evaluated 
descriptively as a whole group and then split into referral source groups; primary or 
secondary care using frequency and mean. Chi-square test was used to explore 
differences in categorical data. Data was subjected to assumption testing including 
normality, detection of outliers and homogeneity of variance, to determine whether 
parametric tests were appropriate for the analysis (Field, 2000). If data was found to 
violate any of the assumptions tests then the equivalent non-parametric tests were 
used (Field, 2000) Secondly data collected from the outcome measures at pre, post 
and follow-up were computed to determine if there were changes and the level of 
significance using parametric paired t-test. Following paired t-tests Analysis of 
variance (ANOVA) was computed to look at the level of change between each time 
point of the study and this was followed with post-hoc tests using a Bonferroni 
adjustment. Effect sizes were also calculated to provide an indication of the size of 
change on each of the variables. Effect sizes defined for Cohen’s d test as 0.20 small; 
0.50 moderate and 0.8 or more as large (Lakens, 2013). Finally the data was split into 
condition types; low back pain and chronic widespread pain including fibromyalgia 
and the change scores for each variable were computed pre to post and then 
independent t-test was computed to assess if there were differences in change 
scores between the two different groups. Significance was set at p < 0.05. 
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5 Results 
5.1 Patient characteristics for those completing the physiotherapy intervention 
A total of 78 potentially eligible patients were asked to participate in the study 
between January and December 2014. A total of 53 (68%) patients consented to take 
part in the study. Of those who started the study, one hundred percent of 
participants (n=53) completed the five week intervention, whilst 35 (66%) completed 
the follow-up session at 12 weeks. 
Table 5.1 - Baseline demographic and background information of patients who completed the 5 weeks intervention n=53 
Characteristic Completed intervention (n=53) 
Age mean (SD) 51.6 (12.08) 
Gender n (%) 
Male 8 (15.1)  
Female 45 (84.9)  
Work status  
Working 11 (20.8) 
Not working 22 (41.5) 
Retired 20 (37.7) 
Ethnicity  
White 44 (83) 
Asian 6 (11.3) 
Other 3 (5.7) 
Condition type  
Low back pain 16 (30.2) 
Multi-site pain including Fibromyalgia 37 (69.8) 
Co-morbidities  
None 29 (54.7) 
1 > co morbidity 24 (45.3) 
Referral source  
Primary care 22 (41.5) 
Secondary care 31 (58.5) 
 
Table 5.1 shows the demographic characteristics and outcome measures used for 
participants who started the study (n=53) with baseline scores. The study sample had 
a mean age of 51.6, was predominantly female 45 (84.9%), white, 44 (83%) and had 
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multi-site pain, 37 (69.8%). The work status of the participants was slightly higher for 
those not working, 22 (41.5%), compared to those who were retired, 20 (37.7%) 
whilst a smaller proportion, 11 (20.8%) were continuing to work. More participants 
were referred from secondary care (consultant-led services), 31 (58.5%) and had no 
additional health issues (co-morbidities), 29 (54.7%) compared with primary care 
referrals. 
Table 5.2 - Baseline scores for Patient reported outcome measures and physical function tests for patients who 
completed the 5 weeks intervention n=53 
Patient reported outcome measures Mean (SD) 
Fear of movement/re-injury (TSK) 40.9 (7.05) 
Disability/low back pain (RMDQ) n=19 11.7 (4.48) 
Disability/multi-site (PDQ) n=34 107.6 (19.9) 
Anxiety (HADS) n=51 11.9 (4.06) 
Depression (HADS) n=51 9.8 (3.60) 
Self-efficacy (PSEQ) n=53 25.4 (12.2) 
Physical Function test  
20 metre timed walk 21.6 (11.40) 
5 minute walk 263.7 (102.36) 
Step-ups 19.0 (7.57) 
 
Table 5.2 shows the baseline scores for the outcome measures suggest the sample 
had high levels of fear of movement 40.9. They also reported moderate levels of 
psychological distress as measured by the HADS, depression 9.8 and anxiety 11.9. In 
addition the sample had low levels of self-efficacy 25.4. 
5.2 Analysis of baseline patient characteristics by referral source 
The group offers a service for those referred from both primary care (GP) and 
secondary care (hospital consultant). As part of the analysis a comparison of 
demographic and baseline data based on referral source was made to determine if 
there were any differences, Table 5.3 shows this data. Participants from secondary 
care were generally younger (mean age 49.7 years), not working 15 (48.4%), with 
multi-site pain and a fairly equal number had no additional health problems, 15 
(48.4%). 
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5.3 Analysis of categorical data 
A chi-square test for association was conducted between referral source, co-
morbidity, and condition type and work status. All expected cell frequencies were 
greater than five, apart from condition type and therefore analysis for this variable 
was not computable. There was no statistically significant association between 
referral source and co-morbidity, χ2 (1) = 0.62, p = 0.43 or work status, χ2(2) = 1.02, 
p= 0.60. A Mann-Whitney U test was carried out to determine if there were 
differences in age between those referred from primary and secondary care. Median 
age was not statistically significant between primary (58.00) and secondary care 
(50.50), U = 249, z = -1.725, p = 0.08. 
Table 5.3 - Baseline characteristics of participants by referral source completed the intervention compared with those 
who did not complete the follow-up on self-reported outcome measures 
Characteristic Primary care (n=22 ) Secondary care (n=31) 
Age mean, (SD) 54.6 (10.10) 49.7 (13.14) 
Gender n (%) n (%) 
Male 6 (27.3) 2 (6.5) 
Female 16 (72.7) 29 (93.5) 
Work status   
Working 6 (27.3) 5 (16.1) 
Not working 7 (31.8) 15 (48.4) 
Retired 9 (40.9) 11 (35.5) 
Ethnicity   
White 20 (90.9) 24 (77.4) 
Asian 1 (4.5) 5 (16.1) 
Other 1 (4.5) 2 (6.5) 
Co-morbidities   
None 14 (63.6) 15 (48.4) 
1 > co-morbidity 8 (36.4) 16 (51.6) 
Condition type   
Low back pain 16 (72.7) 2 (6.5) 
Multi-site pain  6 (27.3) 29 (93.5) 
Outcome measure name Mean + SD  
Fear of movement/re-injury(TSK) 39.4 (6.72) 41.6 (7.17) 
Disability/low back pain (RMDQ) 11.0 (4.77) 12.3 (3.75) 
Disability/multi-site (PDQ) 91.8 (39.81) 109.7 (15.77) 
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Characteristic Primary care (n=22 ) Secondary care (n=31) 
Anxiety (HADS) 10.7 (4.68) 14.0 (3.29) 
Depression (HADS) 7.9 (3.35) 10.6 (3.45) 
Self-efficacy (PSEQ) 28.8 (14.32) 23.9 (11.09) 
Speed of walking - timed walk over 20 metres 17.8 (8.01) 23.7 (12.51) 
5 minute in metres (between 2 markers 20m 
apart) 
325.9 (100.44) 230.6 (88.13) 
Total number of Step-ups in 1 minute 22.9 (9.68) 16.9 (5.13) 
TSK, Tampa scale of Kinesiophobia; HADS, Hospital Anxiety and Depression Scale; RMDQ, Roland Morris 
Disability Questionnaire; PDQ, Pain Disability Questionnaire; PSEQ, Pain Self-efficacy questionnaire. 
5.4 Analysis of patient-reported outcome measures by referral source 
To determine if there were differences in TSK score between referral sources, 
Independent-samples t-tests were run. Assumptions for the test were only met for 
TSK, HAD-A, and HAD-D. Analysis was not possible for RMDQ as there was only one 
participant referred from secondary care with low back pain. Analysis with 
parametric independent t-test was also not possible for all the physical function tests 
because there were multiple extreme outliers and data was not normally distributed. 
Thus non-parametric equivalent was carried out for this analysis using the Friedman’s 
ANOVA test. 
Table 5.4 – Independent t-test for TSK, and HADS (anxiety and depression) between referral sources; primary and 
secondary care. 
Variable name Primary care 
baseline 
score 
(± SD) 
Secondary 
care 
Baseline 
score 
(± SD) 
Difference 
between 
scores 
(95% 
confidence 
interval) 
Independ
ent t-test 
 
 
Significance p-
value 
<0.05* 
 
Fear of movement/re-
injury (TSK) 
39.65 
(6.13) 
41.9 
(7.63) 
-2.24 
(-6.18 to 
1.66) 
-1.155 < 0.02* 
Anxiety (HADS) 10.71 
(4.14) 
12.70 
(3.87) 
-1.99 
(-4.26 to  
-0.291) 
-1.753 < 0.08 
Depression (HADS) 8.57 
(3.29) 
10.63 
(3.60) 
-2.062 
(-4.053 to  
-0.071) 
-2.081 < 0.04* 
TSK, Tampa scale of Kinesiophobia; HADS, Hospital Anxiety and Depression Scale; 
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5.4.1 Fear of movement (TSK) 
There were no outliers in the data, as assessed by inspection of a boxplot. TSK for 
each level of referral source were normally distributed, as assessed by Shapiro-Wilk's 
test (p > 0.05), and there was homogeneity of variances, as assessed by Levene's test 
for equality of variances (p = 0.198). The mean score was lower for the primary care 
referrals (39.65 ± 6.13) than secondary care (41.9 ± 7.63), a statistically significant 
difference of -2.24, (95% CI, -6.18-1.66), t(51) = -1.155, p = 0.02. 
5.4.2 Anxiety (HAD-A) 
The mean score for primary care referral source was lower in anxiety score (10.71 ± 
4.14) than secondary care (12.70 ± 3.87), a non-statistically significant difference 
between referral sources of -1.99, (95% CI, -4.26-0.291), t(49) =-1.753, p=0.08. 
5.4.3 Depression (HAD-D) 
The mean score for primary care referral source was lower in depression (8.57 ± 3.29) 
than secondary care (10.63 ± 3.60), a statistically significant difference between 
referral sources of -2.062, (95% CI, -4.053 to -0.071), t(49) =-2.081, p=0.04. 
The analysis has revealed that the secondary care cohort were significantly more 
fearful and depressed suggesting a more psychologically distressed cohort which 
potentially explains why they were under secondary care services. However, there 
were no other statistically significant differences between referral sources. 
5.5 Changes from pre-to post- physiotherapy-led intervention for all outcome 
measures 
Analysis on pre- to post changes that occurred on each of the patient-reported 
outcome measures and physical function test was undertaken to answer the primary 
aim of the study; what effects does a physiotherapy-led group intervention have in 
terms of pre-to post changes in patient-reported outcome measures. 
Table 5.5 shows the pre- to post-treatment changes that occurred on each of the 
outcome measures. Assumptions for a parametric t-test were met and were run on 
all outcome measures pre- to post-intervention (Table 5.5) and pre- to follow-up (see 
Appendix 21 - t test for pre to post intervention and pre to follow-up on page 151). A 
paired-samples t-test was used to determine whether there was a statistically 
Page 85 of 152 
 
significant mean difference between the outcome measures from baseline to post-
intervention. Data are mean ± standard deviation, unless otherwise stated. 
Table 5.5 - Pre- to post-intervention for the whole data set n=53 
Variable name Baseline 
score 
Post 
score 
Mean 
change 
(± SD) 
t-test 
 
Significance p-
value 
 
Cohen’s d 
effect size 
Fear of 
movement/re-
injury (TSK) 
40.9 33.6 -7.33 
(5.78) 
9.19 < 0.001 1.26 
Anxiety (HADS) 11.9 10.6 -1.33 
(2.99) 
3.18 < 0.003 0.44 
Depression (HADS) 9.8 7.4 -2.41 
(2.39) 
7.22 < 0.001 1.01 
Disability/Low back 
pain (RMDQ) 
11.9 9.2 -2.73 
(2.88) 
 
-7.66 < 0.001 0.94 
Disability/multi-site 
(PDQ) 
107.6 90.4 -17.15 
(17.46) 
4.14 < 0.001 0.98 
Self-efficacy (PSEQ) 25.4 35.5 +10.0 
(9.48) 
5.73 < 0.001 1.06 
Speed of walking -
timed walk >20 
metres 
21.7 17.7 -4.06 
(7.49) 
3.72 < 0.001 0.54 
Distance covered in 
5 minutes in metres  
261.3 291.7 +30.42 
(62.43) 
3.38 < 0.001 0.48 
Total number of 
Step-ups in 1 
minute 
19.0 24.7 +5.68 
(5.53) 
7.04 < 0.001 1.03 
TSK, Tampa scale of Kinesiophobia; HADS, Hospital Anxiety and Depression Scale; RMDQ, Roland Morris 
Disability Questionnaire; PDQ, Pain Disability Questionnaire; PSEQ, Pain Self-efficacy questionnaire. 
5.5.1 Primary outcome measure – fear of movement (TSK) 
Participants had a change score from baseline mean (SD) fear of movement (40.92 ± 
7.05) to post-intervention (33.62 ± 7.33), a statistically significant decrease of -7.30 
(95% CI, 5.71 to 8.89), t (52) = 9.192, p < 0.001, with a large effect size score, d = 1.26. 
Significant reductions were also seen in disability, anxiety and depression (Table 5.5). 
Whilst there were significant increases (improvements) in self-efficacy, speed and 
distance of walking in addition to more step-ups performed. Large effect sizes (>0.8) 
were observed in fear of movement, disability self-efficacy, depression and number 
of step–ups, and moderate effect size (>0.5) for walking speed and distance and 
anxiety. 
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The paired sample t-test analysis suggest that the physiotherapy-led group 
intervention had a positive impact and was both statistically and clinically significant 
in terms of both psychological and physical factors pre-to post-intervention and that 
these changes were sustained at 3-month follow-up. A one-way repeated measures 
ANOVA was conducted to determine whether there were statistically significant 
differences in the measures at the three time points used for data collection; 
baseline, post intervention and 3-month follow-up. 
5.6 One way – ANOVA primary outcome measure - fear of movement measured 
(TSK) 
There was one outlier but the data was normally distributed, as assessed by boxplot 
and Shapiro-Wilk test (p > 0.05), respectively. The assumption of sphericity was not 
violated, as assessed by Mauchly's test of sphericity, χ² (2) = 4.878, p = 0.87. The 
physiotherapy pain management intervention elicited statistically significant changes 
in TSK over time, F (2, 68) = 39.593, p < 0.001. with TSK reducing from 40.94 ± 7.13 
baseline to 34.03 ± 6.89 post-intervention to 33.03 ± 7.27 at 3-month follow-up. Post 
hoc analysis with a Bonferroni adjustment revealed that TSK was statistically 
significantly decreased from baseline to post-intervention -6.91 (95% CI, -9.36 to -
4.46) p < 0.001, and from baseline to 3-month follow-up -7.91 (95% CI, -10.74 to -
5.12), p < 0.001, but not from post-intervention to 3-month follow-up with a trend -
1.00 (95% CI, -3.01 to 1.00), p = 0.06. 
5.6.1 Pain related disability measured for those with low back pain with (RMDQ) 
There were no outliers for the RMDQ and the data was normally distributed. The 
assumption of sphericity was not violated, as assessed by Mauchly's test of 
sphericity, χ2 (2) = 0.892, p = 0.50. The physiotherapy pain management intervention 
elicited statistically significant changes in RMDQ over time, F(2, 26) = 8.823, p < 
0.001. with RMDQ reducing from 11.93 ± 4.12 baseline to 9.29 ± 2.52 post-
intervention to 8.29 ± 4.79 at 3-month follow-up. Post hoc analysis with a Bonferroni 
adjustment revealed that TSK was statistically significantly decreased from baseline 
to post-intervention -2.64 (95% CI, -4.77 to -.516) to p < 0.014), and from baseline to 
3-month follow-up -3.64 (95% CI, -6.46 to -.83), p < 0.011, but not from post-
intervention to 3-month follow-up with a trend -1.00 (95% CI, -1.39 to 3.39), p = 0.81. 
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5.6.2 Pain-related disability measured for those with widespread pain with (PDQ) 
There was one outlier for the PDQ and the data was not normally distributed, as 
assessed by boxplot and Shapiro-Wilk test (p < 0.05), respectively. The assumption of 
sphericity was also violated, as assessed by Mauchly's test of sphericity. Therefore a 
Friedman test was run to determine if there were differences in disability measured 
with the PDQ. Pairwise comparisons were performed with a Bonferroni correction for 
multiple comparisons. PDQ reduction was statistically significantly different at the 
different time points during the physiotherapy intervention, χ2(2) = 19.60, p < 0.001. 
Post hoc analysis revealed statistically significant differences in PDQ from pre- (Mdn = 
113.50) to post-intervention (Mdn = 98.50) (p < 0.001) and pre to follow-up (Mdn = 
83.50) (p = 0.002), but not post-intervention and follow-up (p=1.00). The result also 
represents an overall change from extreme disability (101-150) to moderate disability 
(71-100) at the end of the study. 
5.6.3 Depression measured with HADS 
There was one outlier but the data was normally distributed, as assessed by boxplot 
and Shapiro-Wilk test (p > 0.05), respectively. The assumption of sphericity was not 
violated, as assessed by Mauchly's test of sphericity, χ2 (2) = 1.43, p = 0.48. The 
physiotherapy pain management intervention elicited statistically significant changes 
in depression over time, F(2, 64) = 30.02, p < 0.001 with depression reducing from 
9.61 ± 3.80 baseline to 7.30 ± 3.41 post-intervention to 6.33 ± 3.83 at 3-month 
follow-up. Post hoc analysis with a Bonferroni adjustment revealed that depression 
was statistically significantly decreased from baseline to post-intervention -2.30 (95% 
CI, -3.28 to -1.32) p <0.001, and from baseline to 3-month follow-up -3.27 (95% CI, -
4.39 to 2.16), p = < 0.001, but not from post-intervention to 3-month follow-up -
0.970(95% CI, -0.21 to 2.15), p=0.12. The change in depression brings the mean score 
below 10 which has been suggested to be the cut-off point for referral for 
management to mental health services for depression and is therefore an important 
change score for a physiotherapy-led intervention. 
The repeated measures ANOVA has shown that changes pre-to post-intervention and 
pre-to follow-up were statistically significant but that there was no statistically 
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significant difference between post intervention to follow-up. This indicates that 
improvements were maintained at medium term follow-up. 
Figure 2 shows patient reported outcome measures (PROMS) from baseline to 3-
month follow-up. 
Figure 2 - Outcome measure scores over time for PROMs 
 
 
5.7 Analysis of patient-reported measures between condition types 
The second part of the data analysis was performed to determine whether there 
were significant differences in change scores between the different condition types; 
low back pain and multi-site pain, following the intervention. The current evidence 
suggests that physiotherapy-led interventions for chronic low back pain are effective 
however there is no evidence to suggest that physiotherapy-led group intervention 
for mixed condition types are effective. 
Table 5.6 shows the pre- to post-change scores with mean changes for condition 
type. 
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Table 5.6 - Differences in self-report and physical function tests between condition types 
Variable Low 
back 
pain 
(n=17) 
pre-
score 
Low 
back 
pain 
(n=17) 
post 
score 
Mean 
change 
score 
t-
test 
P 
value 
 
Multi-
site 
pain 
(n=36) 
Pre 
score 
Multi-
site 
pain 
(n=36) 
Post 
score 
Mean 
change 
score 
t-test P 
value 
TSK 38.84 
(7.24) 
32.63 
(6.53) 
-6.21 
(3.98) 
6.80 .001 42.09 
(6.77) 
34.18 
(7.77) 
-7.91 
(6.56) 
7.04 <.001 
HADS-A 10.20 
(4.77) 
8.95 
(3.50) 
-1.33 
(2.60) 
2.36 .030 12.76 
(3.75) 
11.48 -1.28 
(3.22) 
2.27 <.030 
HADS-D 7.83 
(3.55) 
5.79 
(3.17) 
-2.04 
(2.21) 
4.26 .001 10.85 
(3.19) 
8.33 
(2.87) 
-2.52 
(2.50) 
5.78 <.001 
RMDQ 11.95 
(4.39) 
9.21 
(3.58) 
-2.74 
(2.88) 
4.14 .001 n/a n/a n/a n/a n/a 
PDQ  n/a n/a n/a n/a n/a 107.56 
(19.92) 
90.41 
(27.52) 
-17.15 
(17.46) 
2.94 <.001 
PSEQ 32.28 
(12.19) 
41.58 
(10.75) 
9.28 
(11.17) 
-
3.52 
.003 21.79 
(10.76) 
32.29 
(11.27) 
10.50 
(8.61) 
-
7.11 
<.001 
20m 
walk  
18.35 
(8.40) 
15.13 
(8.33) 
3.22 
(5.78) 
2.39 .30 23.35 
(12.51) 
19.31 
(17.32) 
4.04 
(8.32) 
2.94 <.006 
5 min 
Walk  
307.06 
(113.35
) 
337.50 
(124.1
2) 
30.44 
(79.83) 
-
1.75 
.10 240.62 
(89.15)  
268.75 
(87.39) 
28.13 
(53.00) 
-
3.00 
<.001 
Step ups 22.90 
(9.08) 
30.81 
(11.65) 
8.22 
(7.63) 
-
4.22 
.001 17.06 
(5.89) 
21.22 
(6.08) 
4.16 
(3.63) 
-
6.83 
<.001 
TSK, Tampa scale of Kinesiophobia; HADS, Hospital Anxiety and Depression Scale; RMDQ, Roland Morris 
Disability Questionnaire; PDQ, Pain Disability Questionnaire; PSEQ, Pain Self-efficacy questionnaire; 20m, 
speed of walking in seconds over 20 metres; 5min, distance walked in 5 minutes measured in metres; step 
ups, total number of step ups in 1 minute. 
Data are mean ± standard deviation, unless otherwise stated. There were 19 
participants with low back pain and 34 chronic widespread pain participants. Analysis 
was not performed on pain-related disability as there were no comparable groups i.e. 
different outcome measures used dependent on pain site, (RMDQ or PDQ). 
An independent-samples t-test was run to determine if there were differences in 
outcome to a physiotherapy-led pain management intervention between participants 
with low back pain and chronic widespread pain. There were no outliers in the TSK 
and PSEQ data, as assessed by inspection of a boxplot. TSK and PSEQ scores for each 
condition were normally distributed, as assessed by Shapiro-Wilk's test (p > 0.05), 
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and there was homogeneity of variances, as assessed by Levene's test for equality of 
variances (p = 0.77 and 0.18 respectively). Fear of movement reduced more for 
participants with CWP (-6.21± 3.98) than LBP participants (-7.91± 6.55), however this 
was not statistically significant -1.71 (95% CI, -1.62 to 5.03), t(51) = 1.02, p = 0.31. 
Similarly PSEQ improved more for CWP participants (10.50 ± 8.61) than LBP 
participants (9.28 ± 11.17). Again, this was not statistically different -1.22 (95% CI, -
6.82 to 4.37), t(50) = -0.43, p =0.66. 
Table 5.7 - Between-groups changes by condition type; low back pain versus multi-site pain 
Variable name Low back pain 
Mean change 
Baseline to post score 
Multi-site pain 
mean change from 
baseline to post 
score 
Independent-
samples t-test, 
p value 
Fear of movement/re-
injury (TSK) 
 
6.21 (3.98) 7.91 (6.56) t=1.028 
p= 0.30 
Self-efficacy (PSEQ) 
 
 
9.28 (11.17) 10.50 (8.61) t= -.439 
p = 0.66 
TSK, Tampa scale of Kinesiophobia; PSEQ, Pain Self-efficacy questionnaire. 
 
There were two outliers in HAD Anxiety and depression data, in addition to all of the 
physical function tests and therefore a Mann-Whitney U test was run to determine if 
there were differences in HAD and physical function test scores between CWP and 
LBP. Distributions of the HAD and physical function scores for CWP and LBP were 
similar, as assessed by visual inspection. Median HAD-A score for CWP (1.00) and LBP 
(2.00) were not statistically significantly different, U = 304, z = 0.139, p = 0.88, using 
an exact sampling distribution for U (Dineen and Blakesley, 1973). 
Median HAD-D score for CWP (2.00) and LBP (3.00) was not statistically significantly 
different, U = 266, z = -0.616, p = 0.538. Similarly, median physical tests for timed 20 
metre walk, 5 minute walk and step-up score were not statistically significant; 20 
metre, CWP (2.50) and LBP (2.00), (U = 243, z = -0.113 p=0.91; 5 minute walk CWP 
and LBP (40.00), (U = 247.50, = z = -0.189, p=0.85 and finally step up score for CWP 
(4.00) and LBP (6.50), U = 198, z = -0.112, p= 0.26. 
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The results from the independent t-test and Mann-Whitney U tests suggest that 
there was no statistically significant difference in outcomes between the two 
condition types; CWP and LBP, receiving the same physiotherapy-led pain 
management intervention. 
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6 Discussion 
6.1 Aims and overview of findings 
This study aimed to determine what effects a 5-week physiotherapy-led group 
intervention based on IBMT principles had in reducing fear avoidance, anxiety and 
depression and improving self-efficacy and physical function in patients with chronic 
pain. Furthermore, the study examined the medium-term effects of the group 
therapy with 3-months follow-up. 
6.2 Summary of Key findings from Phase 2 
The physiotherapy-led intervention produced clinically and statistically significant 
changes at short (pre to post intervention) which were sustained at medium term (3-
month post-intervention) in pain related disability, fear of movement and self-
efficacy. 
There were statistically significant changes were observed for depression, anxiety 
and physical function however no MCID exists for these measures to determine 
whether the changes were clinically significant. These changes were observed during 
the intervention period. 
 However, no significant change in scores on any measures was observed from post 
intervention to 3-month. One potential explanation for this may be plateauing or 
consolidation of effect from the intervention in which the patients are confidence 
enough to apply it into their daily functioning. Further studies are needed. 
As in phase 1, no difference in scores (TSK, PSEQ, HAD-A and -D) were observed 
between condition types (low back pain and widespread pain) providing further 
evidence that a physiotherapy-led intervention with a mixed aetiology group can 
produce positive changes. 
6.2.1 Patient characteristics 
Those who completed the intervention had a female predominance in all groups 
analysed; 84.9% overall; 72.7% primary care and 93.5% secondary care. This was 
expected as females have a higher reporting incidence of pain and multi-site pain, 
(Blyth et al. 2010, cited in Croft et al. 2010). There is a local need to evaluate why 
men do not access the service, or to determine whether their requirements are 
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different, i.e. a preference to individual management or male-only groups, location 
etc. 
This study had no upper age limit during recruitment of the study. Despite this, the 
mean age of the patients was 51.6 years. There was a no statistically significant 
difference between patients referred from primary care, mean age 54.6 years, 
compared to secondary care; 49.7 years despite over a third of the patients (37.7%) 
being retired. In other studies who investigated patients with chronic pain with no 
upper age limit (Cecchi et al. 2010; Armis et al. 2014) similar findings were reported. 
In contrast studies that investigated patients with chronic arthritis pain reported 
higher mean ages, 67 years (Jessep et al. 2009), and 73.9 years (Nicholas et al. 2013) 
respectively. This indicates that degenerative arthritis are most likely to affect the 
older age group compared to patients with widespread pain (Van Hecke et al. 2013). 
The exact mechanisms for these differences are unclear. However, those of working 
age appear to be more likely to seek treatment because chronic pain is most likely to 
interfere with their daily activities. Detailed examination of the data revealed that 
41.4% of the patients were not working and this increased with those referred from 
secondary care (48.4%). They also exhibited higher levels of pain-related disability, 
fear avoidance, depression and anxiety. Additionally, patients from secondary care 
had lower physical function, as measured by walking and step-up repetition. It is 
possible patients who are referred from secondary care have more ill-health as they 
were most likely to have one or more comorbid diseases with 51.6% compared to 
primary care 36.4%. An alternative explanation might be the secondary care group 
with higher psycho-social factors identified on outcome measures are communicating 
through non-verbal behaviour that they are in pain. This is a common presentation in 
people suffering with chronic pain and includes protective behaviour such as slower 
movement, grimacing, sighing, supporting areas of pain and rubbing themselves 
(Aung et al. 2015). 
6.2.2 Fear avoidance 
Movement is essential for daily life. The presence of fear, related to movement and 
re-injury, has been suggested to be one of the mechanisms by which pain-related 
disability continues. This may interfere in daily activities in patients with chronic pain 
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(Vlaeyen et al. 1995). However, the direction of the relationship between fear of 
movement and disability is unclear. Roelofs et al. (2004) suggests that fear of 
movement can affect mood, self-confidence and increase pain-related disability and 
vice versa create resulting in a ‘vicious cycle’. There is currently no research that 
defines the level of severity of fear of movement measured by the TSK. The finding of 
this study with mean TSK baseline score was 40.9; which was similar to other 
physiotherapy-led studies at baseline was, 40.7 (Hay et al. 2005); 39.5 (Woby et al. 
2008), and 39.2 in the medium risk group (Hill et al. 2011) with comparable settings. 
Furthermore, the baseline score was similar to normative data for a chronic pain 
cohort compiled by (Nicholas et al. 2008). Their data was taken from a sample of 
5,941 Australian patients with chronic pain referred to secondary or tertiary care 
specialist pain services, low back pain 41.4; and multi-site pain 42.3. Although the 
figures from (Nicholas et al. 2008) are drawn from a specialist pain service, the TSK 
score was not significantly different from the studies mentioned above. This would 
suggest that TSK scores above 40 are reflective of a significant level of fear-related 
movement enough to effect daily activities. In addition there is no recognised 
Minimal Clinically Important Difference (MCID) for TSK, though (Woby et al. 2009) 
suggest a change of 4 points to be clinically significant. The current study reports a 
mean change of -7.30; (40.92 ± 7.05) to post-intervention (33.62 ± 7.33) which 
equates to a large effect size score, d = 1.26. This reduction was also maintained from 
baseline to 3-month follow-up; a change score of -7.91. This score change was larger 
than observed in (Woby et al. 2008) 4.6, and (Hill et al. 2011) who reported a mean 
change of 5.5 in their intervention group, respectively. Hansen et al. (2010) 
commented that studies with pre and post study designs results should be 
approached with caution as they do not have control groups for comparison. This 
caution notwithstanding, however, the prospective phase of this study did include a 
medium term follow-up and observed the changes were sustained. Interestingly, 
Roelofs et al. (2011) reported the results of their study to develop norms for TSK 
using data from 3,082 Dutch, Swedish and Canadian patients with chronic pain. They 
found an overall mean of 42 but reported patients with low back pain had higher TSK 
scores (43.2) compared to those with fibromyalgia and multi-site pain (36.6). 
However the finding of this study did not show this trend as mean TSK score for low 
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back pain was (38.8), which was lower than for fibromyalgia or multi-site pain (42.1). 
These differences between the different studies might be due to the perception of 
fear avoidance in different cultures and social norms accepted in the community. 
Thus, further study is needed to examine the impact of these factors in patients with 
chronic pain with long-term study. 
6.2.3 Depression 
Depression is known to be both a risk factor and a consequence of living with chronic 
pain. Linton et al. (2011) report that it is still unclear as to why its presence is a risk 
factor for poor outcome following an intervention. This study found that the baseline 
mean score for depression was (9.8). Crawford et al. (2001) suggest that patients 
with depression scores above ten would benefit from a referral to psychological 
services for treatment. If patients are not treated adequately, depression might be a 
confounding factor for poor compliance to rehabilitation outcomes. It is gratifying in 
this study to observe that the physiotherapy-led pain programme produced changes 
in ameliorating depression from baseline score (9.8) to 3-month follow-up (6.3); an 
overall change of -3.5. Although there are no MCID for the HAD the reduced mean 
score is within levels reported by (Crawford et al. 2001) as normal (0-7). This 
reduction in depression was higher than reported in previous studies (Woby et al. 
2008; Hill et al. 2011). The potential explanation for the significant improvements 
may include that all patients were compliant to the full programme and completed 
the 5-weeks therapy. First, the IBMT approach used in this physiotherapy-led 
intervention may have reconceptualised the fear of movement for the patients to 
engage with the exercise aspect of the programme which in turn may have had a 
short-term ‘feel good factor’ on their psychological well-being. Secondly, the group 
exercise programme was designed and tested in the phase 1 study, so was known to 
be acceptable, appropriate whilst still providing graded exposure to address fear of 
movement for this patient group. Furthermore, the peer support during or outside 
the exercise programme may have helped the patients to share their experiences, to 
gain confidence and persevere with the exercise programme. Third, the educational 
component of the programme may have specifically addressed some of the fear and 
misconception of pain, which may have demystified some of the barriers for patients 
to engage with the exercise programme, this was a reported finding in (Moseley et al. 
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2004). However, the last assertion may require further testing in larger sample in 
longitudinal follow-up study. 
However, when the group was split with condition type, it was clear that those with 
multi-site or fibromyalgia had a higher baseline score of depression (10.9) compared 
to low back pain (7.8). The change scores observed in low back pain of 2.5 and multi-
site pain of 2.0 at 5-weeks were sustained at 3-month follow-up. The differences 
between the two groups were small and not statistically different. These findings give 
some evidence for physiotherapists that an IBMT approach in a group setting had 
some effects in reducing depressive symptoms. However it also highlights that 
patients identified with elevated depressive symptoms should be referred for 
psychological therapy where appropriate. 
6.2.4 Anxiety 
The anxiety baseline score in this study was 11.9; over the level that Crawford et.al 
(2001) suggests referral to mental health services. The score was also higher than the 
mean score for the high risk group in the STaRT back (Hill et al. 2011). This study’s 
intervention produced change from 11.9 baseline to 9.2, which was a mean change of 
–2.7 at 3-month follow-up. Again, these changes were statistically significant and 
potentially clinically significant, but no MCID exists. The high score may be indicative 
of the cohort’s mix from both primary and secondary care. Baseline anxiety scores 
were higher in secondary care (14.0) compared to primary care (10.6). Additionally, 
although this study reported statistical and clinically significant changes for both fear 
avoidance behaviour (TSK) and depression, the changes in anxiety, as measured by 
the HADS, was smaller. Whether subgroups of patients e.g. from the secondary care 
may benefit more from this type of specific treatment is still unclear and requires 
further study. Having said this, there were no group differences between the two 
groups in baseline demographic characteristics. The alternative explanation might be 
fear avoidance, although a type of anxiety is specific to movement might be different, 
whilst the HADS measures generalised health related anxiety may not be specific to 
pain. Thus, further studies are needed. Interestingly (Crawford et al. 2001) found that 
in their non-clinical sample, mean anxiety was 6.14 whilst depression was only 3.68, 
suggesting anxiety is more prevalent in the general population anyway. If anxiety is 
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higher in a non-clinical sample it is possible that anxiety will be higher in a clinical 
sample too, the results of this study viewed in this context are therefore not to be 
expected. 
6.2.5 Self-efficacy 
Nicholas (2007) suggests the importance of using self-efficacy (PSEQ) scores as both a 
useful screening tool as well as an outcome measure for interventions. In terms of a 
screening tool he suggests a very low score defined as <17 would require individual 
treatment prior to attending a pain programme to address pain belief systems. 
However, those with a high score >40 might not require a pain management 
programme approach and the reason for them seeking treatment would be better 
explored on an individual basis. Based on these suggestions, 26% (14/53 of 
participants in this study) had baseline scores under 17, and 11% (6/53) scored >40, 
and would potentially be excluded, leaving only 62% 33/53 of this study cohort. Post-
intervention scores revealed that only 4% (2/53) had scores <17 and 40% (21/53) had 
scores >40. Furthermore, at 3-month follow-up, no participants had a PSEQ under 17 
and 49% (17/35) had scores >40. In addition (Nicholas, 2007) discusses that, post-
intervention, a participant who makes behavioural changes but does not score >40 is 
still at potential risk of relapsing and probably requires follow-up or monitoring. The 
overall mean score in this study changed from baseline (25.42) to post-intervention 
(35.62) to 3-month follow-up (39.40) indicating a statistically and clinically significant 
change score was observed. As all the patients in the study have improved in their 
self-efficacy, the findings may have relevance to the management of pain in patients 
with chronic diseases. 
6.2.6 Pain-related disability measured with the Pain disability questionnaire for multi-site 
pain and Roland Morris Disability Questionnaire, RMDQ, for low back pain 
Physiotherapy-led interventions for chronic low back report large changes in pain-
related disability using the RMDQ. Studies using an RCT design (Hay et al. 2005; 
Critchley et al. 2007; Hill et al. 2011), report large change scores from 5.3 to 6.8 and 
these were sustained to at least 12-month follow-up. The cohorts used in these 
studies were mainly primary care and in the specific case of (Hill et al. 2011) patients 
had psychological risk factors identified prior to intervention. Although (Lamb et al. 
2012) had a cohort similar to the medium risk group, in (Hill et al. 2011) the mean 
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change score was lower at 2.9, although this improvement was sustained to 
extended follow-up of 36 months (range 20-50 months). This study reports a mean 
change from the phase 1 preliminary study of -4.5. However, the prospective study 
produced a change score of 3.4 which, although lower, had a smaller low back pain 
sample (n=18 compared to n=81). The significance of the change score in this study 
was despite addressing a mixed condition group; the change in pain-related disability 
for low back pain was comparable to that observed in (Woby et al. 2008) with a 
chronic low back pain-only programme. The ANOVA analysis revealed there was no 
statistical difference between any of the patient-reported outcome measures 
between the condition types, providing further evidence of the effects of the 
intervention for a mixed condition group. 
Gatchel et al. (2006) reported changes in the level of self-reported disability using the 
PDQ in a cohort of patients with chronic musculoskeletal pain following an 
interdisciplinary pain management programme. The PDQ score is divided into three 
distinct categories; mild/moderate (scores of 0-70); severe (scores of 71-100); and 
extreme (scores 101-150). Gatchel et al. (2006) report that 85% of their sample were 
in either the severe or extreme category. This study found that 93% of the sample fell 
into these categories; (69% extreme; 24% severe). Post-intervention the change score 
was both statistically significant from baseline to 3-month follow-up and resulted in a 
change of severity category which suggests a clinical improvement in function, 44% 
remained extreme and 32% severe. This reduced further at 3-month follow-up; only 
10% in extreme category and 65% in severe. Gatchel et al. (2006) report their 
intensive multi-disciplinary team intervention resulted in only 7% of their cohort 
remaining in the extreme category and 56% in the mild/moderate category. This 
study found 25% in the mild/moderate group at 3-month follow-up compared to 7% 
pre-intervention. Despite these differences in outcome, there was a similar trend in 
reduction of PDQ scores in both studies. It is positive that the results from the 
current study are comparable to the findings in (Gatchel et al. 2006). They show that 
with an equally disabled cohort, significant changes in severity of functional disability 
are observed and sustained despite the intervention being a physiotherapy-led 
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programme compared to (Gatchel et al. 2006) using an intensive multi-disciplinary 
team intervention. 
6.3 Physical function (measured with step-up repetitions and walking tests; 
speed and distance) 
In this study, both speed and distance of walking, in addition to number of step-ups 
performed in one minute, have changed following the intervention. There was an 
11% change in distance and 22% change in speed of walking, in addition to a 30% 
change in step-up repetitions. These changes were comparable to (Marcus et al. 
2014) who reported similar changes in a cohort of patients with fibromyalgia. They 
also highlighted the benefit of using physical function tests as their study observed no 
changes in patient-reported outcome measures. Furthermore, (Moseley et al. 2004) 
reported a significant improvement in physical function following a pain education 
session alone and suggest that improvements in physical function are not solely 
related to the effects of physical training but also changes in cognitive processes, i.e. 
reduced fear, improved confidence and self-efficacy. The physical tests chosen for 
this study are considered to be a good representation of everyday activities i.e. 
walking and climbing stairs, and are potentially meaningful for the patient. Harding et 
al. (1994) suggests that adding physical function tests provides quality to outcome 
measurement in chronic pain management services. 
6.4 Critique of methodology and limitations of study 
When considering the apparent effects of this physiotherapy-led intervention there 
are methodological limitations to the generalisability of the findings. Firstly, the study 
used a non-experimental study design which (Sim and Wright, 2000) discuss is a 
threat to both internal and external validity. In the absence of a control or 
comparison group it is feasible that the same results might have been obtained with 
individual physiotherapy intervention or natural history rather than the intervention, 
per se. Both (Woby et al. 2008) and (Sowden et al. 2008) highlighted this as a similar 
limitation in their studies. However, unsolicited informal verbal feedback received 
from the participants indicate their appreciation of the programme and that it was 
helpful in the change they have observed in their physical functioning and ability to 
engage more in social activities see page 55. A future study might choose a mixed 
methodological approach to combine patient-reported outcome measures with a 
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qualitative study to capture any behavioural changes observed after the intervention. 
There was a 34% dropout from post-intervention to 3-month follow up this was 
similar to (Critchley et al. 2007; Johnson et al. 2007). In contrast to (Wells-Federman 
et al. 2002) who reported a 46% attrition rate in their cohort and suggested that this 
rate was consistent with other studies using a group-based CBT approach. Despite 
the small sample size, retaining 100% of the cohort in pre-post intervention is 
positive and may represent satisfaction with the intervention or, potentially, a 
Hawthorne effect of being part of a research trial and an attempt by participants to 
please the researchers; this was reported by (Coleman et al. 2014). In addition, those 
who dropped out of the study post-intervention were more likely to have no 
additional co-morbidities (77.8%), be referred from secondary care 70.1%, and not 
working 55.6%. Baseline scores indicated only self-efficacy 22.9 compared to 26.7 
and pain-related disability RMDQ, 11.07 compared to 14.1, but these findings were 
not statistically significant. This suggests that those who dropped out of the study 
were not different from those who continued from pre- to 3-month follow-up. 
Unfortunately, this service led intervention was constrained with financial, time and 
manpower resources for close follow-up of patients after the intervention. Future 
studies should consider a maintenance programme or telephone contacts in how the 
patients were engaging with the exercise programme and other lifestyle changes 
known to be effective in self-management of long-term conditions. Finally, 
consideration should be given for future studies to include economic analysis of the 
intervention compared with control group using clinically relevant outcome 
measures. It is critical that in the face of growing pressures on health services that 
nay treatments offered provide both the best clinical and cost effective care that are 
available. 
The results from both the preliminary phase 1 on page 55 and the prospective phase 
suggest that the physiotherapy-led intervention produced positive changes in 
reducing cognitive and physical factors associated with chronic musculoskeletal pain 
and there does not appear to be a statistically significant difference in outcomes 
between different condition types. This is potentially important as previous research 
trials examining physiotherapists delivering a pain management approach have 
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focussed on specific condition groups: low back pain (Critchley et al. 2007; Hill et al. 
2011; Lamb et al. 2012) and osteoarthritis (Jessep et al. 2009; Coleman et al. 2012). 
However, caution is required in the interpretation of the findings. 1) The pre-
experimental design meant blinding the patients and the treatment team was not 
possible. 2) The therapists were part of the treatment team, but they were blinded 
from administering and scoring the outcome measures to avoid bias. 3) The study 
was conducted in a single centre study compared to previous studies, which are 
multi-centred studies with large sample size of participants (Lamb et al. 2012; 
Coleman et al. 2012). 4) There was no control group for comparison of findings. 
Finally, the study followed patients only for three months. Thus, the longer-term 
efficacy of intervention at 6 and 12 months are worthy of consideration e.g. return to 
work. 
6.5 Clinical implications 
This study was undertaken to review and provide evidence that the current service 
provision of a mixed aetiology pain management programme delivered by 
physiotherapists had potential positive clinical effects. It has expanded on the original 
intervention ‘Work Back to Life’, described by (Woby et al. 2008) to offer a 
physiotherapy-led intervention for participants with any chronic musculoskeletal 
pain, rather than to a limited low back pain cohort which, based on the author’s 
department, only account for 30% of the total referrals. This study also looked at 
medium-term effects of the intervention by reviewing the outcome measures at 3-
months post-intervention. The study found that all improvements in outcome 
measures were sustained at follow-up review, however the size of change was only 
significant from pre- to post-intervention and pre-intervention to follow-up but not 
significant from post-intervention to follow-up. This possibly suggests that 
participants are either plateauing or consolidating their pain management skills, or 
no further change will occur, or even that they are starting to relapse. Hansen et al. 
(2010) suggested a review was important as most significant changes occur 
immediately post-interventions and therefore their efficacy can be exaggerated. The 
review process is also supported in the UK Map of Medicines (2013) pathways for 
pain and in the British Pain Society (2013) pain management programmes guidelines 
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for adults. A 12-month review of efficacy would be beneficial, but was not possible 
due to the time limitations of this study. In addition, when exploring the use of cut-
off scores for the PSEQ, there is potential of identifying patients who are likely to 
relapse based on their post-intervention self-efficacy score (Nicholas et al. 2007). This 
requires consideration as to be able to identify those patients who are likely to 
relapse would be advantageous for cost and future health care planning. 
6.6 Suggestion for future research 
Future randomised control trials should investigate the efficacy of the intervention in 
comparison to individual therapy or an alternative group intervention without CBT 
principles in a larger sample is recommended. However, Jessep et al. (2009) 
suggested that, despite using an RCT design, interventions that are interactive are 
difficult to replicate in strict research protocols. Whilst this is a further issue that 
effects the generalizability of the results, it also means that such interventions can be 
highly adaptable in the real-life clinical setting and this could be interpreted as a 
positive consequence. 
One of the clinical aims of this study was to establish a referral pathway for those 
patients whose level of psychological distress might require additional management. 
The introduction of the HADS has enabled collection of data on the level of 
psychological distress in the patient population this intervention serves and to 
monitor the level pre- to post-intervention. As a result, there are now closer links 
with primary care partners in mental health services and a referral pathway has been 
established. There are also developments for primary care mental health services in 
Bury called ‘healthy minds’ which offer a taster session within the current 
physiotherapy programme of mindfulness, an evidence based mediation strategy for 
people with chronic pain and other conditions. Further studies should also consider 
the efficacy of physiotherapy-led group intervention based on IBMT principles 
training opportunities for physiotherapists working in primary care to improve their 
clinical practice in referring patients to secondary care. 
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6.7 Conclusion 
The physiotherapy-led group intervention based on IBMT principles had an effect on 
reducing fear avoidance, disability, anxiety and depression whilst increasing self-
efficacy and physical function in patients with chronic pain. 
There is potential that physiotherapists can play a leading role in the development of 
accessible and cost-effective pain management interventions and services for people 
with chronic musculoskeletal pain. This study adds to the body of literature 
suggesting that physiotherapists have the skills to be able to manage patients with a 
range of psycho-social factors that are currently considered complex and requiring 
specialist service input. In view of the increasing incidence of chronic pain, combined 
with an ageing population, the necessity to review current service specification and 
delivery requires careful consideration. In addition exploring professional boundaries 
to ensure that health providers can deal with the crisis and people access timely and 
effective services to enable them to live well, despite pain. This change will require 
the physiotherapy profession to expand their practice and will have implications for 
undergraduate education to enable effective workforce planning for the NHS to 
effectively address the growing problem of chronic pain. 
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7 Overall summary and conclusions 
7.1 Summary of Phase 1 and 2 studies 
This thesis set out to broadly explore the changes, on patient reported outcome 
measures, which occurred for participants attending a local non-specialist 
physiotherapy-led chronic pain management group. In phase 1 a review of the 
current service provision, the Functional Rehabilitation Programme (FRP), at the 
outpatient physiotherapy department of Pennine acute NHS trust was explored. FRP 
had been set up in response to increasing numbers of chronic pain referrals, an 
emerging awareness of the limitations of ‘traditional’ physiotherapy i.e. ‘hands on’ 
mobilisations, electrotherapy, and exercise regimes in addition to the well 
documented growing healthcare of chronic long term pain (Nicholas, 2015). Initially 
the programme had been based on the work of (Woby et al. 2008) who observed 
positive changes with a type of psychologically informed physiotherapy practice 
termed Interactive Behavioural Modification Therapy (IBMT). One of the main 
limitations of this approach clinically was the restriction of the approach to patients 
with chronic low back pain only. An informal ‘trial’ took place at Fairfield general 
hospital to ascertain whether the same group intervention using IBMT could produce 
similar positive changes to those found that (Woby et al. 2008), in a group of patients 
with mixed chronic pain aetiology. Due to the lack of evidence found for this type of 
physiotherapy-led intervention in the literature review, a retrospective study -phase 
1, was undertaken with the main aims of; 
• To evaluate a range of patient reported outcome measures, (PROMS), in terms of 
clinical and/or statistical of a physiotherapy-led functional restoration programme 
for patients with persistent musculoskeletal pain in an outpatient setting. 
• The secondary objective was to evaluate if there were significant differences in 
the outcomes between the two condition types (low back pain and widespread 
pain). 
• Finally to determine the sample size for the phase two prospective study 
There were several limitations of phase one which have been discussed in full in 
chapter 2. The most significant limitations included methodological issues, no control 
group, retrospective data, and incomplete data sets. Despite the limitations of the 
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phase 1 preliminary evidence was gathered that the intervention appeared to be 
producing positive changes in the PROMS. However it was acknowledged that 
changes are most commonly observed from pre to post intervention and are not 
necessarily attributable to the intervention itself, (Hansen et al. 2010). 
Key findings from phase 1 (taken from section 2.11) 
• The physiotherapy-led intervention produced clinically and statistically significant 
short term (pre to post) changes in low back pain related disability (RMDQ) and 
fear of movement in a cohort of patients with chronic MSK pain. 
• Improvements were also observed in pain-related disability for widespread pain 
(PDQ) and for catastrophizing. Due to the lack of MCID established for these 
outcome measures it is unclear as to whether the change scores observed were 
clinically significant however both were statistically significant, p < 0.001. 
• No difference in scores (TSK and Cat-A only) were observed between condition 
types (low back pain and widespread pain) suggesting that a physiotherapy-led 
intervention with a mixed aetiology group can produce positive changes. This last 
observation has potential clinical significance. Chapter 2 highlighted that most 
physiotherapy research in chronic pain group management has focused on either 
classes/groups for low back pain or osteoarthritis but not a mixed aetiology 
chronic pain group. 
• Finally, although informal, qualitative responses from participants from the group 
appear to support changes observed on the PROMS in relation to behaviour and 
lifestyle changes. 
Despite the acknowledged limitations of phase 1, the key findings were used to 
develop the protocol for the prospective phase 2 section of the thesis. Phase 2 used 
the preliminary evidence gained from phase 1 and looked to evaluate further the 
changes that occurred in a broader range of dimensions in the PROMS to capture the 
multi-faceted nature of chronic pain. A number of physical function tests was also 
included to measure physical performance. The additional dimensions explored in 
phase 2 included participants self-efficacy, their confidence to continue with 
everyday activities despite having pain. Self-efficacy has been described as a core 
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strategy for effective management of any long term condition (Nicholas, 2015). 
Additionally the HAD was used to capture information on levels of depression and 
anxiety within the cohort and observing changes between the different time points. 
Depression is traditionally seen as an area that physiotherapists do not feel confident 
about managing and where resources allow refer on to specialist psychological 
services (Woby et al. 2008). However to enable appropriate referrals and establish 
the requirements for specialist services more information was required for both 
clinicians and commissioners on the presence and severity of psychological distress in 
this patient population. 
The key aims of phase 2; 
• To explore the changes in fear avoidance, disability, depression and increase in 
self-efficacy at pre to post 5 weeks intervention following a physiotherapist-led, 
group-based intervention for patients with chronic musculoskeletal (CMSK) pain. 
• To explore the medium-term benefits of the group-based intervention on the 
same outcomes at 3-month follow-up and to investigate differences between 
outcomes in terms of condition type and referral sources 
One of the key findings from phase 2 suggest that physiotherapy can also have a 
positive effect on aspects of mood and self-efficacy. However although statistically 
significant changes were observed for depression and anxiety there are no MCID for 
the HADS measure to determine whether the changes were clinically significant. 
Overall the findings from phase 2 are comparable to those found in phase 1. The 
intervention again produced clinically and statistically significant changes at short 
(pre to post intervention) but in contrast to phase 1, which had no follow-up, were 
sustained at medium term (3-month post-intervention) in pain related disability, fear 
of movement and self-efficacy. Interestingly the changes were observed at pre to 
post and from pre to follow up. No significant change in scores on any measure was 
observed from post intervention to 3-month. One explanation may be plateauing or 
consolidation of effect from the intervention. Finally as in phase 1, no difference in 
scores (TSK, PSEQ, HAD-A and -D) were observed between condition types (low back 
pain and widespread pain) providing further evidence that a physiotherapy-led 
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intervention with a mixed chronic pain aetiology group can produce positive changes 
in PROMS and physical function. 
The climate for healthcare service provision is changing with more competition faced 
by the NHS from private providers for core services. It is envisaged that the findings 
from this thesis will be discussed in relation to service development for local pain 
management services and further research including cost analysis and use of a 
parallel control group will be undertaken to contribute further to this important area 
of potential expansion for the physiotherapy profession. Further research into long-
term condition management will ensure that physiotherapists and physiotherapy-led 
services continue to contribute and play a lead role in this important and changing 
area of health care provision. 
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Appendix 1 – Results for the database search carried out on 23/03/2015 
 
No Search term AMED and 
MEDLINE 
via OVID 
CINAHL SCOPUS Science 
direct 
MEDLINE Cochrane 
1 Physiotherap* OR 
Physical therap* 
18,881 40,883 144,974 14,989 29,568 33,058 
2 “CBT” OR “CBT 
approach” OR 
“cog behave ther” 
OR behav* thera* 
1,874 9,591 144,840 2,491 19,656 35,766 
3 “chronic pain” OR 
“persistent pain” 
OR pain OR “low 
back pain” 
12,632 124,252 73,715 3,084 37,296 7,771 
4 “group therapy” 
OR group OR 
program* OR class 
OR “group 
treatment” 
9,170 408,702 2,954,184 155,297 2,457,384 356,721 
5 1 & 3 & 4 31 1,959 2,902 74 779 440 
6 5 & 2 31 71 80 87 30 190 
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Appendix 4 - Summary of papers in literature review with PEDro scale 
Study 
author/study 
location 
Study design  Pedro 
score 
(0-11; 
0=worst) 
Participant characteristics Intervention Outcome measures 
(OM) 
Primary outcome 
measure (POM) 
Results 
Critchley et al. 
(2007) 
RCT with 18-
month 
follow-up 
7 212 patients with chronic 
low back pain patients. 
Primary care referrals. 
Females 65% 
Mean age 44 
Comparison of 3 types of 
physiotherapy (PT) 
Individual physiotherapy (IP) 
Spinal stabilisation exercises (SSE) 
Physiotherapist-led pain 
management classes (PPM) 
 
POM -Roland Morris 
Disability 
questionnaire 
(RMDQ) 
Numerical rating 
scale (NRS 0-100) 
EQ-5D (Euroqol) 
Economic cost and 
QALY 
OM recorded at 
baseline, 6, 12 and 
18 months follow-up 
RMDQ reduced in all 3 arms, 
mean >4 and was sustained at 18 
months follow-up. No significant 
difference was detected between 
treatment arms. PPM found to be 
most cost effective 
Lamb et al. 
(2012) 
RCT 
With 
extended 
follow-up 
8 701 UK patients recruited 
with low back pain for a 
minimum of 6 weeks. 402 
completed the study. 
Primary care referrals 
Female 60% 
Mean age 53 
Comparison of Group cognitive 
behavioural intervention 
delivered by either a PT, 
Occupational therapist, 
psychologist or nurse for 9 hours, 
6 x 1.5hr sessions (CBI) or 10-15 
minute best care advice and back 
book (BPA) 
POM -RMDQ 
Modified Von Korff 
scale (MVK) disability 
and pain scale 
EQ-5D, HADS, PSEQ 
OM recorded at 
baseline, 3, 6 12 and 
extended follow-up 
(between 20-50 
months) 
RMDQ reduced by 1.6 points in 
the BPA arm and 2.9 in CBI group 
at extended follow-up 
UK BEAM trial 
(2004) 
RCT 
With 3 and 
12 month 
follow-up 
Pedro = 8 
8 1334 UK participants with 
low back age 18-65, 
primary care referrals, 
Females 52% 
Mean age 42.5 
Comparison of 3 different 
treatment approaches; best care 
advice; back school with CBT; 
manipulation in NHS and private 
setting 
POM -RMDQ 
Modified Von Korff 
scale (MVK) disability 
and pain scale 
SF-36, fear avoidance 
beliefs 
All groups improved. 
Exercise group reduced RMDQ at 
3 months only 
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Study 
author/study 
location 
Study design  Pedro 
score 
(0-11; 
0=worst) 
Participant characteristics Intervention Outcome measures 
(OM) 
Primary outcome 
measure (POM) 
Results 
Van de Roer et 
al. (2008) 
RCT 
With 6, 12 
and 52 week 
follow-up 
6 210 Dutch participants 
with non-specific chronic 
low back pain. Participants 
had to be insured by one 
specific insurance 
company in the 
Netherlands 
Female 55% 
Mean age 41.5% 
Comparison of 2 types of 
physiotherapy intervention. 
Intensive group training 
physiotherapists using a 
behavioural approach 
participants had 10 individual and 
20 group sessions. 
Compared to Dutch guidelines 
individual physiotherapy 
sessions; mean no. of sessions 13 
RMDQ 
NRS 
TSK 
No difference between groups on 
RMDQ. Both groups by 5 points 
at 52 weeks. 
NRS was only significant change 
in intensive group reduced by 2.3 
points compared to individual 
physiotherapy of 1.3 points.  
Cecchi et al. 
(2010) 
RCT 
with 12 
months 
follow-up 
9 210 Italian Participants 
with chronic non-specific 
low back pain 
Females 67% 
Mean age 59 
Comparison of three types of 
therapy; 
Individual physiotherapy of 15 
hours; 
Back school group based 
physiotherapy 15 hours; 
Spinal manipulation with a 
physician 
RMDQ 
Pain rating scale (0-6) 
Spinal manipulation intervention 
reduced RMDQ by 6.7 pints 
compared to individual physio 4.4 
and back school 3.7. no 
difference between groups in 
pain rating score. 
60% of the spinal manipulation 
group sought further treatment 
only 10% and 20% of the 
individual group and back school 
did 
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Study 
author/study 
location 
Study design  Pedro 
score 
(0-11; 
0=worst) 
Participant characteristics Intervention Outcome measures 
(OM) 
Primary outcome 
measure (POM) 
Results 
Hay et al. 
(2005) 
RCT 
with 3 and 
12-month 
follow-up 
 
10 402 UK participants with 
sub-acute (>12 weeks 
duration) non-specific low 
back pain 
Comparison of 2 types of 
physiotherapy 
Brief pain management delivered 
on a 1 to 1 basis maximum of 2 
hours and 40 minutes 
Individual physiotherapy 
maximum of 6 sessions 
RMDQ 
TSK 
 
Both groups produced large 
change scores on RMDQ of 8.8 
sustained change at 12 month 
follow-up. TSK increased in both 
groups by over 6 points 
(statistically and clinically 
significant) in both groups at 3 
and 12-month follow-up. No 
discussion as to why this 
occurred 
Coleman et al. 
(2012) 
RCT 
With 8 week 
and 6-month 
follow-up 
6 146 Australian primary 
care participants with 
osteoarthritis of the knee. 
Female 75% 
Mean age 65 
Intervention group; a health care 
professional-led self-
management programme for OA 
of the knee (OAK compared to a 
waiting list control group 
 
SF-36 
WOMAC 
VAS 
Physical function test 
– Timed get up and 
go (TUG) 
Baseline data was different for 
pain, mental health and physical 
function on the Sf-36. Worse in 
the Oak group. 
OAK observed improvement in all 
outcome measures except the SF-
36 sustained at 6-month. 
The study reported a drop-out for 
the waiting list control group at 8 
week follow-up and then an 
increase at 6-month follow up 
which the authors suggest 
effected validity of results. 
Patients also self-enrolled for the 
study therefore arguably more 
likely to self-manage 
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Study 
author/study 
location 
Study design  Pedro 
score 
(0-11; 
0=worst) 
Participant characteristics Intervention Outcome measures 
(OM) 
Primary outcome 
measure (POM) 
Results 
Jessep et al. 
(2009) 
RCT with 12-
month 
follow-up 
7 64 UK participants with 
chronic knee pain 
recruited from primary 
care 
Female 
Mean age 67 
Compared individual outpatient 
physiotherapy over a maximum 
of 10 sessions of 30-minutes with 
a 7-hour physiotherapy-led 
programme ESCAPE; (enabling 
self-management through 
exercise)  
WOMAC 
NRS 
HAD 
 
Both groups showed 
improvement in all outcome 
measures which were sustained 
on follow-up no difference 
between groups. The main 
finding was that the ESCAPE 
group cost less and was more 
cost effective in terms of further 
health care usage over the 
12month follow-up period 
Johnson et al. 
(2007) 
RCT 
12-month 
follow-up 
8 196 UK participants with 
persistent low back pain 
from primary care. 
Female 59% 
Mean age 47.9 
Compared intervention of a 16-
hour physiotherapy-led 
programme using CBT principles 
based intervention to a control 
group of an educational package 
of information posted to 
participants. 
RMDQ 
VAS 
RMDQ reduced in both groups by 
3.2 intervention and 2.2 control. 
Not statistically significant 
between groups. Only small non-
significant change in pain. No 
difference between the 
intervention and control. 
Cost of the treatment was lower 
for the group intervention. They 
demonstrated that patient 
preference of treatment 
influenced treatment outcome. 
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Study 
author/study 
location 
Study design  Pedro 
score 
(0-11; 
0=worst) 
Participant characteristics Intervention Outcome measures 
(OM) 
Primary outcome 
measure (POM) 
Results 
Hill et al. (2011) RCT with 4 
and 12-
month 
follow-up. 
9 851 UK participants with 
back pain from primary 
care. 
Female 59% 
Mean age 49.5 
Compare stratified care pathways 
for participants with low back 
pain based on the prognostic 
Keele STaRT back screening tool. 
This stratified pathway was 
compared to a control group of 
normal physiotherapy care for 
low back pain 
RMDQ 
TSK 
HAD 
PSEQ 
SF-12 
Pain catastrophizing 
scale 
Both control (normal) 
physiotherapy and stratified care 
produced positive changes in all 
outcome measures. The stratified 
(intervention) care produced 
larger changes that were 
sustained at 4 and 12-motnh 
follow up. The stratified care was 
found to be cost effective in 
terms of further care usage than 
the control group over 12-
months 
Woby et al. 
(2008) 
Before and 
after study 
design 
Not 
applicable 
NOT and 
RCT 
137 UK participants with 
chronic low back pain 
recruited following 
physiotherapy 
assessments form both 
primary and secondary 
care 
A physiotherapy-led 17.5 hour 
intervention; ’ work back to life’ 
based on a CBT approach. No 
control group. No follow-up 
RMDQ 
VAS 
TSK 
HAD (depression) 
Statistically significant change 
scores observed in RMDQ TSK 
and depression with smaller 
changes observed in the other 
outcome measures 
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Appendix 5 - Flag indicators 
Table taken directly from URL: http://www.physio-pedia.com/The_Flag_System showing flag 
indicators used in musculoskeletal assessments. Based on work by (Kendall et al. 1997) and 
(Nicholas et al. 2011) 
 
Nature Examples 
Red  Signs of serious pathology  
Cauda equina syndrome, fracture, 
tumour, unremitting night pain, 
sudden weight loss of 10 pounds 
over 3 months, bladder & bowel 
incontinence, previous history of 
cancer, saddle anaesthesia. 
Orange Psychiatric symptoms  
Clinical depression, personality 
disorder 
Yellow  
Beliefs, appraisals and judgements  
Unhelpful beliefs about pain: 
indication of injury as 
uncontrollable or likely to worsen. 
Expectations of poor treatment 
outcome, delayed return to work. 
Emotional Responses  
Distress not meeting criteria for 
diagnosis of mental disorder. 
Worry, fears, anxiety. 
Pain behaviour (including pain and 
coping strategies)  
Avoidance of activities due to 
expectations of pain and possible 
reinjury. 
Over-reliance on passive 
treatments. 
Blue  
Perceptions about the relationship 
between work and health  
Belief that work is too onerous 
and likely to cause further injury.  
Belief that workplace supervisor 
and workmates are unsupportive. 
Black  System or contextual obstacles  
Legislation restricting options for 
return to work. 
Conflict with insurance staff over 
injury claim. 
Overly solicitous family and health 
care providers. 
Heavy work, with little 
opportunity to modify duties. 
Key questions based on (Kendall et al. 1997) 
The following are considered useful key questions to ask in an assessment to determine the 
presence of yellow flag indicators. If the patient responses 
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• What do you think has caused the problem? 
• What do you expect is going to happen? 
• How are you coping with things? 
• Is it getting you down? 
• When do you think you’ll get back to work? 
• What can be done at work to help? 
Structured interview 
If the responses from the key questions has confirmed that there are flags present then these 
can be explored in more depth using the acronym: ABCDEFW. Below are examples of areas to 
explore taken directly from URL: http://www.physio-pedia.com/The_Flag_System 
• Attitudes/Beliefs – What does the patient think to be the problem and do they have a 
positive or negative attitude to the pain and potential treatment? 
• Behaviour – Has the patient changed their behaviour to the pain? Have they reduced 
activity or compensating for certain movements. Early signs of catastrophising and 
fear-avoidance? 
• Compensation – Are they awaiting a claim due to a potential accident? Is this placing 
unnecessary stress on their life? 
• Diagnosis/Treatment – Has the language that has been used had an effect on patient 
thoughts? Have they had previous treatment for the pain before, and was there a 
conflicting diagnosis? This could cause the patient to over-think the issue, leading to 
catastrophising and fear-avoidance 
• Emotions – Does the patient have any underlying emotional issues that could lead to 
an increased potential for chronic pain? Collect a thorough background on their 
psychological history 
• Family – How are the patient’s family reacting to their injury? Are they being under-
supportive or over-supportive, both of which can affect the patient’s concept of their 
pain 
• Work – Are they currently off work? Financial issues could potentially arise? What are 
the patient’s thoughts about their working environment? 
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Appendix 6 - Programme timetable 
 Session 1 Session 2 Session 3 Session 4 Session 5 
9.30 – 
10.30 
Icebreaker – 
concerns and 
expectations 
about the 
group. 
Completion of 
outcome 
measures and 
physical test 
Pacing and 
value based 
activity 
theory and 
discussion 
Explain pain 
(2) 
How to manage 
a flare up of 
pain 
Setback 
planning/ long 
term 
maintenance – 
change cycle 
10.30-
10.40 
Comfort break Comfort 
break 
Comfort 
break 
Comfort break Break 
10.40 – 
11.10 
Interactive 
discussion – 
What effect has 
chronic pain 
had on your 
life? – Chronic 
pain cycle 
Group work – 
pacing 
activity 
Exercise 
individual 
stretching and 
full circuit 
Exercise 
stretching and 
full circuit 
Health trainer 
and expert 
patient tutor 
session 
11.10 – 
11.30 
Break 
 
Exercise – 
individual 
stretching 
and ½ 
exercise 
circuit 
Break Break Completion of 
outcome 
measures and 
physical tests 
11.30 – 
11.50 
Why is exercise 
useful -theory  
Break Stress its 
effects and 
practical 
strategies to 
help manage. 
Sleep 
management  
Local exercise 
on referral 
scheme (BEATS) 
talk and 
discussion 
11.50 – 
12.20 
Practical 
exercise – 
stretching 
group 
Explain pain 
(1) 
Practical – 
abdominal 
breathing 
Comfort break Individual 
reviews and 3 
month goal 
setting 
12.20-
12.30 
Close and 
questions 
Close and 
questions 
Goal setting Relaxation Close, 
questions  
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Appendix 7 - Exercise component for study intervention 
 
1. Stretching programme for week 1 - 5 
Week 1 
The group works through the stretches together as a group with the physiotherapist 
demonstrating each stretch. 
Patients are asked to try all the stretches and to use these instructions as a guide; 
Do each stretch slowly, sustain each stretch for 5 seconds, then slowly release the stretch and 
repeat each stretch twice. 
Patient are asked to complete the exercises on a daily basis at home and provided with an 
illustrated guide. (See appendix for picture reference for each stretch) 
Weeks 2 - 5 
Patients are encouraged to do the stretches individually or as a group without the physiotherapist 
leading. 
2. Exercise circuit for weeks 2 - 5 
The circuit has 12 stations that include strengthening, balance and cardiovascular exercises. The 
exercises are either functional, address positions that patients may be avoiding or have 
components that patients have identified as a problem area i.e. balance, co-ordination. 
Week 2 
Patients are asked to complete ½ circuit (6 exercises) following the stretches. 
Week 3 - 5 
Patients complete stretching programme and full circuit (12 exercises) 
Patients are asked to record the number of repetitions they complete (where applicable) on their 
exercise sheet. 
In addition to their stretching programme patients are asked to complete the circuit exercises at 
home that do not require specialist equipment i.e. bike, cross trainer etc. They are provided with 
a home sheet to record this on. 
Circuit exercises (H denotes exercises for home) 
1. Wobble board 
2. Trampet 
3. Bouncing gym ball along the floor and turning around 
4. Bridging (H) passing small ball underneath hips 
5. 4 point kneeling superman (H) 
6. Step ups (H) 
7. Sit stand from a chair (H) 
8. Bike 
9. Cross trainer 
10. Press ups against wall (H) 
11. Lateral raises (H) 
12. passing small ball behind back then behind head (H) 
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Appendix 8 - Study physical function tests 
 
Instructions for physiotherapists 
 
Please do not add further instructions to the tests this is to ensure that all participants 
receive the same information. Please do not to talk to the participant during any of the 
tests unless the participant reports an adverse reaction or the participant requests to stop 
the tests. 
Participants can use whatever walking aid needed for the walking tests and they can hold 
onto the walls bar if needed during the step-up test. 
1. Test 1 speed of walking over 20 metre distance. 
Record the speed of walking between the two markers in minutes/seconds and record on 
the data collection form. 
“Please walk as quickly as you can today between the two markers.” 
 
Test 2 - Distance covered in 5 minutes between 2 markers set 20 metre apart. 
Record the number of whole lengths covered between the two markers and calculate the 
total distance covered in 5 minutes. 
Instruction to the participant that they should walk at their normal walking pace and you 
will inform them at the end of each minute. 
“Walk in between the two markers for 5 minutes. Walk at your normal walking pace. I will 
let you know at the end of each minute how long you have left. If you need to stop the test 
let me know. 
 
2. Test 3 - number of step up repetitions in 1 minute 
Record the number of whole step ups performed (on and off the step reebok box) in 1 
minute. 
“Step on and off the step as many times as you can in 1 minute. I will let you know when 
you are half way through the test. You can hold onto the wall bars if you need to” 
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Appendix 9 - Tampa Scale of Kinesiophobia 
This is a list of phrases which patients have used to express how they view their condition. 
Please indicate the extent to which you agree or disagree with each statement. 
During the past week… Strongly 
Disagree 
Some- 
what 
Disagree 
Some- 
what 
Agree 
Strongly 
agree 
1. I’m afraid that I might injure myself if I 
exercise 
1 2 3 4 
2. If I were to try to overcome it, my pain 
would increase 
1 2 3 4 
3. My body is telling me I have something 
dangerously wrong 
1 2 3 4 
4. My pain would probably be relieved if I 
were to exercise 
1 2 3 4 
5. People aren’t taking my medical condition 
seriously enough 
1 2 3 4 
6. My accident/condition has put my body at 
risk for the rest of my life 
1 2 3 4 
7. Pain always means I have injured my body 1 2 3 4 
8. Just because Something aggravates my pain 
does not mean it is dangerous 
1 2 3 4 
9. I am afraid that I might injure myself 
accidently 
1 2 3 4 
10. Simply being careful that I do not make any 
unnecessary movements is the safest thing I 
can do to prevent my pain from getting 
worse 
1 2 3 4 
11. I wouldn’t have this much pain if there 
wasn’t something potentially dangerous 
going on in my body 
1 2 3 4 
12. Although my condition is painful, I would be 
better off if I were physically active 
1 2 3 4 
13. Pain lets me know when to stop exercising 
so that I don’t injure myself 
1 2 3 4 
14. It’s really not safe for a person with a 
condition like mine to be physically active 
1 2 3 4 
15. I can’t do all the things normal people do 
because it’s too easy for me to get injured 
1 2 3 4 
16. Even though something is causing me a lot 
of pain, I don’t think it is actually dangerous 
1 2 3 4 
17. No one should have to exercise when 
he/she is in pain 
1 2 3 4 
 
Score 
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Appendix 10 - Pain Disability Questionnaire 
Name 
Instructions: These questions ask your views about how your pain now affects how you 
function in everyday activities. Please answer every question and mark the ONE number 
on EACH scale that best describes how you feel. 
1. Does your pain interfere with your normal work inside and outside the home? 
Work normally Unable to work at all 
0 -------- 1 -------- 2 -------- 3 -------- 4 -------- 5 -------- 6 -------- 7 -------- 8 -------- 9 -------- 10 
2. Does your pain interfere with personal care (such as washing, dressing, etc.)? 
Take care of myself completely Need help with all my personal care 
0 -------- 1 -------- 2 -------- 3 -------- 4 -------- 5 -------- 6 -------- 7 -------- 8 -------- 9 -------- 10 
3. Does your pain interfere with your travelling? 
Travel anywhere I like Only travel to see doctors 
0 -------- 1 -------- 2 -------- 3 -------- 4 -------- 5 -------- 6 -------- 7 -------- 8 -------- 9 -------- 10 
4. Does your pain affect your ability to sit or stand? 
No problems Can not sit/stand at all 
0 -------- 1 -------- 2 -------- 3 -------- 4 -------- 5 -------- 6 -------- 7 -------- 8 -------- 9 -------- 10 
5. Does your pain affect your ability to lift overhead, grasp objects, or reach for things? 
No problems Can not do at all 
0 -------- 1 -------- 2 -------- 3 -------- 4 -------- 5 -------- 6 -------- 7 -------- 8 -------- 9 -------- 10 
6. Does your pain affect your ability to lift objects off the floor, bend, stoop, or squat? 
No problems Can not do at all 
0 -------- 1 -------- 2 -------- 3 -------- 4 -------- 5 -------- 6 -------- 7 -------- 8 -------- 9 -------- 10 
7. Does your pain affect your ability to walk or run? 
No problems Can not walk/run at all 
0 -------- 1 -------- 2 -------- 3 -------- 4 -------- 5 -------- 6 -------- 7 -------- 8 -------- 9 -------- 10 
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8. Has your income declined since your pain began? 
No decline Lost all income 
0 -------- 1 -------- 2 -------- 3 -------- 4 -------- 5 -------- 6 -------- 7 -------- 8 -------- 9 -------- 10 
9. Do you have to take pain medication every day to control your pain? 
No medication needed On pain medication throughout the day 
0 -------- 1 -------- 2 -------- 3 -------- 4 -------- 5 -------- 6 -------- 7 -------- 8 -------- 9 -------- 10 
10. Does your pain force you to see doctors much more often than before your pain 
began? 
Never see doctors See doctors weekly 
0 -------- 1 -------- 2 -------- 3 -------- 4 -------- 5 -------- 6 -------- 7 -------- 8 -------- 9 -------- 10 
11. Does your pain interfere with your ability to see the people who are important to you 
as much as you would like? 
No problem Never see them 
0 -------- 1 -------- 2 -------- 3 -------- 4 -------- 5 -------- 6 -------- 7 -------- 8 -------- 9 -------- 10 
12. Does your pain interfere with recreational activities and hobbies that are important to 
you? 
No interference Total interference 
0 -------- 1 -------- 2 -------- 3 -------- 4 -------- 5 -------- 6 -------- 7 -------- 8 -------- 9 -------- 10 
13. Do you need the help of your family and friends to complete everyday tasks (including 
both work outside the home and housework) because of your pain? 
Never need help Need help all the time 
0 -------- 1 -------- 2 -------- 3 -------- 4 -------- 5 -------- 6 -------- 7 -------- 8 -------- 9 -------- 10 
14. Do you now feel more depressed, tense, or anxious than before your pain began? 
No depression/tension Severe depression/tension 
0 -------- 1 -------- 2 -------- 3 -------- 4 -------- 5 -------- 6 -------- 7 -------- 8 -------- 9 -------- 10 
15. Are there emotional problems caused by your pain that interfere with your family, 
social and or work activities? 
No problems Severe problems 
0 -------- 1 -------- 2 -------- 3 -------- 4 -------- 5 -------- 6 -------- 7 -------- 8 -------- 9 -------- 10 
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Appendix 11 - Pain Self Efficacy Questionnaire 
Please rate how confident you are that you can do the following things at present despite 
the pain. To indicate your answer circle one of the numbers on the scale under each item, 
where 0= not at all confident and 6=completely confident. 
For example: 
  0 1 2 3 4 5 6 
Not at all confident      completely confident 
Remember this questionnaire is not asking whether or not you have been doing these 
things, but rather how confident you are that you can do them at present, despite the 
pain. 
1. I can enjoy things, despite the pain. 
Not at all confident 0 1 2 3 4 5 6 completely confident 
2. I can do most of the household chores (e.g. tidying –up, washing dishes etc.), 
despite the pain. 
Not at all confident 0 1 2 3 4 5 6 completely confident 
3. I can socialise with my friends or family members as often as I used to do, despite 
the pain. 
Not at all confident 0 1 2 3 4 5 6 completely confident 
4. I can cope with my pain in most situations. 
Not at all confident 0 1 2 3 4 5 6 completely confident 
5. I can do some form of work, despite the pain. (“Work” includes housework, paid 
and unpaid work). 
Not at all confident 0 1 2 3 4 5 6 completely confident 
6. I can still do many of the things I enjoy doing, such as hobbies or leisure activity, 
despite the pain. 
Not at all confident 0 1 2 3 4 5 6 completely confident 
7. I can cope with my pain without medication. 
Not at all confident 0 1 2 3 4 5 6 completely confident 
8. I can still accomplish most of my goals in life, despite the pain. 
Not at all confident 0 1 2 3 4 5 6 completely confident 
9. I can live a normal lifestyle, despite the pain. 
Not at all confident 0 1 2 3 4 5 6 completely confident 
10. I can gradually become more active, despite the pain. 
Not at all confident 0 1 2 3 4 5 6 completely confident 
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Appendix 12 - The Roland-Morris Disability Questionnaire 
 
When your back hurts, you may find it difficult to do some of the things you normally do. 
 
This list contains sentences that people have used to describe themselves when they have 
back pain. When you read them, you may find that some stand out because they describe 
you today. 
 
As you read the list, think of yourself today. When you read a sentence that describes you 
today, put a tick against it. If the sentence does not describe you, then leave the space 
blank and go on to the next one. Remember; only tick the sentence if you are sure it 
describes you today. 
 
1. I stay at home most of the time because of my back. 
2. I change position frequently to try and get my back comfortable. 
3. I walk more slowly than usual because of my back. 
4. Because of my back I am not doing any of the jobs that I usually do around the 
house. 
5. Because of my back, I use a handrail to get upstairs. 
6. Because of my back, I lie down to rest more often. 
7. Because of my back, I have to hold on to something to get out of an easy chair. 
8. Because of my back, I try to get other people to do things for me. 
9. I get dressed more slowly than usual because of my back. 
10. I only stand for short periods of time because of my back. 
11. Because of my back, I try not to bend or kneel down. 
12. I find it difficult to get out of a chair because of my back. 
13. My back is painful almost all the time. 
14. I find it difficult to turn over in bed because of my back. 
15. My appetite is not very good because of my back pain. 
16. I have trouble putting on my socks (or stockings) because of the pain in my back. 
17. I only walk short distances because of my back. 
18. I sleep less well because of my back. 
19. Because of my back pain, I get dressed with help from someone else. 
20. I sit down for most of the day because of my back. 
21. I avoid heavy jobs around the house because of my back. 
22. Because of my back pain, I am more irritable and bad tempered with people than 
usual. 
23. Because of my back, I go upstairs more slowly than usual. 
24. I stay in bed most of the time because of my back. 
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Appendix 13 - The Hospital Anxiety and Depression Scale 
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Appendix 14 - NHS permission letter for preliminary study 
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Appendix 15 - Participant study consent form 
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Appendix 16 - Participant study invitation letter 
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Appendix 17 - Participant study information sheet 
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Appendix 18 - NHS REC ethical approval letter 
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Appendix 19 - Insurance letter 
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Appendix 20 - Academic Sponsor letter 
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Appendix 21 - t test for pre to post intervention and pre to follow-up 
 
Variable 
name 
Baseline 
score 
(BS) 
Post 
score 
(PS) 
Mean 
change 
p-value 
(BS-PS) 
Follow 
up (FU) 
Mean 
change 
BS-FU  
p-
value 
BS-FU 
Fear of 
movement/re-
injury (TSK) 
40.9 33.6 -7.33 .001 33.0 -7.91 .001 
Anxiety 
(HADS) 
11.9 10.6 -1.33 .003 9.2 -2.76 .001 
Depression 
(HADS) 
9.8 7.4 -2.41 .001 6.3 -3.27 .001 
Disability/Low 
back pain 
(RMDQ) 
11.7 9.4 -2.32 .006 8.3 -3.36 .011 
Disability/multi
-site (PDQ) 
107.6 90.4 -17.15 .001 79.8 -28.10 .001 
Self-efficacy 
(PSEQ) 
25.4 35.5 +10.0 .001 35.5 +10.08 .001 
Speed of 
walking -timed 
walk >20 
metre  
21.7 17.7 -4.06 .001 17.5 -2.58 .001 
Distance 
covered in 5 
minutes in 
metres  
261.3 291.7 +30.42 .001 313.6 +45.16 .001 
Total number 
of Step ups in 
1 minute 
19.0 24.7 +5.68 .001 24.9 +6.09 .001 
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Appendix 22 – MMU ethical approval confirmation 
 
